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Gelukkig kon ik tijdens mijn promotie op een grote groep mensen steunen. Ik kan niet 
iedereen individueel noemen, maar ik wil enkelen in het bijzonder bedanken.
Jan van Hest heeft er allereerst voor gezorgd dat ik gericht bleef werken ondanks mijn 
brede interesse. Dank je wel voor je sturing en advies. De kwaliteit van dit proefschrift is 
verder te danken aan mijn co-auteurs en hun intellectuele ondersteuning bij het 
experimenteel werk en het schrijven. Goed onderzoek is slechts mogelijk binnen een 
stimulerende gemeenschap. Daarom wil ik mijn collegae bedanken voor een omgeving waar 
naast successen ook uitdagingen gedeeld kunnen worden. Mark Overhand en Matthijs van 
der Knaap zijn met hun gramicidine S varianten van groot belang geweest voor dit 
proefschrift. Henk Busscher, Eefje Engels en Lianne Lageveen stonden vervolgens altijd klaar 
om de praktische waarde van mijn synthetisch werk te evalueren met behulp van 
antibacteriële tests. Verder wil ik Renato Chirivi, TuHa Vong en Joris Meijer danken voor 
hun hulp bij de clickbare ELISA’s. De synthese van veel nieuwe peptiden zou onmogelijk zijn 
geweest zonder Hans Adams. De fluorescente probes van Sander van Berkel zijn van 
onschatbare waarde geweest bij de ontrafeling van de reactiviteit van de clickbare coatings. 
Marjoke Debets en Jan Dommerholt waren altijd bereid om mijn vragen rondom click 
chemie te beantwoorden. Tijdens de verschillende metingen kon ik altijd rekenen op Liesbeth 
Pierson, Barend van Lagen en Peter van Galen. Ik wil Pascal Buskens en zijn groep bedanken 
voor hun hulp bij de coating applicatie. Maaike van den Heuvel wordt bedankt voor haar 
dataverwerking.
Studenten vormen, naast het onderzoek, de andere belangrijke kant van mijn 
promotie. Ik heb genoten van het onderwijs dat ik heb mogen verzorgen; de uiteenlopende 
vragen van studenten dwongen mij scheikunde op een nieuwe manier te benaderen. Dank je 
wel voor deze lessen. Ik wil in het bijzonder mijn waardering uitspreken voor het werk van 
mijn stagestudenten Laurens de Haan, Criest van der Doelen, Chris Schaekens, Remko 
Aubert, Sander Groenen, Judith Rotink en Ralf ten Haaf.
Ik heb verder mogen profiteren van de interactie met de gebruikerscommissies binnen 
het STW en het ‘Pieken in de Delta’ project. Sommige suggesties zijn bepalend geweest voor 
de koers van mijn onderzoek. Een bijzonder voorbeeld is de opmerking van Ton Loontjens
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om ‘azides niet alleen te gebruiken voor de functionalisering, maar ook voor de cross-linking 
van de coating’.
Ook voor de vormgeving van dit proefschrift ben ik dank verschuldigd. Zo is de 
opmaak gebaseerd op een sjabloon van Ton Dirks. Touhami Ennadre wordt bedankt voor het 
beschikbaar stellen van zijn kunst en Joshua Quicken wil ik bedanken voor het ontwerpen 
van de kaft.
Onderzoek is een creatieve onderneming, waardoor werk en privé sterk verweven 
raken. Ik ben dan ook dank verschuldigd aan mijn familie en vrienden voor hun luisterend 
oor en bemoedigende woorden. Mijn paranimfen Stijn van Dongen en Bas Gerrits zijn 
daarnaast bijzonder waardevol geweest bij de afronding van mijn promotie. Delen van dit 
proefschrift hebben verder direct geprofiteerd van zorgvuldige tekstcorrecties door Emily 
Mackay, Haixia Hu en Evert van Steen.
Zoals altijd voel ik grote dankbaarheid jegens mijn moeder Angelina Kool en oma 
Anny Raijmaekers. Hun opofferingen maakten het mogelijk dat ik überhaupt aan mijn 
promotie kon beginnen. Ik hoop dat ik jullie trots heb kunnen maken.
En dit brengt mij eindelijk thuis. Mijn grootste dank gaat uit naar mijn vrouw Haili 
Hu die mij iedere dag weer van nieuwe energie en moed voorziet. Daarnaast heeft ze me ook 
direct geholpen bij de dataverwerking en het nalezen van dit proefschrift. De komst van onze 
zoon Evan Canalle heeft een nieuw licht geworpen op mijn leven. Zijn verwonderlijke blik 
herinnert mij hoe een echte onderzoeker de wereld dient te bestuderen.
Luiz Alberto Canalle 
September 2011
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Voorwoord
| M aterialen  als h o e k ste e n  van  d e  sam en lev in g
Materialen hebben altijd een centrale rol gespeeld in de menselijke geschiedenis. De 
sterke relatie tussen beschavingen en hun materiaalkennis komt tot uitdrukking in termen 
zoals de steentijd, bronstijd en ijzertijd. Materialen geven ons de mogelijkheid om zowel onze 
omgeving als onze samenleving te manipuleren. Nieuwe ideeën zijn vaak pas uitvoerbaar als 
de juiste materialen beschikbaar zijn.
De scheiding van de geslachten Homo en Australopithecus viel, niet geheel toevallig, 
samen met het gebruik van de eerste stenen gereedschappen. Het is nog steeds onzeker hoe 
groot het verschil in vakmanschap was tussen beide geslachten, maar het is waarschijnlijk dat 
de gereedschappen van Homo hen een voordeel gaven ten opzichte van Australopithecus, die 
uiteindelijk uitstierven.
Aanvankelijk maakten mensen gebruik van de materialen die natuurlijk voorhanden 
waren zoals steen, bot en hout. Ambachtslieden vervaardigden gereedschappen en wapens 
door uitsluitend de vorm van deze materialen te bewerken. De intrinsieke materiaal­
eigenschappen van de grondstoffen werden ongemoeid gelaten. De materiaaleigenschappen 
van klei bleken echter dramatisch te veranderen door het simpelweg te verwarmen. De 
keramiek die resulteerde, was het eerste materiaal dat door de mens zelf vervaardigd werd. 
Keramiek zorgde dat eten beter opgeslagen en getransporteerd kon worden. Deze nieuwe 
mogelijkheden droegen op hun beurt bij aan de overgang van jagen en verzamelen naar 
landbouw.
Steen en keramiek werden beperkt door hun brosheid. Dankzij de introductie van 
metalen konden mensen betere gereedschappen vervaardigen. Koperen ploegen waren 
bijvoorbeeld veel duurzamer dan stenen ploegen en vergrootten het landoppervlakte dat 
bewerkt kon worden. Door de grotere hoeveelheid voedsel konden nederzettingen vervolgens 
uitgroeien tot de eerste steden.
Ondanks het feit dat ijzer meer voorkomt op aarde dan koper, goud en zilver, duurde 
het veel langer voordat mensen ijzer en staal gingen gebruiken. Dit kwam doordat men veel
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hogere temperaturen nodig had om ijzer uit zijn erts te bevrijden. Zonder staal zou de 
stoommachine, en daarmee de industriële revolutie, echter onmogelijk zijn geweest.
Samenvattend kunnen we stellen dat nieuwe materialen een steeds complexere 
samenleving ondersteunen die op haar beurt alsmaar verfijndere materialen vervaardigd. 
Deze wisselwerking is zelfs in een stroomversnelling geraakt, waarbij nieuwe materialen 
steeds sneller grootschalig ingezet worden na hun aanvankelijke ontdekking. Na de 
ontdekking van ijzer, drieduizend jaar geleden, duurde het bijvoorbeeld nog honderden jaren 
voordat het algemeen beschikbaar werd. Aluminium kon, na zijn ontdekking in de 
negentiende eeuw, reeds binnen tientallen jaren economisch vervaardigd worden. Polymeren, 
die pas in de twintigste eeuw hun intrede maakten, werden zelfs binnen enkele jaren breed 
toegepast door de industrie.
| P olym eren
De eerste polymeren werden verkregen door natuurlijke grondstoffen te modificeren 
tot semi-kunstmatige materialen. In de negentiende eeuw werd hierin grensverleggend werk 
verricht met cellulose en rubber. Aan het begin van de twintigste eeuw werd Bakeliet®, de 
eerste volledig kunstmatige polymeer, geïntroduceerd.
Ondanks de snelle ontwikkeling in de synthese en toepassing van polymeren, duurde 
het tot de jaren twintig van de twintigste eeuw tot de moleculaire structuur van deze stoffen 
goed werd begrepen. Polymeren bestaan uit een groot aantal eenheden die herhaald worden 
in lange ketens, zoals parels in een parelketting.
Deze bijzondere structuur zorgt dat polymeren unieke eigenschappen hebben. Ze zijn 
lichtgewicht, makkelijk vervormbaar bij verhoogde temperaturen en de hardheid van het 
materiaal kan eenvoudig veranderd worden. Er is dan ook een breed spectrum aan 
voorbeelden variërend van zeer zachte materialen, zoals rubber, tot zeer stijve materialen, 
zoals Kevlar dat gebruikt wordt in kogelvrije vesten. Deze variabiliteit heeft ervoor gezorgd 
dat polymeren uiteenlopende toepassingen hebben gevonden.
| B iofu n ction ele  m ateria len
Tot nu toe heeft de mens voornamelijk materialen gebruikt vanwege hun fysische 
eigenschappen. Voorbeelden omvatten de hardheid van staal, de optische kwaliteiten van glas 
en het geleidend vermogen van silicium. In de éénentwintigste eeuw zullen steeds meer 
kunstmatige materialen ook interactie hebben met biologische systemen.
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Kunstmatige materialen die chemische interacties kunnen hebben met cellen op 
moleculair niveau, worden biofunctionele materialen genoemd. Deze materialen kunnen 
actief deelnemen in de biologische processen van de cel en ze zelfs beïnvloeden. 
Biofunctionele materialen zouden bijvoorbeeld de groei van cellen kunnen aansturen en 
daarmee als ondergrond kunnen dienen voor de groei van nieuwe organen voor 
transplantaties. Bacteriewerende oppervlakten vormen een alternatieve toepassing, waarbij 
antibacteriële stoffen onderdeel zijn van het biofunctionele materiaal en zodoende 
voorkomen dat bacteriën zich op het oppervlak kunnen nestelen. De interactie tussen 
biofunctionele materialen en biologische systemen kan ook gebruikt worden in sensoren 
tegen ziekteverwekkers. Deze nieuwe materialen zullen, net zoals voorgaande innovaties, 
verregaande gevolgen hebben voor de mensheid.
| H et v e rrich te  o n d e rz o e k
Eiwitten spelen een centrale rol bij de biologische processen binnen de cel. Veel 
eiwitten versnellen chemische reacties en ze zijn essentieel bij de stofwisseling van de cel. 
Eiwitten zijn ook belangrijk bij andere processen in het lichaam, zoals transport, 
communicatie en regulatie. De verfijning waarmee eiwitten bij dit alles te werk gaan, overtreft 
alles wat de mens kan produceren.
Eiwitten zijn aantrekkelijke componenten bij de vervaardiging van biofunctionele 
materialen. Eiwitten zijn echter zeer gevoelig voor veranderingen in temperatuur en 
zuurtegraad. Het is ook moeilijk om eiwitten op een oppervlakte vast te zetten. Deze 
problemen kunnen opgelost worden door eiwitten te koppelen aan polymeren. De polymeren 
beschermen de eiwitten en dienen als draagvlak. Door de complexe structuur van eiwitten is 
het echter moeilijk om ze op een gecontroleerde manier te koppelen aan polymeren. 
Traditionele chemische reacties geven allerlei bijproducten die de biologische activiteit van 
het uiteindelijke biofunctionele materiaal negatief beïnvloeden.
Tijdens ons onderzoek waren we continue op zoek naar de nieuwste chemische 
reacties die zo efficiënt èn selectief mogelijk waren. Onze eerste pogingen maakten gebruik 
van een koper katalysator, deze zorgde echter voor verschillende problemen. Koper werd 
gemakkelijk gedeactiveerd door zuurstof waardoor de koppeling moeilijk verliep. Koper 
stoorde ook met de functionaliteit van de uiteindelijke materialen. Binnen onze 
onderzoeksgroep werden tijdens dit project nieuwe chemische technieken ontwikkeld die 
geen koper nodig hadden. Deze geavanceerde chemische koppelingen werden vervolgens 
door ons aangewend bij de vervaardiging van biofunctionele materialen. De succesvolle
14 Voorwoor
toepassing hiervan werd niet alleen beschreven in verschillende internationale tijdschriften, 
maar werd ook beloond met een Europees patent.
Deze technologie opent de weg naar een veeltal nieuwe biofunctionele materialen. Dit 
proefschrift beschrijft onder andere hoe deze technologie aangewend kan worden voor de 
vervaardiging van bacteriewerende oppervlaktes en medische sensoren. Deze laatste 
toepassing wordt momenteel door ModiQuest, Euro-Diagnostica en Synaffix verder 
ontwikkeld tot een volwaardig product.
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Introduction
1.1 | B iofunction al m aterials
Since the discovery of Bakelite® at the beginning of the twentieth century, 1 synthetic 
polymers have been used as construction materials and have increasingly replaced natural 
materials such as wood, cotton, and wool. This development has not only been fuelled by the 
low production cost and easy processability of polymers, but also by their easily tuneable 
mechanical properties. There is now a growing interest in developing materials that not only 
have tuneable physical properties, but are also biologically active. The surface of a material 
plays an important role in this, as it determines the interaction between the material and its 
environment. The introduction of biochemically active compounds to the surface allows 
materials to respond to, and operate within, complex biological systems, such as cell cultures, 
or even the human body. The presence of these bioactive materials opens up a whole new set 
of applications; a variety of prominent examples is discussed briefly below.
Biosensors are analytical devices that combine a biochemically sensitive element on 
the surface of the device with a physical or chemical transducer in order to quantitatively 
detect specific compounds in a given external environment.2 The biochemically sensitive 
element either reacts or binds with the target compound from the sample. The resulting 
change from this recognition event can be subsequently registered by various methods 
ranging from optical spectroscopy3-5 or microfabricated cantilevers, 6 to electrochemical 
techniques such as surface plasmon resonance7 and impedance spectroscopy.8 Depending on 
the applications of the biosensor, target compounds can range from biologically active agents 
and biomarkers for certain diseases to toxic materials and environmental pollutants.9
Tissue engineering is another area in which bioactive materials have a stimulating 
effect on their environment. Bioactive materials can act as physical scaffolds thereby 
controlling cell adhesion, migration, and differentiation. By acting in this way the bioactive 
materials ensure that the manufactured tissue or organ has the appropriate size and shape. 10 
Tissue growth and organization is guided by molecular cues that mimic certain aspects of 
structure or function of the natural extra-cellular microenvironments of multicellular 
organisms. In order to create fully functional structures, these molecular clues do not only
1
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require a suitable spatial organization, but must also be presented in the proper temporal 
manner.
Additional medical applications for bioactive materials can be found in bio-implants 
that range from orthopaedic implants, which replace load-bearing joints, to ophthalmic 
devices such as intraocular lenses, and cardiovascular prostheses including synthetic heart 
valves. 10 Bioactive materials can control the cell and tissue responses to these implants by 
providing proper molecular signals. Depending on the application of the bio-implant, the 
material might have to stimulate cell adhesion as mentioned, be resistant to biofouling, or 
have antimicrobial activity.
Bacteria can readily colonize the surfaces of synthetic materials, which can be a source 
of infection. As the growing colony encapsulates itself with a protective exocellular bacterial 
polysaccharide layer, the biofilm becomes much harder to combat than bacteria that freely 
circulate in solution. 11 Therefore, there is an increasing need to reduce the bacterial 
colonization of surfaces. This can be achieved by employing surfaces that are equipping with 
features that are unfavourable for bacterial attachment and growth. These antimicrobial 
surfaces can be divided into two categories: bacteriostatic surfaces, which limit the growth of 
bacteria, and bactericidal ones, which actively kill bacteria. Applications are found in 
medicine where the sterilization of implants and devices is essential, but also extend to water 
and air purification and the packaging industry. 12
These examples not only illustrate the potential of bioactive materials, but also 
demonstrate that this is a very broad and rapidly expanding field. This thesis concentrates on 
new and flexible strategies for the production of bioactive -  specifically antimicrobial -  
surfaces.
1.2 | Traditional antim icrobial coatin gs
For the production of antimicrobial coatings, those antibiotics active against a wide 
range of bacteria are selected. Roughly speaking, one can distinguish two methods for the 
preparation of antimicrobial coatings. 12 A polymer can simply be mixed with an organic or 
inorganic antibiotic during processing. As the antibiotic is not covalently linked to the 
polymer, the antibiotic slowly leaches out of the polymeric blend, killing bacteria in close 
vicinity of the material. A disadvantage of this slow release to the environment is that the 
material consequently loses its antimicrobial activity over time. Furthermore, this blending 
method exposes bacteria to relatively low concentrations of antibiotics for a prolonged time 
span, which can trigger the building up of resistance in the bacteria.
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Alternatively, a polymeric material can be prepared, onto which the antibiotic is 
covalently linked. This can be achieved by either polymerizing monomers that contain an 
antibiotic moiety or by attaching the antibiotic to a reactive side-chain functionality on a pre­
fabricated polymer chain. Exposure of the antibiotic on the surface of the final material 
subsequently provides the biological activity. The covalent immobilization of the antibiotic 
circumvents the disadvantages of the blending method, but also limits the choice of suitable 
antibiotics. As the antibiotic can no longer enter the bacterial cell, it has to be active on the 
bacterial membrane. The actual effectiveness of the final material is also determined by the 
spacer length between the polymer backbone and the antibiotic, as this determines the 
freedom with which the antibiotic can move. 12
Silver ions are the most widely used antibiotic employed in blending. 13 They can be 
mixed with a polymer and the subsequent release rate correlates with the antimicrobial 
activity of the polymeric coating. The big advantage of silver ions lies in the combined high 
antimicrobial activity and remarkably low human toxicity. Silver ions primarily act by 
displacing essential metal ions, such as those of calcium or zinc, from the active sites in 
proteins. Alternatively, silver ions can also bind to bacterial DNA which in turn can inhibit a 
number of important transport processes, interact with cellular oxidation processes and 
disturb the respiratory chain.
Alternative antibiotics14 used in blending include small organic antibiotics such as 
triclosan and allyl isothiocyanate. Simple acids like propionic, benzoic, sorbid, or acetic acid 
can also be added to coatings and work by simply acidifying the direct environment of the 
coating when released. A more unusual approach is the incorporation of enzymes in the 
polymeric blend. Examples include lysozyme, which damages the bacterial cell wall by 
hydrolysing peptidoglycans, or glucose oxidase, which releases highly reactive hydrogen 
peroxide after glucose metabolism.
Where antibiotics are covalently linked, cations are the most widely used. By linking 
them to a polymeric chain, a macromolecular polycation is created that has antimicrobial 
activity and can be applied to a surface. Ammonium salts are most commonly used, but 
biguanide groups, pyridinium salts, phosphonium salts and sulfonium salts have also been 
investigated. 12 Chitosan is another cationic polymer, and is obtained by deacetylation of 
chitin, which is the main component of the exoskeletons of arthropods such as shrimps and 
crabs. 15 All these polycations have similar modes of action and target the cytoplasmic 
membrane of bacteria. Their preference for bacterial membranes over the membranes of 
plants and animals is caused by the different charge distribution in these structures. Whereas 
the outermost leaflet of bacterial membranes is heavily populated by lipids with negatively 
charged phospholipid headgroups, the outer leaflet of the membranes of plants and animals is
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composed principally of lipids with no net charge. In these membranes the negatively charged 
lipids are located on the inner leaflet, which shields them from the outer environment. After 
binding to the bacterial membrane, the polycations disrupt the lipid bilayer like a needle 
bursting a balloon. The increase in permeability of the membrane causes death through the 
loss of essential cellular materials. Of those understood, the exact mechanism by which the 
membrane is disturbed varies for each polycation. 16 Interestingly, it has been shown that 
several of these cationic polymers exhibited higher antimicrobial activities in solution than 
their corresponding low molecular weight monomers. 12 The higher activity of the 
polycationic compounds has been interpreted as a result of the electrostatic interaction, which 
causes the initial absorption of these positively charged antibiotics onto the negatively 
charged bacterial cell surface. As the charge density carried by the polycations is greater than 
that of the monomeric cations, absorption is expected to take place more efficiently, leading 
to greater membrane disruption. 17
1.3 | A ntim icrobial p ep tid es  an d  th eir p ep tid e -p o ly m er b io co n ju g a te s
Antimicrobial peptides (AMPs) are produced by both eukaryotes and prokaryotes and 
are an important part of their defence against microorganisms. 18 They have a broad-spectrum 
activity and can target both Gram-positive and Gram-negative bacteria. Despite their ancient 
origin, AMPs remain effective weapons against bacteria, demonstrating how difficult it is for 
bacteria to develop resistance to these antibiotics.
Although there is a great diversity of amino acid sequence, AMPs are nearly all 
cationic. Furthermore, most AMPs can assume a shape in which clusters of hydrophobic and 
cationic amino acids are spatially separated from one another. This amphiphilic structure 
targets the bacterial membrane in much the same way as polycationic polymers. The 
proposed mechanisms for the subsequent disruption of the lipid bilayer are almost as diverse 
as their amino acid sequence and include the depolarization of the bacterial membrane, 19 the 
creation of physical holes or channels that cause cellular contents to leak out, 20 the activation 
of deadly processes such as induction of hydrolases that degrade the cell wall, 21 the scrambling 
of the lipid distribution within the membrane, 22 and the damaging of intracellular targets after 
internalization of the peptide. 23
A downside of these peptides is that they are not completely selective towards 
bacteria. Their antibacterial activity is often accompanied by haemolysis, the breakdown of 
red blood cells. However, there are many examples of analogs of natural antimicrobial 
peptides being synthesized with decreased haemolytic activity.24-30
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The broad-spectrum activity of AMPs makes them attractive candidates for the 
development of a new class of antimicrobial coatings. As interest in the in vivo functions of 
mammalian AMPs is increasing, it is becoming still clearer that they can also stimulate and 
enhance the adaptive immune system of the host, 31 making them especially attractive 
antibiotics for the incorporation into antimicrobial bio-implants. However, studies 
concerning the use of AMPs in antimicrobial coatings32-35 have been limited. This thesis will 
therefore further explore the potential applications of AMPs by covalently coupling 
antimicrobial peptides to synthetic polymers. The antimicrobial activity of the resulting 
peptide-polymer bioconjugates will be subsequently evaluated and can act as a guide for the 
future optimization of the system.
1.4 | Thesis ou tlin e
Although peptides offer the possibility of introducing an array of functions to peptide­
polymer bioconjugates, they are also chemically complicated molecules, which contain many 
different kinds of reactive group. This imposes special requirements on the chemistry used 
when constructing peptide-polymer bioconjugates. Chapter two provides an overview of the 
strategies and methods that have been developed for the synthesis of these hybrid systems.
Prime examples of such methods are the so-called ‘click’ reactions. Besides the broadly 
applied copper-based version, several copper-free alternatives have been developed recently, 
in order to restrict the use of copper as much as possible, because of its inherent toxicity. 
These novel methods have been used in the synthesis of peptide-polymer bioconjugates, with 
good control over the architecture of the product. Until now click chemistry has been mostly 
limited to the construction of head-to-tail coupled peptide-polymer bioconjugates. An 
attractive alternative, however, is the comb-shaped structure where peptides are installed as 
side-chain groups along a polymer backbone. The resulting high loading capacity is 
favourable for bioconjugates with AMPs, where multiple copies of the peptide have to be in 
close proximity in order to become active. Chapter three describes the scope and limitations 
of copper-free click reactions for the construction of comb-shaped bioconjugates in solution.
Lessons learned were used for the development of a copper-free clickable coating. 
Chapter four primarily describes the coating formulation and application. Several click 
reactions were used to immobilize fluorescent probes, which allowed reactions to be followed 
over time and compared.
Chapter five extends the assessment of the coating technology from chapter four 
towards the immobilization of AMPs. The fact that these big and complicated peptides can be 
immobilized using the same methods as the small fluorescent probes, underlines the modular
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and robust nature of the developed technology. The resulting hybrid coatings showed no 
significant antimicrobial activity, and therefore the chapter concludes with several 
suggestions to improve their activity.
Peptides and proteins in general fulfil a wide variety of tasks within biology, ranging 
from catalysis to receptor-ligand interaction. Changing the peptide component in the 
bioconjugate system opens up a wide range of application. The technology developed within 
this research project is therefore not only applicable to the creation of antimicrobial coatings, 
but is also relevant for the construction of other types of biofunctional material, such as 
catalytic surfaces and biosensors. Chapter six describes the adaptation of the outlined coating 
technology for the fabrication of biosensors, which ultimately led to the development of a 
successful enzyme-linked immunosorbent assay (ELISA) against rheumatoid arthritis.
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Conjugation techniques
2.1 | In tro d u ction
Traditionally, synthetic polymers have mainly been exploited for their structural 
properties and as such have successfully replaced natural materials in a wide variety of 
applications. A reason for their success is that synthetic polymers can be obtained in a large 
range of compositions and architectures, which allows for a convenient fine tuning of their 
properties. However, even with the current synthetic techniques, there is still limited control 
over monomer composition and molecular weight. A synthetic polymer sample is therefore a 
mixture of many different macromolecules, which makes it difficult to translate information 
from the single polymer chain to the polymeric ensemble.
On the other hand, naturally produced peptides or proteins can be regarded as highly 
refined polymers. They are monodisperse and have a precisely defined primary sequence, 
which allows them to hierarchically fold and organize into three-dimensional structures. This 
permits polypeptides to exhibit (bio)functional features like catalysis or receptor recognition. 
As a downside to this delicate folding behaviour, proteins are sensitive to temperature and pH 
changes. They have furthermore limited solubility in organic solvents, are susceptible to 
enzymatic degradation, and their use in biomedical applications can be restricted by their 
possible toxicity and undesired elicited immune response.
In this chapter, we will focus on synthetic pathways that can be used to combine 
synthetic polymers with proteins or peptides. The chemistry and synthetic strategies involved 
in the construction of these hybrid conjugates have become more selective and specific in 
recent years, resulting in better defined polypeptide-polymer bioconjugates. The resulting 
bioconjugates can synergistically combine the properties of the individual components and 
overcome their separate limitations. The protein or peptide element can impart 
(bio)functional properties to the bioconjugate, whereas the polymer component can improve 
protein stability, solubility and biocompatibility. The synthetic polymer can also introduce 
new properties such as self-assembly and phase behaviour and even modulate protein activity. 
This emerging multidisciplinary field has opened the door to a wide range of applications 
which will not be discussed in this chapter, but have been extensively reviewed in recent 
literature. 1-7
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2.1.1 | Specificity
Most traditional conjugation methods rely on a nucleophilic attack of a functional 
group of an amino acid side-chain in the polypeptide on an appropriate electrophilic centre 
within the synthetic polymer. Due to the polyfunctional nature of proteins and peptides 
however, such approaches ultimately lead to a mixture of products.
As a result, the search for more specific modification methods has been the topic of 
significant academic research during the last decade. Site specific modifications would first of 
all help with the purification and characterization of the obtained products, because mixtures 
are avoided. Furthermore, if the modification is directed to a specific location, the protein 
activity might be better preserved. For instance, the site of the polymer conjugation can be 
located far away from the active site to avoid interference with the biological functioning of 
the protein. Alternatively, it can also be located nearby, or even within the active site, in order 
to control the biological activity of the protein.
No universal technique exists to date, but significant advances have been made in the 
development of more specific methods.8 When using naturally occurring functionalities in 
proteins or peptides there has been a trend to modify amino acid targets that are less 
common. Alternatively, the conjugation step can be carried out under conditions directing 
the availability of the modification sites. Examples are the use of protective groups on 
peptides or the blockage of the active site of proteins with a substrate during the conjugation 
reaction. In some cases biochemical approaches are used, such as mutagenesis to limit the 
amount of accessible, reactive amino acids, or the use of enzymes to enhance the 
regioselectivity of the conjugation reaction. In addition, unnatural functionalities can be 
introduced into proteins and peptides. Because this introduces a bigger palette of potential 
chemical transformations, it is possible to establish bio-orthogonal coupling methodologies 
which tolerate a diverse array of natural functionalities. A less used method is to couple the 
protein and polymer via non-covalent interactions using, for example, natural cofactors.
2.1.2 | A rch itectu re
The architecture of the bioconjugate has to be adjusted to the application for which it 
is developed. The most common architecture is the head-to-tail conjugate (Figure 1.1A). This 
set-up can be described as a linear AB block copolymer where the polymer serves as one block 
and the protein or peptide as the other. This architecture is often used for conjugates where 
polymers act as protective shields around the biomolecule. Alternatively, one can imagine a 
comb-shaped structure with peptides or proteins installed as side-chain groups on a polymer 
backbone (Figure 1.1B). The high loading capacity of this architecture makes it an interesting
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drug delivery system. It can furthermore be a favourable architecture in cases where the 
bioactivity is related to having multiple copies of a peptide in close proximity of each other. 
The density of the biomolecules can be increased even further by using dendrimers as the 
support structures (Figure 2.1C).
Figure 2.1 | Cartoon representation of the most common architectures of bioconjugates. The curved 
lines represent the synthetic polymer com ponent and the ellipses the peptide or protein: A) Head-to-tail 
conjugate, B) Comb-shaped structure, C) Dendritic architecture.
2.1.3 | S tra te g y
This chapter will be structured around the three different strategies used for the 
synthesis of polypeptide-polymer bioconjugates.
The grafting to strategy is the most well-established and involves the coupling of a 
preformed polymer with a protein or peptide. Because this strategy tries to bring two 
macromolecules together, the coupling reaction has to be very efficient. This demanding 
coupling can sometimes be aided by an indirect functionalization. In this context the protein 
is not reacted directly with a polymer, but is rather linked to a heterofunctional spacer first. In 
this way a more reactive secondary functionality is introduced into the protein which 
alleviates problems associated with the lack of reactivity when bringing two large molecules 
together.
The grafting from  strategy is based on a polymer chain propagating (growing) from a 
protein or peptide surface. In this set-up the protein or peptide acts as a macroinitiator. 
Consequently, an initiating moiety needs to be introduced into the biological molecule. This 
strategy has only become practical since the advance of controlled radical polymerization 
(CRP) 9 techniques which tolerate a wide variety of functional groups within the reaction 
mixture and can be performed under benign conditions. Alternatively, a peptide can be 
grown from a preformed synthetic polymer serving as the macroinitiator.
Finally, the grafting through strategy involves the polymerization of peptide- 
functionalized (macro)monomers. Peptides are functionalized with a polymerizable group 
which serves as a handle to string the monomeric units together, thus resulting in a comb­
shaped structure with a high density of peptides.
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When compared to grafting to, grafting from  and grafting through have the potential to 
facilitate an efficient synthesis of bioconjugates, because at first only a small component needs 
to be coupled to the protein or peptide after which the polymer component is grown in a 
stepwise fashion.
2.2 | G rafting to  using n atu ral fu n ction alities
2.2.1 | A m ine co n ju g atio n
The first-generation of methods that were developed to create protein polymer 
hybrids under mild chemical conditions were based on reactions between the activated 
hydroxyl group of poly(ethylene glycol) (PEG) chains and primary amines from proteins. 10 
The latter groups are abundantly present on the surface of proteins in both lysine residues 
and the N-terminus. This facilitates easy functionalization by both alkylation, which 
maintains the positive charge of the protein at physiological pH, and acylation, which is 
accompanied by loss of charge at the conjugation site.
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Scheme 2.1 | First-generation conjugation methods, which use activated hydroxyl groups for the 
functionalization of primary amines from peptides and proteins via alkylation and acylation.
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The oldest PEGylation method uses cyanuric chloride.11, 12 Originally, cyanuric 
chloride was used in industrial applications to covalently couple dye molecules to fabrics. 
After being coupled to PEG, the second chloride of the PEG dichlorotriazine derivative (1) 
can easily react with amines from a protein at room temperature and at pH 9 to form a 
secondary amine linkage (2) . 10 A drawback of dichlorotriazine activated PEG, however, is that 
it can react with other nucleophilic residues, such as cysteine, serine, tyrosine and histidine. 
Moreover, the third chloride, while less reactive, can still partially react with nucleophilic 
groups, which can result in cross-link formation. A way around this problem is to decorate 
cyanuric chloride with two PEG chains before conjugation, leaving only one chloride on the 
triazine ring available for coupling with the protein. 13 A final important consideration for in 
vivo applications is still the potential toxicity of cyanuric chloride and its derivatives.
Another reagent that was designed to couple proteins to polymers via a secondary 
amine is tresylate (3 ) . 14 PEG tresylate has the advantage over PEG dichlorotriazine that it has 
a higher specificity towards amines. However, it was shown that during the conjugation with 
small amines, PEG tresylate does not always simply react by the familiar C-O cleavage process 
associated with sulfonic esters (4). Conjugation can also occur through a sulfoacetamide 
linkage (5).15, 16 Because the resulting sulfoacetamide linkage is more susceptible to hydrolysis, 
the formation of such a heterogeneous mixture can hamper the applicability of this method.
Reacting the hydroxyl end-group of PEG with epichlorohydrin allows a terminal 
epoxy moiety to be introduced. The epoxy-functionalized PEG (6 ) can subsequently be 
employed to modify the polymer chain with a protein by amine bond formation (7 ) . 17
Another widely used method for the activation of PEG towards amines uses N- 
hydroxysuccinimide esters (NHS). The NHS ester can be introduced into a PEG polymer 
chain by coupling it to the carboxylic acid of succinylated PEG. 18 The succinimidyl succinate 
PEG (8 ) which is formed is highly reactive towards amines at physiological pH and forms 
amide bonds with proteins (9). The major drawback of this method is the potential hydrolysis 
of the ester bond of succinylated PEG. A way to avoid this problem is coupling of NHS to the 
PEG chain via a carbonate group (10).19, 20 The carbamate bond that is formed after 
conjugation with a protein (11) is very stable against hydrolytic cleavage. Interestingly, the 
reactivity of the NHS ester appears to decrease when the distance between the activated ester 
and the PEG backbone is increased. This was illustrated when the spacer molecule was 
extended from a propionic acid to a butanoic acid. 21 The reactivity was further decreased by 
introducing an a-branching methyl group into the spacer. This difference in reactivity was 
attributed to the steric hindrance of the extra branching moiety, demonstrating the subtlety of 
this coupling process.
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In the abovementioned cases the NHS group was introduced into the polymer chain 
in a post-polymerization modification process. In order to avoid possible problems that can 
arise from this approach, such as incomplete modification, NHS-functionalized initiators (17 
and 18) have been employed to build up a functional polymer chain (Scheme 2 .2 ). This 
approach was shown to be successful for the synthesis of polymethacrylates using atom 
transfer radical polymerization (ATRP).22, 23 In accordance to the decreased reactivity of the 
propionic- and butanoic-based NHS ester after introducing a branching moiety, 21 it was also 
found that when the NHS-functionalized initiator 17 was replaced by initiator 18 the 
resulting polymer was unable to couple to the protein.
Scheme 2 .2  | NHS-functionalized ATRP initiators.
Other activated esters that have been used to couple polymers to proteins via acylation 
include p-nitrophenyl carbonate (12) , 24 trichorophenyl carbonate (13),24 imidazole carbamate
(14),25 pentafluorophenyl ester (15, R = F) 26 and its more water soluble counterpart 4-sulfo- 
2,3,5,6-tetrafluorophenyl ester (15, R = SO3Na) 27 (Scheme 2.1). All these derivatives are less 
reactive than the above mentioned succinimidyl carbonate. Generally speaking, however, a 
lower activity of the coupling moiety will result in a higher selectivity towards a specific 
amino acid residue within the protein.
Until now we have seen strategies where polymers are first functionalized with a 
reactive group and then coupled to a peptide in a separate step. Instead, conjugation can also 
be accomplished directly by activating the polymer in situ with the use of a carbodiimide.28 In 
this manner, the carboxylic group of succinylated PEG18 was activated and coupled to various 
peptides. 29 When using organic solvents, N,N’-diisopropyl carbodiimide (19, DIC) is the 
coupling reactant of choice. The water-soluble 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (20, EDC) is suitable for reactions in the aqueous phase.
17 18
Scheme 2 .3  | Structures of the carbodiimides DCC and EDC.
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A drawback of PEGylation, and of bioconjugation with polymers in general, is the 
polydisperse nature of the polymeric part of the conjugates, which could lead to populations 
of structures with different biological properties. Such can of course be circumvented by 
making use of monodisperse polymers as has been elegantly demonstrated by Kochendoerfer 
et. al.30 A second, more prominent, limitation arises from the heterogeneous nature of the 
bioconjugates synthesized with the abovementioned first-generation PEGylation methods. 
Because the attachment of the PEG chains via these methods is non-specific, products 
generally suffer from a severe loss in bioactivity, ranging from 2 0 % to 95% . 31 This illustrates 
the requirement and importance of site-selective conjugation methods. Possibilities to gain 
the needed control over the macromolecular architecture of the bioconjugates will be 
discussed in the next sections.
2.2.2 | A ctive site  b locking during co n ju g atio n
One possibility to get better selectivity over the synthesis of the bioconjugates, is to 
shield the active site of the enzyme or the recognition area of the protein during the coupling 
reaction (Figure 2.2). To achieve this, an inhibitor, a substrate or a ligand can be used to 
cover the reactive groups in the sensitive areas. This strategy was first illustrated by Veronese 
et. al. by protecting the enzyme trypsin with benzamidine during conjugation with an NHS- 
activated PEG chain. 32 In a related example, 33 avidin was PEGylated in the presence of a 
biotin-PEG conjugate as a protective agent. Shielding of avidin’s biotin binding site proved 
effective during conjugation of large PEG chains (10 and 2 0  kDa). However, in the case of 
smaller PEG chains (5 kDa) this protection strategy had no positive effect on the affinity of 
the resulting avidin conjugate.
nh2 n h2
Figure 2 .2  | Active site blocking during bioconjugation. An inhibitor, substrate or ligand is added during 
the conjugation step, thereby shielding the reactive groups in the sensitive area (marked with a cross).
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2.2.3 | M u tag en esis
A second method to increase the selectivity of the above described first-generation 
conjugation reactions is to limit the availability of the reactive groups in the protein by 
replacing reactive amino acids by non-reactive ones, using mutagenesis. Following this 
strategy Yamamoto et. al. prepared a phage library expressing tumor necrosis factor-a  
(TN F-a) in which all lysine residues were replaced by other amino acids. After screening 
the library, a TN F-a mutant was isolated which was fully bioactive. Since the N-terminus 
was the only remaining primary amine, this position could be specifically PEGylated 
using standard succinimidyl chemistry.34-36 A similar strategy was successfully employed for 
the conjugation of epidermal growth factor (EGF) to PEGylated liposomes.37 However, 
removing lysines from a protein structure can be a risky strategy. When adapting this 
approach to interferon-ß-1b (IFN-ß-1b) the biological function of the protein was completely 
lost.38 In such instances, other ways for increasing the specificity of the conjugation reaction 
have to be explored.
2.2 .4  | Solid p h ase
In solid phase peptide synthesis (SPPS)39 an amino acid is first anchored with its C- 
terminus to a swollen cross-linked polystyrene resin. In suspension, sequential deprotection 
and addition of N-protected amino acids affords a growing peptide chain in a stepwise 
fashion. Cleavage from the resin support finally affords the final product.39,40 Because the 
solid support can be purified from unreacted substrates and by-products by simple filtration, 
coupling reactions can be driven to high conversions using large excesses of reagents. 
Furthermore, as all reactive amino acid side groups are protected during the synthesis, 
selectivity problems are avoided. In this way, the N-terminus of the synthetic peptide can not 
only be reacted with an amino acid, but can also be specifically coupled with a polymer chain 
functionalized with a carboxylic acid or succinimidyl moiety.41, 42 After cleavage from the resin 
and side-chain deprotection, the crude product can be purified using dialysis or reverse-phase 
high-performance liquid chromatography (HPLC). However, this approach is limited by both 
the molecular weight of the polymer which is coupled and the nature of the N-terminal amino 
acid.43 Unhindered amino acids such as glycine were functionalized quantitatively with PEG 
derivatives with molecular weights of up to 5000 g/mol. PEGylation of hindered amino acids 
such as isoleucine only proceeded smoothly with polymers with molar masses below 200 
g/mol. These limitations are due to the reduced end-group reactivity of larger polymers and 
their decreased diffusion rates into the cross-linked resin.
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A polymer can also be selectively coupled to the C-terminus of a peptide by first 
attaching a polymer to the solid support, followed by the subsequent assembly of the peptide 
from the polymer using standard solid phase chemistry.44 This approach can be seen as a first 
example of the grafting from  strategy, which will be discussed in more detail in section 2.5. 
When a PEG chain is planned as the synthetic component, the commercially available 
Tentagel PAP resin can be used. This resin consists of a polystyrene matrix and a pre-attached 
PEG chain with a labile benzyl ether linkage. From this PEG chain the peptide can directly be 
built up as the bioconjugate.45-50 By combining both strategies for the functionalization of the 
C- and N-terminus, an ABA triblock was synthesized with two outer polystyrene blocks.51
Besides modification of the peptide termini, amino acid side-chains can also be 
conjugated with polymers during a SPPS procedure. Lu and Felix developed two routes for 
the site-selective PEGylation of lysine and aspartic acid residues.44 In the first route, the 
targeted amino acid was first coupled to a PEG chain and then built into the peptide during 
solid phase synthesis. In the second route, the peptide was first synthesized on the solid 
support with N£-allyloxycarbonyl lysine or ß-allyl aspartate at the conjugation site. These 
orthogonal protection groups were removed selectively after which the peptide was site- 
selectively PEGylated, while still on the resin.
Bayer and Mutter used the concepts from SPPS and transformed them into a liquid­
phase procedure.52 Peptides were assembled on a linear PEG support in a homogeneous 
solution. After each step, excess reagents and by-products were removed by membrane 
dialysis or precipitation of the growing peptide in diethyl ether. The advantage of this method 
is that intermediate products can be analyzed using standard techniques such as NMR. The 
method has however never found widespread application in the synthesis of peptide polymer 
conjugates, possibly because it can be difficult to find the optimal synthetic conditions.
2.2.5 | R ed u ctive alkylation
As the s-amine group on lysine and the primary amine at the N-terminus have 
different pKa’s, (about 10.0-10.2 and 7.6-8.0, respectively) , 53 their difference in reactivity 
under slightly acidic conditions can in principle be utilized for the selective functionalization 
of the N-terminus with the previously mentioned activated esters. In practice, however, this is 
very difficult because of the reactive nature of these esters and only a few successful examples 
are known.54, 55 An alternative for achieving specific conjugation is changing the chemistry 
used. One possibility is to introduce an aldehyde on the polymer chain ( 2 1  ) , 56 that can be 
coupled to an amine and form a Schiffs base (2 2 ). This intermediate is reduced in the 
presence of sodium cyanoborohydride to a stable secondary amine (23).57-61 Using this
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reductive alkylation method, selective functionalization of the N-terminal amine group is 
possible38, 62-64 while leaving the lysine side-chain amines untouched.
Scheme 2 .4  | Mechanism of the reductive alkylation.
Reductive alkylation proves to be quite efficient. When comparing immobilization 
methods for human serum albumin (HSA) to monoliths composed of methacrylate-based 
polymers,65 the reductive alkylation protocol resulted in a more efficient immobilization than 
the epoxy, 17 succinimidyl carbonate19, 20 and carbodiimide28 methods.
However, reductive alkylation has as a drawback the use of sodium cyanoborohydride, 
which is both water-sensitive and has the potential for reducing disulfide bonds within 
proteins. A variation of this method avoids these problems by using a water-stable iridium 
catalyst for the reduction.66 However, this method is not as efficient as the classical reduction 
and no selectivity for the N-terminal amine has been shown yet. Another variation of the 
reductive alkylation procedure used an acetal moiety which was converted to an aldehyde in 
situ before coupling. By storing the aldehyde functional polymer as its corresponding acetal 
derivative, a longer shelf life was guaranteed. The acetal moiety was either coupled to a pre­
existing polymer67 or built into a polymer by synthesizing the polymer with an acetal- 
functional initiator.68
2.2.6 | C ystein e co n ju g atio n
The frequent occurrence of lysines on protein surfaces makes it hard to site-selectively 
target the amine groups of these residues. As mentioned above, reductive alkylation can target 
the N-terminus selectively and active site blocking, mutagenesis and solid phase synthesis can 
be used to limit the amount of available lysines on the protein or peptide.
Another, easier way to create well-defined polypeptide-polymer bioconjugates is to 
target a more specific functionality within the peptide or protein. In polypeptides there are 
only a few cysteines which do not participate in disulfide bonds. This low natural abundance 
makes it easier to functionalize proteins via the available cysteines at a specific location and 
thus minimize loss of biological activity. As an additional advantage, the overall charge of the 
polypeptide is maintained. In the absence of a free and accessible cysteine in the native 
structure, one can be added by site-directed mutagenesis69, 70 or by introducing a cysteine-
reduction
R'
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containing peptide connector in a fusion-protein.71 However, these strategies can be 
dangerous as the addition of a single cysteine increases the possibility of incorrect disulfide 
formation and protein dimerization.
Generally speaking, conjugations which target cysteines can be divided into thioether 
and disulfide forming reactions, which will be discussed in the next sections.
2.2.6.1 | T h io eth er fo rm atio n
One of the cysteine reactive reagents that react with thiols via a Michael addition is the 
alkylating agent vinyl sulfone (24) (Scheme 2.5). Because of the soft nature of this 
electrophile, it is quite selective to thiols, even in the presence of other hard nucleophiles such 
as amines and hydroxyl groups. However, the vinyl sulfone group reacts only slowly with 
thiols. The reaction is accelerated by increasing the pH, but this will also give more side 
reactions with lysines. The charge environment of the cysteine can furthermore also have an 
effect on the ease of the reaction.72
Scheme 2 .5  | Cysteine conjugation using vinyl sulfone.
A more widely used Michael acceptor is the maleimide group (26) (Scheme 2.6). It 
reacts faster than vinyl sulfone and the conjugation can also be performed in slightly acidic 
conditions (pH 6-7). However, the resulting product (27) is less stable in water. The 
maleimide group can be introduced in various ways, for instance by first reacting an amine- 
terminated PEG (28) with maleic anhydride (29), followed by dehydratation and ring-closure 
of the intermediate maleamic acid by acetic anhydride and sodium acetate.73 In an alternative 
procedure, a polymer with a terminal amino group (31) was first coupled to an N- 
hydroxysuccinimide (NHS) activated maleimide (32) and then conjugated to a cysteine, 
which was introduced into cytochrome b5 by site-directed mutagenesis of a surface accessible
threonine.74
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Scheme 2 .6  | Use and synthesis of maleimide-functionalized polymers.
An a-maleimide functional polymer can also be synthesized by performing an ATRP 
polymerization with a maleimide functional initiator. However, before polymerization, the 
maleimide initiator needs to be protected, for instance via a Diels-Alder reaction with 
dimethylfulvene (34) 75 or furan (35) . 76 After polymerization, the protecting group can be 
liberated by refluxing the polymer at elevated temperature.
Scheme 2 .7  | Maleimide-functionalized ATRP initiators.
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An alternative procedure which is gaining interest, uses the century-old addition of 
thiols to alkenes through a photochemically or thermally induced radical mechanism 
(Scheme 2.8) . 77
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Scheme 2 .8  | Mechanism of the thiol-ene coupling.
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This thiol-ene coupling (TEC) is bio-orthogonal, efficient and compatible with water 
and oxygen. Its potential for bioconjugation was first demonstrated by the conjugation of 1,2- 
polybutadiene (PBD) and PBD-fo-PEG to short model peptides, resulting in peptide hybrid 
amphiphiles.78, 79 In a separate report, the selective functionalization of a heterotelechelic 
polystyrene (PS) with both an alkene and an azide end-group furthermore demonstrated the 
orthogonality of the TEC coupling with the copper-catalyzed azide-alkyne 1,3-dipolar 
cycloaddition, which will be discussed in section 2.3.1.80
2.2.6.2 | Disulfide fo rm atio n
Another strategy for the conjugation to cysteines involves the formation of disulfide 
bonds. To this end, the thiol group of the cysteine residue on the peptide is reacted with an 
activated disulfide group on a polymer. A thiol-disulfide exchange subsequently forms a new 
disulfide bond connecting the peptide with the polymer. An advantage of this strategy is that 
the activated disulfide group reacts specifically with thiols under a broad pH range (pH 3-10). 
The disulfide bond formation is completely reversible and can be reduced using standard 
reducing agents like dithiothreitol (DTT). Depending on the application, this can be regarded 
as either an advantage or disadvantage.
The most widely used activated disulfide is o-pyridyl disulfide (40) (Scheme 2.9). It 
reacts very efficiently towards the end product, because the o-pyridyl disulfide group is 
expelled from the substrate as a nonreactive compound (42) which can no longer participate 
in the thiol-disulfide exchange reaction. This strategy has been adopted for both a grafting to 
strategy81, 82 and for a grafting from  strategy using pyridyl disulfide-functionalized initiators.83
Scheme 2 .9  Thiol-disulfide exchange with o-pyridyl disulfide.
2.2.6.3 | B rid ged  disulfide bon d
As previously stated, it is very rare to have naturally occurring unpaired cysteines on 
the surface of proteins. Cysteines in disulfide bridges are more common. However, most of 
them are buried and only few are accessible on the surface of peptides. A newly developed 
strategy for the site-selective modification of peptides targets these disulfide bridges (Scheme 
2.10 ) . 84 Under mild reducing conditions and without the use of denaturants, it was possible to 
selectively reduce the surface accessible disulfide bridges only. The two liberated thiols were
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treated with a bis-alkylating PEGylation agent (43). The addition of the first thiol (44) 
resulted in the elimination of a sulfinic acid derivative. The conjugated double bond which 
was formed (45) provided the addition site for the second thiol. With this method, PEG was 
conjugated via a three-carbon bridge that links the two original sulfur atoms (46). The 
sequential nature of the addition-elimination reactions ensures the efficient rebridging of the 
original disulfide bond, stabilizing the correct tertiary structure of the peptide. This strategy 
has been shown for the selective functionalization of interferon a-2 , leptin, asparaginase and 
antibody fragments.85
46
Scheme 2 .10  | Mechanism of disulfide bridge form ation using a bis-alkylating PEGylation agent.
2.2.7 | T yrosine co n ju g atio n
As a complement to the use of cysteines and lysines, tyrosine offers another possible 
conjugation site on proteins and peptides. An added advantage of tyrosine is that it can be 
introduced or removed genetically without changing the total charge of a protein (as with 
lysine) or its redox sensitivity (as with cysteine).
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Scheme 2.11 | Reaction between tyrosines and a diazonium functionalized bead.
It is known that tyrosines can react with diazonium salts (Scheme 2.11). In line with 
this method, poly(vinyl alcohol) was cross-linked into water-insoluble beads and then 
diazotized.86 Using these diazonium functionalized beads (47), BSA and ß-glucosidase were 
immobilized. However, it was noted that the diazonium moiety can also react with the 
electron-rich aromatic systems of the histidine side-chain, which could result in uncontrolled 
side reactions.
Francis et. al. developed two tyrosine conjugation methods which are more selective 
and could prove very useful in the synthesis of protein-polymer hybrids. The first one is based 
on a three-component Mannich-type reaction between tyrosine (48), an aliphatic aldehyde
(50) and an aniline derivatized fluorescent probe (51) (Scheme 2 .1 2 A) . 87 This method was 
used to label chymotrypsinogen A, lysozyme and RNase A. However, this method requires a 
large excess of the aldehyde and aniline. Therefore a second method was introduced which 
only requires a small excess of the synthetic partners.88 There, an inert allylic acetate (53) was 
first activated by a palladium catalyst. The electrophilic n-allyl complex (54) was subsequently 
coupled to the tyrosine of chymotrypsinogen A (48), introducing either a fluorescent probe 
or hydrophobic tails on the protein (55) (Scheme 2.12B).
A
Scheme 2 .12  | A) Three com ponent Mannich-type tyrosine conjugation; B) Palladium assisted tyrosine 
conjugation.
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2.2.8 | N ative C hem ical Ligation
Native chemical ligation (NCL) is based on a mechanism known from nature, which 
involves intein-associated protein splicing.89 It was first adopted in the preparation of 
synthetic peptides as a convenient technique that enables chemoselective coupling of two 
unprotected peptide segments.90 In the first step of the reaction a peptide fragment with a C- 
terminal a-thioester (56) reacts with another polypeptide with an N-terminal cysteine (57). 
Initially, a thioester-linked species (58) is formed, which spontaneously rearranges via an 
intramolecular reaction to form a native peptide bond at the ligation site (59) (Scheme 2.13). 
This reaction proceeds to high yields at neutral pH. The requirement to have a cysteine at the 
ligation site limits the applicability of NCL as cysteines are relatively rare amino acids in 
natural proteins. Several approaches however, have recently been described that circumvent 
the use of cysteines.91, 92
Scheme 2 .13  | Mechanism of the Native Chemical Ligation.
NCL was first applied by Merkx and Meijer as a bio-conjugation tool for attaching 
oligopeptides and recombinant proteins to dendrimers.93, 94 For dendrimers of generation one 
and two, full conversion was observed. For the third generation dendrimers, a mixture of 
products was found, probably due to steric crowding. After having shown the viability of this 
methodology for the coupling of peptides it was extended for proteins by coupling green 
fluorescent protein (GFP) to a first-generation dendrimer. GFP protein was first expressed as 
an intein fusion protein (Scheme 2.14). Binding of this fusion protein on a resin (60) was 
followed by a nucleophilic attack with sodium 2-mercaptoethanesulfonate (MESNA) (62) 
which reacted with the transient thioester (61) at the intein fusion site. After coupling this 
GFP-based MESNA thioester (63) to the dendrimer, the remaining cysteines were further 
functionalized with peptide-based mercaptopropionic acid-leucine (MPAL) thioesters.
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Scheme 2 .14  | Functionalization of the N-terminus of GFP with MESNA (62) using an intein fusion 
protein.
Becker used discrete PEG-based oligomers carrying thioester moieties for the 
functionalization of an array of peptides and proteins using NCL.95 Here it was shown that 
this procedure leads to the reversible attachment of polymer chains to any internal cysteine 
residues via thioester bonds. N-terminal cysteines on the other hand, are permanently 
modified through amide bond formation as shown in Scheme 2.13. This difference in bond 
formation between internal and N-terminal cysteines effectively allowed Rab GTPase, which 
contains three cysteines, to be selectively functionalized at the N-terminus.
2.2.9 | S ite-selectiv e  m od ification  using en zym es
Site-selective PEGylation of proteins can be accomplished by using enzymes in the 
conjugation step. The first example of this biosynthetic approach used the enzyme 
transglutaminase (TGase) . 96 In its natural environment TGase catalyzes the post-translational 
modification of proteins by alkylating the amine group of glutamine with a primary 
alkylamine (Scheme 2.15).97
H Ï  Ca2+ R’^  S — Í  TG ase) R“ NH:
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Scheme 2 .15  | TGase is activated by Ca2+. In this conformation a thiol residue (65) is coupled to the 
glutamine side-chain of its substrate (64). Transamidation of the interm ediate structure 66  releases the 
alkylated product (67).
Mammalian TGase has a stringent sequence requirement for the amine acceptor site 
around the glutamine residue. Therefore, in order to conjugate amine functionalized PEG to 
the human protein interleukin-2 (hIL-2) using mammalian TGase a short substrate sequence 
had to be cloned onto the N-terminus of hIL-2. The chimeric protein could be selectively
o
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functionalized at the appended substrate sequence and retained most of its bioactivity, while 
showing prolonged circulation in rat plasma. Alternatively, microbial TGase can be used for 
the conjugation reaction. This enzyme recognizes a wider variety of protein substrates as an 
amine acceptor. This allowed for one glutamine residue in native hIL-2 to be identified as a 
substrate for the microbial TGase. The other five glutamines in the hIL-2 sequence were left 
untouched resulting in a well-defined bioconjugate. Recently an excellent review was 
published covering the field of PEGylation mediated by transglutaminase.98
For the site-specific conjugation of serine and threonine residues a different enzyme 
has been used.99 In an example, three therapeutic human glycoproteins were expressed in 
Escherichia coli (E. coli) in their nonglycosylated form and PEGylated in a two-step 
procedure. First, their natural O-glycosylation site was functionalized with the sugar N- 
acetylgalactosamine (GalNac) using GalNac transferase. Subsequently, sialic acid- 
functionalized PEG was enzymatically coupled to the GalNac residue by sialyltransferase.
Another interesting pathway100 that is inspired by the natural selectivity of enzymes 
takes advantage of the ability of Ofi-alkylguanine-DNA alkyltransferase (AGT) to transfer the 
benzyl group of Ofi-benzylguanine (BG) to one of its cysteine residues. 101 Originally, AGT was 
used in biochemistry for the labelling of proteins. To this end, the protein of interest is fused 
to an AGT tag and subsequently coupled covalently to a BG-functionalized fluorescent probe. 
Similarly, an AGT-fusion protein can react with a polymer in order to create a bioconjugate. 
This strategy was illustrated by reacting an AGT-fusion protein specifically with BG- 
functionalized polymer brushes, thereby immobilizing the fusion protein to the surface. 
Because the bioconjugation occurred exclusively via the reaction of the AGT tag, 
immobilization could be carried out directly from the crude cell lysates without the need for 
separate purification steps. The mild procedure left the fusion protein intact and free to react 
with its substrate. Furthermore, the density of protein on the surface was varied by changing 
the amount of BG which was anchored to the brush.
Currently, three other tags are used for covalent labelling of proteins inside living 
cells: the CLIP tag, 102 the tetracysteine tag103 and the HaloTag. 104 One could envision that these 
tags could also be employed for bioconjugation using the same strategy.
2.3 | G rafting to  using u n n atu ral fu n ction alities
Peptides and proteins are both rich in structural complexity and diverse in their 
functional reactivity. We have seen that the high number of electrophilic and nucleophilic 
sites can make it difficult to selectively couple peptides and proteins to polymers using 
naturally occurring functional groups. Therefore, chemoselective ligation reactions have been
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developed in which two mutually and uniquely reactive functional groups react with one 
another. The chosen reactive groups are bio-orthogonal, tolerating a diverse array of other 
functionalities, and thus render protecting groups unnecessary. Because of their robust 
nature, these reactions are commonly grouped under the name ‘click’ reactions.
2.3.1 | C o p p er-ca ta ly zed  azid e-alk y n e 1 ,3 -d ip o la r cy clo ad d itio n
Thermally induced 1,3-dipolar cycloadditions have been intensively studied by 
Huisgen since the 1950s (Scheme 2.16A).105 Sharpless and Meldal showed that the 1,3-dipolar 
cycloaddition between azides (6 8 ) and alkynes (69) can be greatly accelerated by adding a 
copper catalyst which allows the reaction to be performed at room temperature (Scheme 
2.16B).106, 107
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Scheme 2 .16  | A) Thermally induced cycloaddition between azides and alkynes; B) Regioselective 
copper-catalyzed azide-alkyne 1,3-dipolar cycloaddition.
This copper-catalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC) has recently 
enjoyed tremendous interest as a synthetic route for the synthesis of complex materials 
because of its high conversion and mild experimental conditions. Azides and alkynes can be 
easily introduced in both synthetic polymers and biomolecules. The reaction can be 
performed at room temperature and in water, making it compatible with biological systems. 
Because this method involves a cycloaddition rather than a nucleophilic substitution, proteins 
can be modified with extremely high selectivity, so little or no by-products are formed and no 
protective groups are required.
CuAAC was first used on proteins for the labelling of protein capsids of the cowpea 
mosaic virus (CPMV) with a fluorescent dye. 108 The possibilities of the CuAAC for the 
bioconjugation with polymers were first shown by the site-specific PEGylation of human 
superoxide dismutase-1 (SOD), a key enzyme in preventing the formation of reactive oxygen
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species in cells (Scheme 2.17).109 The alkyne was introduced into the PEG polymer by 
coupling propargylamine with an NHS ester-activated PEG (71). The azide was incorporated 
into the SOD protein (70) by introducing p-azidophenylalanine (73) as a 21st amino acid 
(Scheme 2.18). This was achieved by extending the repertoire of the cell’s translational 
machinery with an orthogonal tRNA and tRNA synthetase. 110 This gives the possibility to site- 
selectively introduce an azide, while keeping the rest of the primary structure unchanged. The 
CuAAC ligation was performed in a phosphate buffer at pH 8 , resulting in a PEGylated SOD
(72) that had approximately the same bioactivity as the native enzyme.
Scheme 2 .17  | PEGylation of the SOD protein using CuAAC.
Alternatively, azide groups can be incorporated into recombinant proteins by 
expressing them in methionine auxotrophic bacterial cultures growing in methionine-free 
medium which are supplemented with azido-homoalanine (74) (Scheme 2.18).111 Because of 
the close resemblance of azido-homoalanine to methionine, azido-homoalanine is simply 
activated by methionyl-tRNA synthetase and thereby replaces each methionine in the 
proteins expressed. Although this means that several azide groups can be introduced into the 
protein, the low methionine abundance together with its hydrophobicity will limit the 
amount of surface accessible azides incorporated. Accordingly, this strategy was used to site- 
specifically PEGylate the enzyme Cal B . 112
Instead of a biochemical approach, the azide group can also be introduced in a 
chemical manner into both peptides and proteins using diazo transfer agents (Scheme 2.18). 
Solid phase bound peptide amines can be easily converted into azides by a diazo transfer 
using triflyl azide (75) in the presence of divalent copper ions. 113 The water-soluble diazo 
transfer agent 76114 can be used on proteins in an aqueous solution to substitute the amines of 
both lysine residues and the N-terminus by azide groups. 115 This diazo transfer has even been 
performed selectively towards a single amine by carefully controlling the copper content and 
pH of the reaction mixture. 116
70 n= 114, 455 72
Conjugation techniquee 43
Scheme 2 .18  | Structures of azide-containing amino acids and diazo transfer agents.
In another example of CuAAC bioconjugation, the azide and alkyne functionalities 
switched places as an azide-terminated PS was coupled to either an alkyne functionalized 
peptide or protein. 117 The PS block was synthesized by ATRP and the terminal bromide was 
subsequently reacted with azidotrimethylsilane and tetrabutylammonium fluoride (TBAF) to 
introduce the azide group. The peptide with the sequence Gly-Gly-Arg was synthesized by 
SSPS and fluorescently labelled. While still on the solid support, the peptide was reacted with 
3-butynylchloroformate, introducing the alkyne function on the N-terminus. The subsequent 
CuAAC was performed in THF with the same copper catalyst used for the ATRP synthesis of 
the PS block. In order to demonstrate the scope of the reaction, the azide functional PS was 
also conjugated to an alkyne functionalized BSA. Towards this goal, the available thiol from 
the cysteine-34 residue of BSA was first coupled to a maleimide bearing an alkyne. The 
alkynylated BSA was then reacted with the azide functional PS using the same reaction 
conditions as for the synthesis of the peptide-PS hybrid.
In the previous examples, the clickable groups on the polymer chain were introduced 
after the polymerization. An alternative strategy for obtaining clickable polymers is to use an 
azide- or alkyne-functional initiator. Scheme 2.19 shows some examples of azide- and alkyne- 
containing initiators for ATRP (77, 78),118, 119 ring-opening polymerization (ROP) of amino 
acid N-carboxyanhydrides (NCA) (79, 80),119 Reversible Addition-Fragmentation chain 
Transfer (RAFT) (81)120 and nitroxide-mediated radical polymerization (82, 83).121 It has 
been shown that the azide and (protected) alkyne functionalities survive the polymerization 
conditions, effectively eliminating the need for postpolymerization modifications.
Scheme 2 .19  | Structures of azide- and alkyne-containing initiators.
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Besides the construction of linear bioconjugates, CuAAC has also been employed for 
the synthesis of polymers with a brush structure by introducing clickable groups in the 
monomer side-chain (Scheme 2 .2 0 ) . 122 A polyester with acetylene moieties was produced by 
ROP of a-propargyl-ô-valerolactone (84).123 Complementary to polyester 85, the amine 
terminus of a Gly-Arg-Gly-Asp-Ser oligopeptide sequence was first capped with 6 - 
bromohexanoic acid, after which the bromide was substituted with an azide. Surprisingly the 
azide-terminated pentapeptide 8 6  could only be coupled to polyester 85 at 100 °C. Another 
branched structure was produced by coupling acetylene terminated dendrimers with azide- 
functional peptides via CuAAC. 124 Because low reaction rates were observed, Liskamp et. al. 
tried to accelerate the reaction by microwave irradiation. Varying yields were obtained, 
ranging from 14% to 97%, possibly due to steric hindrance.
Scheme 2 .20  | Side-chain functionalization of a polyester with an oligopeptide using CuAAC.
CuAAC has even been used to decorate complex systems such as polymersomes, 125 
which illustrates the power of this bio-orthogonal reaction. However, amino groups present 
in peptides and proteins can chelate the copper ions, thereby interfering with the 
cycloaddition reaction. Both the toxicity of the copper required and the copper-induced 
denaturation of proteins126 furthermore indicate that this methodology needs to be improved. 
To this end several copper-free click reactions have been developed which will be discussed in 
the next sessions.
2.3.2 | S tau d in g er ligation
In 1919 Staudinger and Meyer reported the reduction of azides using 
triphenylphosphine. 127 This reaction involves the formation of an aza-ylide intermediate 
which is hydrolyzed to generate an amine and triphenylphosphine oxide. When Saxon and
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Bertozzi incorporated a methoxy ester as an electrophilic trap into one of the phenyl rings
(8 8 ), the nucleophilic aza-ylide 90 was captured before its hydrolysis (Scheme 2 .2 1 ) . 128 Via an 
intramolecular cyclization the intermediate rearranged and after hydrolysis ultimately 
coupled both reaction partners via an amide bond (92). Just like with the CuAAC, both 
reactive groups of this Staudinger ligation (i.e. the azide and the triphenylphosphine) are 
absent from peptides and proteins and although they have a high intrinsic reactivity to one 
another, they do not react with any natural occurring functionalities. This property can be 
exploited in the synthesis of well-defined bioconjugates without the need of protecting 
groups.
Scheme 2.21 | Mechanism of the Staudinger ligation
Accordingly, the Staudinger ligation was used for the site-specific PEGylation of 
azido-homoalanine containing trombomodulin. 129 Functionalization of an amine-terminated 
PEG with phosphine 93, allowed PEG derivative 95 to be selectively conjugated to the C- 
terminus of the protein.
Scheme 2 .22  | Functionalization of PEG with a phosphine moiety suited for the Staudinger ligation.
Alternatively, the C-terminus of RNase A was specifically functionalized with an azide 
group following the same strategy as for the synthesis of protein-based MESNA thioesters 
(Scheme 2.14). Here the target protein was expressed as an intein fusion protein and attacked 
by an azido-bearing a-hydrazine acetamide (96).130
o
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Scheme 2 .23  | Structure of hydrazine used to introduce an azide into an intein fusion protein.
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Although the Staudinger ligation reaction works well, products retain a triaryl 
phosphine oxide moiety. In two independent publications131, 132 traceless Staudinger ligations 
were reported in which the used phenylphosphine contained a cleavable linker (97) which 
was released once the aza-ylide attacked the carbonyl group (Scheme 2.24). The 
phosphonium species of the rearranged product 99 was then subsequently liberated during 
the final hydrolysis step. Among the phosphines tested, 101 and 104 exhibited the best 
reactivity. One limitation of this ligation method was that it needed to be carried out in 
organic or mixed solvents. More recently however, a water soluble phenylphosphine (105) 
was developed which should extend the applicability of this reaction. 133 These traceless 
variants of the Staudinger ligation produce a clean amide bond after coupling, which might 
improve the biocompatibility of the prepared bioconjugates. However, the side-products 
formed might make purification of the product necessary.
One of the first applications of the traceless Staudinger ligation was the assembly of 
peptide segments synthesized by SPPS into a final synthetic peptide. In contrast to NCL, the 
traceless Staudinger ligation does not need a cysteine residue at the ligation site. This freedom 
was first exploited in the total synthesis of RNase A . 134 The full scope and the limitations of 
the Staudinger ligation in peptide chemistry still need to be explored, however. Questions 
about side-chain dependence and whether or not protecting groups are required remain 
unanswered.
Scheme 2 .24  | Mechanism of the traceless Staudinger ligation together with the structure of the 
cleavable linker incorporated in the phosphines tested.
The use of the traceless Staudinger ligation has now also been extended to the 
immobilization of proteins via a surface tethered PEG spacer.135, 136 By having phosphine 102 
on a PEG spacer, RNAse A was covalently coupled after which its immobilization was 
evaluated by a ribonucleolytic activity assay and immunostaining.
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2.3.3 | H yd razon e an d  o x im e  ligation s
Instead of using an azide functionality for either a CuAAC or a Staudinger ligation, 
proteins and peptides can be site-selectively conjugated using ketones and aldehydes. These 
groups are not commonly present in natural proteins and can react with either hydrazide
(106) or hydroxylamine ( 1 1 0 ) groups forming a hydrazone (108) or oxime ( 1 1 1 ) bond, 
respectively.
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Scheme 2 .25  | Hydrazone and oxime ligation.
Hydrazone chemistry was originally developed to couple polypeptide fragments 
together into artificial proteins. 137 Oxime chemistry was first employed to modify proteins 
with small organic substances, 138 but was later also used for the ligation of polypeptide 
fragments. 139 As a side reaction during these ligations, amino groups of proteins can form a 
Schiffs base with the ketones or aldehydes which can lead to cross-linked aggregates. 
However, this side reaction can be suppressed under acidic conditions which protonates the 
amino groups. Because hydrazides and hydroxylamines are weaker bases than primary 
amines, the desired reaction can still occur. In this way, these coupling reactions can be 
performed regioselectively, making them good candidates for the well-defined formation of 
bioconjugates without the need for protection groups during the conjugation step. Before 
elaborating on these conjugation methods, we will describe how to introduce ketone or 
aldehyde groups into proteins and peptides.
When working with glycoproteins, the incorporated carbohydrate provides a target 
which can be oxidized under mild conditions to afford the necessary ketones and aldehydes 
within the protein. 140-142 Naturally occurring glycosylation sites are usually well removed from 
the protein active site and are readily accessible, making them excellent attachment sites for 
polymer chains. Using this method, multiple attachment sites are generated on the 
carbohydrate, but all modifications are confined to the glycosylation site. When no 
glycosylation sites are available, they can be engineered into the protein.143, 144
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Another way of introducing ketones or aldehydes into proteins is to oxidize the N- 
terminal serine or threonine with sodium periodate under mild conditions. 145 A method with 
fewer restrictions on the nature of the N-terminal amino acid groups, is the metal-catalyzed 
transamination. 145 However, the conditions for this reaction are known to be potentially 
harmful to the protein. Also, both oxidation methods have only been used with varying 
success together with oxime coupling.
A more general strategy for the incorporation of ketones in larger proteins was first 
demonstrated by Tirrell et. al., which is analogous to the earlier described multisite 
replacement approach of methionine for azido-homoalanine. 146 Briefly, E. coli’s tRNA- 
synthetase for phenylalanine was mutated in such a way that it could also accept p- 
acetylphenylalanine (112). By feeding phenylalanine auxotrophic cell lines p- 
acetylphenylalanine instead of phenylalanine, the unnatural amino acid was incorporated at 
all phenylalanine positions. Schultz et. al. created a cell line which introduced ketones site- 
specifically into proteins by using an orthogonal tRNA and tRNA synthetase couple which 
made p-acetylphenylalanine amenable for ribosomal protein production incorporating it site- 
specifically as a 2 1 st amino acid. 147
Scheme 2 .26  | Structures of a ketone-containing amino acid and ketone-bearing tags.
Another possibility is to react specific residues with ketone-bearing tags. In one such 
example, the tyrosine residues of the protein capsid of the tobacco mosaic virus (TMV) were 
reacted with p-acetylbenzenediazonium salt (113).148 The resulting surface exposed ketones 
were coupled to hydroxylamine-functional PEG. In another example, NHS esters of p - 
formylbenzoic acid (114) were efficiently reacted with lysine residues in order to install 
aldehydes on the exterior of the MS2 capsid. 149 Since this kind of chemistry is not site-specific, 
ketones can be introduced at multiple sites. So, even though the oxime conjugation itself is 
bio-orthogonal, constructing well-defined bioconjugates with this approach can be difficult.
A more controlled way of introducing a ketone functionality into proteins was 
described by the group of Francis.150, 151 N-terminal amino acids can undergo a transamination 
reaction upon exposure to pyridoxal 5’-phosphate (PLP, 116) at 37 °C in an aqueous solution
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(pH 6.5), resulting in the corresponding pyruvamide derivative (117). Because of the 
selectivity for the N-terminal amino group, the ketone is introduced at a single location, 
leaving the amines of the lysine side-chains unchanged. This reaction was first demonstrated 
on proteins with an N-terminal glycine, valine, lysine and methionine, 150 and more recently 
for N-terminal aspartic and glutamic acid. 151 Apart from serine, threonine, cysteine, 
tryptophan and proline, it is expected that this reaction should also be applicable for the 
remaining natural amino acids at the N-terminus.
Scheme 2 .27  | Introduction of a ketone moiety to the A-terminus using PLP.
Hydrazide can be easily introduced into PEG152 and be reacted with ketones and 
aldehydes to produce a hydrazone linkage under acidic conditions. The hydrazone linkage is 
not very stable but may be reduced with sodium cyanoborohydride to a more stable alkyl 
hydrazide (109). In a proof-of-concept, it was shown that hydrazone formation is compatible 
with and orthogonal to CuAAC. 153 Poly(norbornene)-based random copolymers possessing 
both ketone and azide functionalities were synthesized using ring-opening metathesis 
polymerization. A subsequent one-pot functionalization step with a library of small organic 
and biological molecules provided multifunctional polymers.
Alternatively, a ketone- or aldehyde-functionalized polypeptide can be attached to a 
hydroxylamine bearing polymer. The oxime bond which is formed is more stable than the 
hydrazone linkage and does not need a successive reduction to produce a stable product. 
Using oxime chemistry, Kochendoerfer and co-workers site-selectively attached two 
branched polymer chains efficiently at two of the four glycosylation sites of synthetic 
erythropoiesis protein (SEP) . 30 The protein was synthesized as four individual peptide 
fragments by SPPS, where a non-coded, ketone-bearing amino acid, N£-leuvulinyl lysine, was 
introduced at the desired positions. The PEG-based polymer was also synthesized on solid­
phase resin and functionalized with hydroxylamine. The final construct was assembled by 
first coupling the PEG chains to the target sites with oxime-forming conjugation, followed by 
ligation of the four fragments using NCL. In a second study, this strategy was used to screen 
several SEP-polymer bioconjugates for their activity. 154 Using the same strategy, the small 
anti-HIV protein CCL-5 was site-specifically PEGylated. 155
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Just like hydrazone formation, oxime ligation also has to be performed under acidic 
conditions. Since many proteins are unstable at low pH it would be desirable to perform the 
ligation at neutral conditions. This has been made possible recently by the addition of p - 
methoxyaniline, which acts as a nucleophilic catalyst and accelerates the reaction rate. 156
Besides solid-phase chemistry there have been other approaches developed for the 
convenient functionalization of polymers with a hydroxylamine moiety. One example is the 
solution-based displacement of the terminal alcohol group by N-hydroxyphthalimide under 
Mitsunobu conditions. 148 Another example used tert-butyloxycarbonyl (Boc) protected 
hydroxylamine initiators for ATRP . 157 Using such controlled radical initiators, HEMA, N- 
isopropylacrylamide (NIPAAm) and poly(ethylene glycol) methacrylate (PEGMA) were 
polymerized with low polydispersities (PDI). Deprotection with trifluoroacetic acid liberated 
the hydroxylamine moiety, allowing a chemospecific coupling with N£-leuvulinyl lysine 
functionalized BSA.
In a further variation of the oxime coupling method, the two moieties used, i.e. the 
hydroxylamine and the ketone or aldehyde switch places. In this opposite approach, a PEG- 
based polyamide chain was functionalized with terminal serine residues, after which the 
alcohol functions were oxidized with periodate into glyoxylyl groups. 158 Complementary to 
this, a hydroxyamine group was attached to the N-terminus of a peptide using Boc- 
aminooxyacetyl N-hydroxysuccinimide during SPPS. In the final step, a well-defined 
bioconjugate was synthesized by coupling the synthetic polymer to the peptide through the 
formation of an oxime bond. In the same way, an aminooxyacetic acid was protected with 
acetone and incorporated into CCL-5 using SPPS. 159 After deprotection, the peptide was 
conjugated to an aldehyde-functionalized PEG.
2.3 .4  | M iscellan eou s c o p p e r-fre e  click re a ctio n s
Several additional copper-free click reactions have been developed within chemical 
biology in recent years which increase the reactivity of dipolarophiles towards azides in 1,3- 
dipolar cycloadditions. Prime examples are the oxanorbornadiene-based tandem 
cycloaddition-retro-Diels-Alder (crDA) reaction (118),160 the difluorinated cyclooctyne-
(121) , 161 dibenzocyclooctyne- (124)162, 163 and bicyclo[6.1.0]non-4-yne-based (127)164 strain- 
promoted azide-alkyne 1,3-dipolar cycloadditions (SPAAC).
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Scheme 2 .28  | Examples of copper-free click reactions based on a 1,3-dipolar cycloaddition with azides.
All four reactions proceed with high yields and without the formation of interfering 
by-products. When comparing the extent of functionalization of an azide-containing coating, 
both the oxanorbornadiene-based crDA reaction and dibenzocyclooctyne-based 
cycloaddition gave better results than the CuAAC and Staudinger reactions. 165 Solubility in 
aqueous solutions, however, remains an issue with the oxanorbornadiene being the most 
hydrophilic. Examples of bioconjugations using these reactive groups are still limited,166, 167 
and most studies focus on the labelling of proteins with small organic probes. From these 
studies however, it is apparent that these methods are good candidates for selective 
bioconjugation.
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Lin and co-workers reported a method using tetrazoles (130) which generate nitrile 
imines (131) under UV light that can subsequently react with substituted alkene 
dipolarophiles.168 This photoactivated 1,3-dipolar cycloaddition reaction was used to 
selectively label a genetically encoded alkene-containing protein (132). In another recent 
example of a 1,3-dipolar cylcoaddition as a bioconjugation tool, norbornene-modified DNA
(134) was smoothly reacted with several modified nitrile oxides (135).169
134 136 R'
Scheme 2 .29  | Examples of copper-free click reactions based on 1,3-dipolar cycloadditions with nitrile 
imines and nitrile oxides.
Another bio-orthogonal coupling reaction, which was recently used for C-terminal 
PEGylation, is based on the thioacid/azide amidation reaction.170 In short, protein splicing of 
a recombinant protein yielded the small ubiquitin protein with a thioacid group at the C - 
terminus (137), which was subsequently selectively amidated by the electron-deficient 
sulfoazide 138. Only mono-PEGylated product was obtained, confirming the 
chemoselectivity of the reaction. However, the reaction was accompanied by some hydrolysis 
resulting in a yield of only about 65%.
137 139
Scheme 2 .30  | C-terminal PEGylation of ubiquitin using the thioacid/azide amidation reaction.
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Diels-Alder reactions are now also being explored as possible conjugation methods. In 
one example an inverse electron demanding Diels-Alder reaction between trans-cyclooctenes
(140) and tetrazines (141) was followed by a retro-[4+2] cycloaddition producing the 
conjugated product and nitrogen in quantative yield.171, 172
Scheme 2.31 | Conjugation reaction between tran-cyclooctene and tetrazine.
Very fast conjugation of macromolecular blocks was shown to be possible between the 
thiocarbonate endgroup of a RAFT polymer (143) and a cyclopentadienyl-functionalized 
polymer (144).173 This retro-Diels-Alder reaction can be accelerated by using trifluoroacetic 
acid (TFA) as a catalyst, resulting in quantitative yields in just a few minutes.
polymer A polymer B
TFA
^polymer A J''
143 144 145
polymer B
Z
Scheme 2 .32  | Conjugation of tw o macromolecular blocks through a Diels-Alder reaction.
2.4  | G rafting to  using n o n -co v a le n t in teractio n s
Instead of covalently coupling polymers and proteins, bioconjugates can also be 
prepared by strongly coordinating polymers to proteins. This can be done by the use of 
cofactors. Cofactors are small organic molecules that are positioned in the active site of 
certain proteins. They are usually of great importance for the activity of these proteins. The 
cofactor can be removed from the protein and attached to a polymer. By simple mixing the 
protein and the polymer-functionalized cofactor, a bioconjugate is created when the cofactor 
is reconstituted in the pocket of the protein. This strategy is efficient, provided that the 
modification of the cofactor does not hinder the complexation with the protein.
This strategy was first explored using the well-studied biotin-(strept)avidin system. 
The cofactor biotin (vitamin B7) has an affinity for avidin (Ka«10 15 M-1) or streptavidin 
(Ka«1013 M-1) which is so high that it can be regarded as irreversible. 174 The naturally
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occurring carboxylic acid of biotin provides an easy way to couple it to pre-made polymers,175, 
176 block copolymers,177, 178 dendrimers, 179 polymer brushes180 or for the incorporation into 
cross-linked thin films.181, 182 In order to circumvent the need for postpolymerization 
modifications, biotin can already be incorporated into the initiator which is used for the 
synthesis of the polymer. This approach has been carried out for azonitrile initiators, 183 
cyanoxyl-mediated polymerization,184, 185 ATRP186-188 and RAFT.189, 190 Because the acid group 
is not involved in the complexation with the protein, these modifications do not change the 
binding characteristics much. To facilitate a smooth incorporation of the cofactor into the
protein a hydrophilic175, 179, 186-188 or hydrophobic176, 177, 181, 182 spacer can be included between
biotin and the polymer chain.
Similarly, one of the carboxylic acids of the heme cofactor protoporphyrin IX was 
used for the attachment of a polystyrene chain. The heme-functionalized polymer was 
subsequently reconstituted into the HRP enzyme191 or the oxygen binding protein myoglobin 
(Mb) . 192 A hydrophilic spacer was built between the hydrophobic polystyrene and the cofactor 
to assure the compatibility between polymer and protein. Even so, the reconstitution had a 
negative effect on the biological activity of both heme proteins. In the case of HRP, the 
enzymatic activity decreased. For Mb the stability of the oxy complex was reduced. This 
negative effect is probably due to a disturbed binding of the cofactor in the protein or a 
restricted access of substrates to the active site caused by the presence of the polymer chain. 
This illustrates that even when the position of polymer attachment is precisely known and 
controlled, it can still have a negative effect on protein activity when it is near the active site.
2.5 | G rafting from
We have seen that high requirements are put on the coupling chemistry when using 
the grafting to strategy, especially with regard to yield and specificity. Instead of conjugating a 
preformed polymer to a protein or peptide, a polymer can also be grown from these biological 
molecules. Alternatively, an amine terminal polymer can act as a macroinitiator of a 
polypeptide using ROP of amino acid N-carboxyanhydrides (NCA). The benefit of these 
strategies is that the need for a conjugation between macromolecules is averted, because only 
a small initiator moiety needs to be introduced to either the biological component or the 
polymer. The lower steric hindrance during the functionalization of the macromolecules 
simplifies the procedure. Furthermore, the product can be easily purified once the polymer is 
grown from the macroinitiator, as only the unreacted monomer has to be removed, as 
opposed to a preformed polymer.
Conjugation techniquee 55
2.5.1 | P ep tid e  m acro in itia to rs
One of the first examples of this strategy was reported by Börner et. al. who used an 
oligopeptide as a macroinitiator. 193 The pentapeptide Gly-Asp(t-Bu)-Gly-Phe-Asp(t-Bu) was 
synthesized by SPPS and the N-terminus was acylated with 2-bromopropionic acid, a 
standard initiator for ATRP. Next, the oligopeptide initiator was carefully cleaved from the 
solid support as to avoid side group deprotection, and subsequently used for the ATRP of n- 
butyl acrylate. The resulting oligopeptide-poly(n-butyl acrylate) block copolymer had a 
number average molecular weight (Mn) of 10,000 g/mol and a PDI of approximately 1.19. 
However, interactions between the copper catalyst and the oligopeptide were observed which 
caused a slow polymerization rate and a decrease of propagating radicals during the 
polymerization. Other reports described the same effects and slightly higher PDIs (1.22-1.37) 
when using this strategy. 194 This observation was ascribed to a low initiator efficiency of the 
amide-containing initiator. To overcome these drawbacks, oligopeptide-based initiators were 
synthesized for RAFT polymerizations. Using this copper-free controlled polymerization 
method, n-butyl acrylate (PDI ~ 1.1)195, 196 NIPAAm (PDI ~ 1.2) 196 and oligo(ethylene glycol) 
acrylate (OEGA) (PDI ~ 1.2) 196 were polymerized from peptide macroinitiators.
Instead of functionalizing the N-terminus, amino acid side groups can be used as 
initiation sites. A peptide-based ABA triblock copolymer was prepared by the solid phase 
synthesis of a peptide with the sequence Ser-Ala-Gly-Ala-Gly-Glu-Gly-Ala-Gly-Ala-Gly-Ser- 
Gly. 197 Before the peptide was cleaved from the solid support, the alcohol side groups of the 
two serines were functionalized with an a-bromo ester moiety to create a bifunctional ATRP 
initiator. Using living radical polymerization, methyl methacrylate (MMA) was polymerized 
in solution yielding a well-defined ABA triblock copolymer. Alternatively, Fmoc-protected 
serine was first modified with an ARTP198 or nitroxide-mediated radical polymerization 
(NMP) initiator199 and then incorporated into a peptide by SPPS. This strategy allows for a 
polymer modification at a specific site without having to rely on a distinctly different 
chemistry of the targeted residue within the sequence.
Instead of synthesizing the peptide on the solid support and sequentially performing 
the polymerization in solution, Wooley and co-workers have shown that the entire 
bioconjugate can be synthesized on the resin. By functionalizing the N-terminus of a peptide 
with an alkoxyamine, a poly(acrylic acid)-b-poly(methyl acrylate) (PAA-b-PMA) copolymer 
was synthesized via NMP while keeping the macroinitiator on the resin.200 This method has 
also been extended to ATRP,201, 202 showing the general applicability of this strategy.
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2.5.2 | P ro tein  m acro in itia to rs
Macroinitiations from complete proteins were initially conducted by simple free 
radical polymerization in the presence of proteins. The initiators are generally redox-,203 
thermally-204 or radiation-induced205. This creates radicals on the protein surface from which 
polymers were grown. In these examples, however, the grafting of the polymer occurs at 
completely random positions and there is no control over the amount of polymer chains 
attached.
This approach was made more specific by Matyjaszewski et. al. by attaching 2- 
bromoisobutyryl bromide to the lysine residues of a-chymotrypsin (aCT).206 Up to 8 
initiating moieties were coupled from which PEGMA chains with a low PDI were grown via 
ATRP. However, the exact location of attachment could not be controlled.
Functionalization of cysteines gives better control over the location of the initiating 
site. For this purpose BSA was first reduced. This freed three cysteines for functionalization 
with a pyridyl disulfide or maleimide ATRP initiator from which NIPAAm, PEGMA and 
dimethylaminoethyl methacrylate (DMAEMA) chains were grown.207,208 In the case of the 
pyridyl disulfide initiator, the disulfide bond between BSA and the polymer was reduced after 
polymerization. The detached polyNIPAAm was analyzed by gel permeation chromatography 
(GPC) indicating a PDI of 1.34. This work was reproduced for the macroinitiation of PEGMA 
and NIPAAm using RAFT polymerization.209, 210 This approach was also applied to a lysozyme 
mutant bearing a single cysteine, which was functionalized with an ATRP initiator.207
This macroinitiation strategy can be combined with a non-covalent coupling strategy. 
This was demonstrated using the abovementioned biotin-streptavidin couple. A biotinylated 
initiator was complexed in the streptavidin binding pocket. Subsequently macroinitiation 
from the protein complex was performed.211
2.5.3 | P olym er m acro in itia to rs
In the section concerned with SPPS (2.2.4), we saw that a peptide can be grown from a 
polymer using solid phase synthesis in a stepwise fashion.44-50 Using amine functionalized 
polymers (146), it is also possible to initiate the ROP of amino acid NCAs (147), forming 
poly(amino acids) (Scheme 2.33). Recent reviews have extensively discussed the synthesis of 
linear peptide-polymer block copolymers synthesized in this manner and the reader is 
referred to these papers for a more detailed overview.212, 213
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Scheme 2 .33  | ROP of NCAs using a primary amine initiator and a nickel catalyst; bipy = 2,2'-bipyrydine; 
COD = 1,5-cyclooctadiene.
The major drawback of the conventional amine-initiated NCA polymerization is that 
it is plagued by chain-breaking transfer and termination reactions which prevent the 
poly(peptide) chain length to be controlled accurately. This problem can be overcome by 
using high vacuum techniques in order to create and maintain the conditions necessary for 
the living polymerization of NCAs with primary amines.214 A second way to get better control 
over the poly(peptide) synthesis is to replace the free primary amine initiator with its 
corresponding amine hydrochloride salt. 215
Enhanced control of the NCA polymerization can also be obtained by using a zero­
valent nickel complex (149) as initiator. 216 The transition metal mediates in the addition of 
monomers to the active polymer chain-end (150), suppressing chain-transfer and 
termination side reactions.
In another example of this macroinitiator strategy, a dual initiator was synthesized 
containing a primary amine and a nitroxide group.217 ROP yielded poly(y-benzyl-L- 
glutamate) with high structural control. Macroinitiation of styrene by nitroxide-mediated 
controlled radical polymerization yielded a block copolymer with a polydispersity around 1 .1 . 
Both polymerizations were also successfully conducted in one pot without intermediate 
isolation owing to the high compatibility of both polymerization techniques.
2.6 | G rafting th ro u g h
An interesting peptide-polymer bioconjugate architecture places the peptide moieties 
as side-chain functionalities on a polymer backbone. When aiming for these comb-shaped 
structures the grafting to strategy can fall short as it is very difficult to achieve quantitative 
functionalization.122, 167 To overcome this problem, another strategy has been developed in 
which the peptide is attached to the monomer unit. Therefore, after polymerization, every 
monomer is inherently functionalized. The disadvantage of this strategy is that synthesizing
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peptide-functionalized monomers is not trivial, and compatibility issues between the 
polymerization technique and peptide moiety have to be taken into account.
As one of the first examples, the dipeptide Leu-Ala was introduced to both 
methacrylamide218 and methacrylate219 units and polymerized by free radical polymerization. 
Extension of this procedure to an acrylamide having a Leu-Ala-based oligopeptide side-chain, 
afforded an oligomer with a degree of polymerization between 3-8 .220 The peptide moiety of 
the resulting product maintained its a-helical structure after polymerization in 
chlorobenzene, but the conformation was lost in DMF.
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Scheme 2 .34  | ROMP and ADMET of peptide-functionalized monomers.
In another early example, norbornene-derived peptide-functionalized monomers with 
the cell adhesive sequences Gly-Arg-Gly-Asp and Ser-Arg-Asn (153) were polymerized via 
ring-opening metathesis polymerizations (ROMP) using a Grubbs’ catalyst (Scheme 2.34) . 221 
Incorporation of a PEG-functionalized monomer (152) was found to prevent premature 
precipitation of the polymer during the course of polymerization and yielded a water soluble 
product. In a further study, a polymer substituted with a Gly-Arg-Gly-Asn-Ser peptide was 
shown to be significantly more active than the free peptide. 222 This result demonstrates that 
the increased local concentration of peptides in comb-shaped bioconjugates can lead to 
multivalent interactions and thereby significantly enhance the observed biological activity. In 
a further example of the use of the Grubbs’ catalyst, dipeptide olefin monomers (155) were 
polycondensated via acyclic diene metathesis (ADMET) (Scheme 2.34 ) . 223
Isocyanide moieties have also been introduced as monomeric units on the N-terminus 
of oligopeptides.224, 225 These monomers were subsequently polymerized using a nickel catalyst 
and formed rigid ß-helical rods. This rigidity was caused by the hydrogen bonding network 
formed between the amide groups of the peptide side-chains. Moreover, it was shown that the 
handedness of the helix could be steered by changing the enantiomeric configuration of the 
peptide side-chain.
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Scheme 2 .35  | ATRP of peptide-functionalized monomers.
The recent emergence of controlled radical polymerizations has provided a new 
momentum to the field of peptide-functionalized monomers by presenting better control 
over the polymerization reaction. The possibilities were first illustrated with the ATRP 
polymerization of a methacrylate coupled to Val-Pro-Gly-Val-Gly, a pentapeptide sequence 
derived from the structural protein tropoelastin (157).226 The polymerization of this 
monomer with the initiator ethyl 2-bromo-2-methylpropionate (158, Ebib) proceeded in a 
controlled fashion and yielded polymers with a reasonably low PDI (1.25). Using a 
bifunctional PEG-based macroinitiator (160) it was even possible to synthesize triblock 
copolymers with fairly narrow molecular weight distribution (PDI 1.27).227 Using the same 
bifunctional initiator, monomers with an Ala-Gly-Ala-Gly side-chain were also polymerized 
in a controlled manner (PDI 1.12) . 228 The living character of the ATRP process was 
furthermore illustrated by extending the block copolymer with a further MMA block via an 
in-situ macroinitiation (PDI 1.17).
It was possible to polymerize even bulkier peptide-functionalized monomers with 
ATRP. The cyclic ß-sheet forming decapeptide gramicidin S was modified with a 
methacrylate handle and subsequently polymerized via ATRP. 229 Although the 
polymerization was very slow, first-order kinetics were observed and a low PDI was obtained 
(1.09). The secondary structure of the peptide moiety was retained within the resulting 
polymer, as indicated by IR spectroscopy.
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The study with the Val-Pro-Gly-Val-Gly-functionalized methacrylate monomer was 
repeated with RAFT. 230 Using this technique, polymers with a higher degree of 
polymerization and lower PDIs were isolated. In ATRP the copper catalyst might complex 
with the amide bonds in the peptide side-chains and be deactivated. The absence of this 
peptide-induced deactivation in RAFT explains the improved polydispersities which were 
obtained.
2.7 | C onclusion
The combination of synthetic polymers with polypeptides has opened the path 
towards a great new set of materials with unprecedented properties obtained in part because 
of the intrinsic (bio)functionalities of proteins and peptides. As these applications become 
ever more sophisticated, the requirement for selective and even specific coupling methods 
increases. This development has been illustrated in this chapter, where we have shown the 
advancement from early day coupling methods based on nucleophilic attack of amines 
present in proteins and peptides, to the introduction of bio-orthogonal click reactions. In the 
future, this trend will only continue into the expansion of more facile and widely applicable 
bio-orthogonal conjugation methods.
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Peptide-polymer conjugates in solution
3.1 | Introduction
By combining peptides and polymers in so-called bioconjugates, synthetic polymers 
can be created that are not merely structural materials, but also have functional properties. 
This new class of hybrid polymers has drawn much attention since these peptide 
bioconjugates can be potentially used for a wide range of applications including drug delivery, 
stimulus-responsive materials, bioactive surfaces and self-assembling structures.1-3 Chapter 
two described how the full potential of these bioconjugates can only be achieved with 
synthetic strategies that give good control over the architecture of the envisioned polymer 
products.4 Because of the highly functional nature of peptides however, this is especially 
difficult.5
An attractive bioconjugate architecture is the so-called comb-shaped structure, where 
peptides are installed as side-chain groups along a polymer backbone. The high loading 
capacity of this architecture makes it an interesting drug delivery system for example.6, 7 A 
high grafting density can furthermore be favourable in cases where the bioactivity is related to 
having multiple copies of a peptide in close proximity of each other. These bioconjugate 
materials can be synthesized from peptide-functional monomers using controlled (radical) 
polymerization techniques.8-11 However, compatibility issues between the polymerization 
technique and peptide moiety have to be taken into account and the size of the monomeric 
unit can furthermore greatly limit the speed of polymerization and molecular weight which 
can be obtained.
To overcome these problems of this grafting through strategy, another strategy has 
been developed in which the peptide is only attached to the reactive side-chains of a polymer 
after polymerization.12-14 The modular nature of this grafting to strategy makes it easier to vary 
the peptide component attached to the polymer backbone. However, in order to obtain (near) 
quantitative functionalization, the conjugation reaction needs to be very robust, efficient and 
bio-orthogonal. Several conjugation reactions have been developed which satisfy these 
requirements and which are commonly referred to as ‘click’ reactions. Prime examples for the 
construction of bioconjugates include the copper-catalyzed azide-alkyne 1,3-dipolar
3
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cycloaddition (CuAAC),15, 16 the strain-promoted azide-alkyne 1,3-dipolar cycloaddition 
(SPAAC)17-19 and the Staudinger,20, 21 oxime22, Diels-Alder23, 24 and thiol-ene reactions.25
These methods have until now been rarely used for the synthesis of comb-shaped 
peptide-polymer bioconjugates.14 A particular interesting example where multivalency is of 
importance is in the case of antimicrobial activity. Although the exact mechanism of action 
for most antimicrobial peptides (AMPs) is still unclear, it seems that the assembly of multiple 
molecules plays a crucial role for several AMPs.26-28 Pre-organization of AMPs on a polymer 
backbone might therefore increase their activity.
In this chapter we want to explore the scope and limitations of CuAAC and SPAAC 
for the construction of comb-shaped bioconjugates in solution. The copper catalyst needed 
for CuAAC limits the use of any resulting products both in vitro and in vivo because of its 
inherent toxicity.29 Therefore, SPAAC appears to be the preferred technique for the synthesis 
of these peptide-containing functional materials.
3.2 | R esu lts an d  d iscu ssion
Using a modified literature procedure,30 2-azidopropyl methacrylate (1, APMA) was 
synthesized from 2-hydroxypropyl methacrylate (HPMA) via a Mitsunobu reaction using 
hydrazoic acid as the nucleophile (Scheme 3.1). Because of hydrazoic acid’s toxicity, special 
precautions have to be taken (see experimental). Initial copolymerization of APMA with 
HPMA via a free radical polymerization using benzoyl peroxide (BPO) failed, probably due to 
azides reacting with the propagating radicals, resulting in uncontrolled network formation. 
This type of cross-linking can be circumvented using a living radical polymerization 
technique such as Atom Transfer Radical Polymerization (ATRP). A copolymer of APMA 
and HPMA (2) was obtained accordingly, using ethyl 2-bromoiso butyrate (EBIB) as an 
initiator and CuCl/2,2’-bipyridine as a catalyst (Scheme 3.1). The consumption rates of 
APMA and HPMA during polymerization were similar, suggesting a random composition for 
the resulting copolymer. Because a small deviation from first-order kinetics indicated 
termination during polymerization, the reaction was stopped at low conversion (47%) as to 
maintain a narrow molecular weight distribution (polydispersity index = 1.17).
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Scheme 3.1 | Synthesis of APMA (1) and subsequent copolymerization with HPMA via ATRP. Reagents 
and conditions: i) toluene, DEAD, Ph3P, HN3, 0 °C to r.t., 16 h (6 8 %); ii) MeOH, Ar Atm., 40 °C, 7 h, Mn = 
7.1 x103 g mol-1, PDI = 1.17.
containing a p-nitro phenylalanine residue (3) according to a literature procedure.33 The side- 
chain nitro-group was selectively reduced by transfer hydrogenation using ammonium 
formate and palladium on charcoal. The resulting amine (4) was functionalized with either a 
dibenzocyclooctyne group (5a, DIBAC) or a terminal alkyne (5b) using standard peptide 
coupling conditions with 2-(7-Aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HATU) and N,N-diisopropylethylamine (DiPEA) as coupling agents 
(Scheme 3.2). The crude products (6a and 6b) were finally purified by LH-20 gel-filtration.
The gramicidin S analogs were conjugated to the azide-containing APMA/HPMA 
copolymer. The SPAAC-conjugation between DIBAC-functional gramicidin S 6a and 
polymer 2 was conducted by simply mixing the peptide and polymer in methanol with a 
molar ratio of alkyne groups to azides of 1.1/1 (Scheme 3.3). Excess peptide was subsequently 
scavenged using an azide-functional resin,34 followed by dialysis. Evidence for the occurrence 
of the bioconjugation was obtained from SEC analysis, which showed that the final 
bioconjugate had an increased molecular weight compared to the azide-containing polymer 
substrate (Figure 3.1A). The molecular weight distribution of product and substrate 
remained virtually the same and suggests that the post-polymerization functionalization step 
does not change basic polymer properties and goes to a high level of completion. However, 
the FTIR spectrum of bioconjugate 7a showed a small residual azide band at 2105 cm-1 
(Figure 3.1B), suggesting that functionalization was not quantitative. 1H-NMR spectroscopy 
was also used to estimate the degree of functionalization. Comparison of the aromatic signals 
from gramicidin S 7a (between 8 and 7 ppm) with the alkyl signal next to the ester found
Gramicidin S31, 32 was chosen as the AMP for this study and an analog was synthesized
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solely in the polymer component (between 3.9 and 3.7 ppm) suggested a functionalization of 
around 70%.
Scheme 3.2 | Synthesis of clickable gramicidin S analogs 6a and 6b. Reagents and conditions: i) EtOH, 
HCO2NH4, 10% Pd/C, 1 h (quant.) ii) CH2Q 2, HATU, DiPEA, 2 h (80% for 6a and 95% for 6b).
To investigate whether the incomplete DIBAC bioconjugation was due to the bulk of 
the peptide or due to the coupling moiety used, sterically less hindered reaction partners (8 
and 9) were chosen. While keeping the molar ratio between these DIBAC-probes and the 
azides from polymer 2 at 1.1/1, neither probe showed full conversion. Even with 2.5 
equivalents of the DIBAC reaction partner only partial functionalization was seen. The 
incomplete functionalization with the small coumarin-probe (9) suggests that the steric bulk 
of peptide 6a and PEG 8 does not form the limiting factor for the conjugation. DIBAC’s 
reactivity should not cause problems either, as it is known that azide-containing polymers 
react very fast with DIBAC.30 It would therefore appear that the steric bulk of the DIBAC 
moiety itself limits the degree of grafting in these highly dense systems.
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Scheme 3.3 | Conjugation of the clickable gramicidin S analogs (6a and 6b), PEG (8) and coumarin (9) to 
the APMA/HPMA copolymer (2) using either the SPAAC reaction or CuAAC. Reagents and conditions: iii) 
MeOH, 35 °C, 20 h iv) CH2Q 2, azide-functional resin, 3 days v) MeOH/H2O, 35 °C, 20 h vi) CH2Q 2, 35 °C, 24 h
vii) MeOH, CuBr, tris((1-((O-ethyl)carboxymethyl)-(1,2,3-triazol-4-yl)) methyl)amine, Ar atm., 35 °C, 18 h
viii) CH2Q 2, CuBr, tris((1-((O-ethyl)carboxymethyl)-(1,2,3-triazol-4-yl)) methyl)amine, azide-functional 
resin, Ar atm., 22 h.
In order to confirm this assumption, the less sterically hindered gramicidin S 6b, 
containing a terminal alkyne, was conjugated to polymer 2 using CuBr and tris((1-((O- 
ethyl)carboxymethyl)-(1,2,3-triazol-4-yl)) methyl)amine35, 36 as catalyst at an alkyne/azide 
molar ratio of 1.1/1 (Scheme 3.3). A similar work-up and purification procedure was 
followed as for the SPAAC bioconjugation. SEC analysis indicated a molecular weight 
increase of bioconjugate 7d compared to the starting material. The molecular weight 
distribution of the product again matched that of the substrate polymer. Moreover, the 
molecular weight shift observed for the CuAAC was bigger than the one observed for the 
DIBAC-based SPAAC bioconjugation (Figure 3.1 A), suggesting a higher grafting density. 
This was confirmed by FTIR, where the azide band completely disappeared (Figuur 3.1B). 
Using the *H-NMR analysis which was described earlier, a degree of functionalization of 
>95% was found. These spectral data clearly show that the CuAAC reaction was efficient, and 
(near) quantitative functionalization was achieved.
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Figure 3.1 | A) SEC traces of the APMA/HPMA copolymer 2 and the bioconjugates 7a and 7d.
B) FTIR spectrum of the APMA/HPMA copolymer 2 and the bioconjugates 7a and 7d. The assignment of 
the separate lines can be found in the insert of both figures.
The comb-shaped bioconjugates 7a and 7d were subsequently Boc-deprotected, 
resulting in two cationic polymers. Several cationic polymers are known in literature which 
exhibit higher antimicrobial activities in solution than their corresponding low molecular 
weight monomers.37 It was therefore hoped that the deprotected gramicidin S bioconjugates 
would be highly active. The antimicrobial activity of these bioconjugates was established by 
determining the minimal inhibitory concentration (MIC) during an incubation series in a 
standard screening assay in broth on several Gram-positive and Gram-negative bacterial 
strains (Table 3.1). Staphylococcus aureus, CNS, and Steptococcus mitis are Gram-positive 
species, whereas Escherichia coli and Pseudomonas aeruginosa are Gram-negative species. The 
antimicrobial activity of native gramicidin S is included in the table for comparison and is in 
agreement with previously reported data.38
Native gramicidin S Deprotected conjugate 7a Deprotected conjugate 7d
Incubation time (h) 24 48 72 96 24 48 72 96 24 48 72 96
S. aureus 7323 8 8 8 8 32 64 64 64 >64 >64 >64 >64
CNS 5277 8 8 8 8 32 32 32 64 >64 >64 >64 >64
S. mitis BMS 8 16 16 16 32 64 64 64 >64 >64 >64 >64
E. coli ATCC25922 32 32 32 32 >64 >64 >64 >64 >64 >64 >64 >64
Ps. aeruginosa ATCC19582 >64 >64 >64 >64 >64 >64 >64 >64 >64 >64 >64 >64
Table 3.1 | Antimicrobial screening assay of gramicidin S and the bioconjugates 7a and 7d after Boc- 
deprotection on several Gram-positive and Gram-negative bacterial strains (MIC in ^g/mL).
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The final gramicidin S bioconjugates are far less active than the native gramicidin S, 
unfortunately. Comparison of the deprotected bioconjugates 7a and 7d, suggests that 
increasing the distance between the peptide and the polymer backbone is favourable for the 
antimicrobial activity, and it is clear that the spacing between polymer backbone and 
gramicidin S should be increased further. Although these are not very encouraging results, 
the current bioconjugates might still prove to be active in vivo. AMPs can stimulate and 
enhance the adaptive immune system of their host,39 thereby magnifying their own activity. 
Extrapolation of in vitro results to in vivo activities in an actual clinical situation should 
therefore always be performed with certain caution.
3.3 | C onclusion
We have shown a modular strategy for the construction of highly dense comb-shaped 
peptide-polymer bioconjugates in which either the DIBAC-based SPAAC or CuAAC 
reactions were utilized. The CuAAC gave a high grafting density under mild conditions. This 
is in sharp contrast with previously reported bioconjugations of highly dense systems which 
needed high temperatures or microwaves to obtain high conversion.14, 40
The steric bulk of the DIBAC-moiety on the other hand, seemed to limit the degree of 
functionalization. The recently developed bicyclo[6.1.0]non-4-yne (BCN) probe41 might offer 
a solution. Like the DIBAC-moiety this strained alkyne spontaneously reacts with azides, but 
because of the absence of the two aromatic rings its size is greatly reduced. Preliminary results 
indeed suggest that it can be used for the synthesis of comb-shaped bioconjugates with high 
grafting densities in a copper-free fashion.
The deprotected gramicidin S bioconjugates showed no significant antimicrobial 
activity, unfortunately. The point of attachment and chemical linkage have been chosen in 
such a way as to minimize their influence on the activity of gramicidin S.33 The length of the 
spacer molecule however still needs to be investigated further as it is particularly important in 
governing the ease with which the conjugated peptides can interact with the membranes of 
approaching bacteria.42, 43 In the course of this research, poly(ethylene glycol)-based spacers 
with an terminal alkyne- and BCN-handle were synthesized. It proved difficult however, to 
couple these molecules to gramicidin S.
The relative efficiencies of the CuAAC and the SPAAC conjugation furthermore 
illustrate that the size of the conjugation moiety can have significant influence on the 
feasibility of certain specific architectures. Efficiency, biocompatibility and water-solubility 
are common targets in the on-going search for better conjugation techniques. However, 
reducing the size of the conjugation moiety itself is a worthwhile goal as well.
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3.4 | Experim ental
Reagents. All purchased chemicals were obtained from common commercial sources and 
used as received. 2-hydroxypropyl methacrylate (HPMA) was distilled prior to use. 
Tetrahydrofuran (THF) was distilled from sodium and benzophenone. Dichloromethane 
(CH2O 2) was filtered over CaCl2 and dried by distilling from CaH2 and triethylamine (Et3N). 
Dry N ,N -dimethylformamide (DMF) was purchased from BioSolve. Columbia Agar with 
sheep blood was purchased from OXOID; nutrient broth from Difco (ref. nr. 234000, lot nr. 
6194895) and yeast extract from OXOID (LP 0021, lot nr. 900711). Water was demineralized 
prior to use. MilliQ grade water was obtained using the Labconco Water Pro PS. The HCl 
solution in EtOAc was prepared by saturation of EtOAc with chlorine gas.
Instrumentation. NMR spectra were recorded on a Bruker DMX300 (300 MHz for 1H and 75 
MHz for 13C) and Varian Inova 400 (400 MHz for 1H). 1H-NMR chemical shifts (ô) are 
reported in parts per million (ppm) relative to a residual proton peak of the solvent: ô = 3.31 
for CD3OD and ô = 7.26 for CD Q 3. Multiplicities are reported as: s (singlet), d (doublet), t 
(triplet), q (quartet), p (pentet), se (sextet), dd (double doublet), dt (double triplet), tt (triple 
triplet), ddd (double, double doublet) or m (multiplet). Broad peaks are indicated by br. 
Coupling constants are reported as a /-value in Hertz (Hz). The number of protons (n) for a 
given resonance is indicated as nH, and is based on spectral integration values. 13C-NMR 
chemical shifts (ô) are reported in ppm relative to CD3OD (ô = 49.0) or CDCl3 (ô = 77.0). ESI- 
MS analysis was performed using Thermo Scientific Advantage LCQ  Linear-Ion trap 
Electrospray (LRMS). Electrospray ionization time-of-flight (ESI-ToF) spectra were measured 
with a /EOL AccuToF (HRMS). FT-IR spectra were recorded on an ATI Matson Genesis Series 
FT-IR spectrometer fitted with an ATR cell. Vibrations (v) are given in cm-1. Molecular 
weight distributions were measured using size exclusion chromatography (SEC) on a 
Shimadzu system (DGU-20A5, LC-20AT, SIL-10AD and CTO-20A) with Shimadzu refractive 
index (RID-10A) and UV-Vis (SPD-20A) detectors. The system was equipped with a guard 
column and a PL gel 5 ^m mixed D column from Polymer Laboratories using NMP as the 
mobile phase at 1.0 mL/minute and 65 °C. Poly( styrene) standards in the range of 162 to
6,035,000 g/mol were used to calibrate the SEC. Data collection was performed with the 
program LCsolution 1.21 SP1 by Shimadzu. Hydrogenation was performed with a Parr 
Hydrogenation Apparatus. Thin layer chromatography (TLC) was carried out on Merck 
precoated silica gel 60 F-254 plates (layer thickness 0.25 mm). Compounds were visualized by 
UV, KMnO4, ninhydrin or iodine colouring. Column chromatography was performed using 
Acros silica gel (0.035-0.070 mm, pore diameter ca. 6 nm). Peptide purification was
Peptide-polymer conjugates in solutioi 81
performed on a Gilson GX-281 automated HPLC system, equipped with a preparative Gemini 
C18 column (150 x 21.20 mm, 5^). The applied buffers were: A: 0.2% aqueous TFA and B: 
MeCN. Dialysis tubes were purchased from Spectrum Laboratories (Spectra/Por Biotech, 
regenerated cellulose, Mw < 3500 g/mol cut off).
Synthesis o f 2-azidopropyl methacrylate (APMA, 1). In a three-necked-flask equipped with a 
dropping funnel, a thermometer and a gas outlet tube, a paste was prepared from sodium 
azide (6.00 g, 0.09 mol) and water (7.5 mL). Toluene (30 mL) was added and the mixture was 
cooled to 0 °C. The gas outlet tube was connected to a flask filled with a saturated aqueous 
sodium hydroxide solution, quenching any evaporating hydrazoic acid. Cold concentrated 
H2SO4 (4.4 g, 0.05 mmol) was added drop wise while keeping the temperature below 5 °C. 
The mixture was stirred for an additional hour after which the aqueous phase was separated 
from the organic layer containing the hydrazoic acid (build-up of pressure should be 
avoided). Caution: Hydrazoic acid is highly toxic and volatile. These operations must be carried 
out in a well-ventilated hood.
In a two-necked-flask, triphenylphosphine (8.73 g, 0.03 mol) and 2-hydroxypropyl 
methacrylate (HPMA, 3.14 g, 0.02 mol) were dissolved in toluene (18 mL) and cooled to 0 °C. 
A gas outlet tube was again connected to a flask filled with saturated aqueous sodium 
hydroxide solution. The hydrazoic acid solution was added drop wise, followed by drop wise 
addition of diethyl azodicarboxylate (DEAD, 14.4 mL of a 40% solution in toluene, 0.03 mol), 
during which some gas build-up was observed. After addition, the mixture was slowly 
warmed to room temperature and stirred overnight. The mixture was washed with aqueous 
sodium hydroxide (1M, 50 mL) in order to neutralize any residual hydrazoic acid. The 
aqueous layer was extracted with toluene (3 x 50 mL). The toluene was evaporated in vacuo 
and the crude was purified by column chromatography using EtOAc/n-heptane (1/10) as 
eluent. This afforded the product as a colourless oil (2.50 g, 68%). The product was stored at 
-80 °C under an argon atmosphere. RF: 0.3 (EtOAc/n-heptane 1/10).
1H-NMR (400 MHz, CDCl3): 6.16 (m, 1H), 5.62 (m, 1H), 4.25-4.05 (m, 2H), 3.78 (m, 1H), 
1.96 (m, 3H), 1.26 (d, 3H) ppm. FT-IR vmax film (cm-1): 2954, 2116, 1718, 1636, 1377, 1165. 
LRMS (ESI+) m/z calcd. for C7HnN3NaO2 [M+Na] + 192.1, found: 192.0.
Preparation of APMA-HPMA copolymer 2. Cu(I)Cl (9.66 mg, 0.10 mmol) was placed under 
argon by three vacuum-argon cycles. Anisole (246 ^L, 2.25 mmol), 2,2’-bipyridine (31.69 mg, 
0.20 mmol), HPMA (657.8 mg, 4.56 mmol), and APMA (381.5 mg, 2.26 mmol) were added. 
Methanol (4.0 mL) was used to rinse the walls of the reaction mixture and the mixture was 
degassed by five freeze-pump-thaw cycles. Finally, the reaction mixture was heated to 40 °C
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and ethyl 2-bromoisobutyrate (16.8 ^L, 0.09 mmol) was added as initiator.12 During the 
reaction, samples were taken for SEC and NMR analysis where anisole acted as an internal 
standard. After 25 hours (and a 47% conversion according to NMR), the reaction was stopped 
by drop wise addition of the reaction mixture to an aqueous EDTA solution (0.065M, 
100 mL). The precipitate was filtered off and dissolved in THF and the precipitation step was 
repeated, after which the product was dried in vacuo resulting in an off-white product 
(221 mg, 45 %).
Number-average molecular weight (Mn) = 7.1x103 g mol-1, polydispersity index (PDI) = 1.17. 
1H-NMR (400 MHz, CDCl3) ô: 4.18-3.92 (m, 4H), 3.92-3.71 (m, 3H), 3.71-3.54 (m, 2H), 
2.17-1.71 (m, 5H), 1.37-1.16 (m, 10H), 1.16-1.04 (m, 3H), 1.04-0.76 (m, 5H) ppm. FT-IR vmax 
(cm-1): 3417 (br), 2971, 2933, 2358, 2103, 1722, 1593, 1450, 1381, 1389, 1242, 1148.
General procedure for the synthesis o f the clickable gramicidin S analogs (6a and 6b). The acid 
(3 eq, 150 ^mol, 5a or 5b) was dissolved in CH2O 2 (2 mL) after which HATU (2.9 eq, 
145 ^mol) and DiPEA (3 eq, 150 ^mol) were added. The mixture was preactivated for
1 minute and finally added to a solution of amine-functional gramicidin S (50 ^mol, 4) in 
CH2CL (100 |xL). The reaction mixture was stirred for 2 hours and the solvent was then 
evaporated in vacuo. The crude was purified by LH-20 gel filtration using methanol as eluent. 
The amides were obtained in 80-95% yield.
Gramicidin S-dibenzocyclooctyne (6a): LC/MS: Rt = 11.62 minutes (10 ^  90% MeCN, 
15 minutes). LRMS (ESI+) m/z calcd. for C90H125N 14O16 [M+H] + 1657.93, found: 1658.20. 
Gramicidin S-pentyne amide (6b): LC/MS: Rt = 11.69 minutes (10 ^  90% MeCN, 
15 minutes). LRMS (ESI+) m/z calcd. for C75H114N 13O15 [M+H] + 1436.85, found 1436.20.
Synthesis o f azide-functional resin (I). Prepared according to a modified literature procedure:34
1-Amino-11-azido-3,6,9-trioxaundecane44 (3.00 g, 13.70 mmol), NaCNBH3 (0.88 g, 13.97 
mmol) and AcOH (0.9 mL, 15.75 mmol) were dissolved in DMF/MeOH (1/1, 50 mL).
4-(4-Formyl-3-methoxyphenoxy) butyryl AM resin (1.37 g, loading 1 mmol/g) was added 
and the mixture was heated to 75 °C for 2.5 hours. During the reaction, N2 was gently bubbled 
through the suspension for mixing purposes. The resin was filtered, rinsed extensively with 
DMF, CH2CL and methanol and finally dried to the air. FT-IR Vmaxfilm (cm-1): 3347, 2920, 
2103, 1450, 1200, 1031, 698.
Tris((1-((O-ethyl)carboxymethyl)-(1,2,3-triazol-4-yl))methyl)amine (II). Prepared according 
to a literature procedure:35 Quantities used: ethyl azidoacetate in ethanol (25%, 13.5 mL,
21.3 mmol), 2,6-lutidine (3.2 mL, 27.6 mmol), tripropargylamine (0.71 mL, 5.0 mmol),
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MeCN (15 mL), Cu(MeCN)4PF6 (88 mg, 0.24 mmol). The product was obtained as a light 
brown solid (1.98 g, 76%).
1H-NMR (400 MHz, CDCk): 7.85 (s, 3H), 5.16 (s, 6H), 4.26 (q, /  = 7.2 Hz, 6H), 3.81 (s, 6H),
1.29 (t, /  = 7.2 Hz, 9H) ppm. LRMS (ESI+) m/z calcd. for C21H31N 10O6 [M+H]+ 519.2, found
519.3.
Bioconjugation between the APMA-HPMA copolymer 2 and gramicidin S 6a (7a).The APMA- 
HPMA copolymer 2 (1.00 mg, azide content of approximately 0.0022 mmol) and gramicidin
S 6a (4.00 mg, 0.0024 mmol) were dissolved in methanol (2.0 mL) and stirred at 35 °C for 
20 hours. The reaction mixture was concentrated in vacuo and redissolved in CH2Cl2 
(2.0 mL). The excess gramicidin S was removed by shaking the solution together with an 
azide-functional resin (I, 85 mg) for 20 hours. The reaction mixture was concentrated in 
vacuo again, redissolved in methanol (2.0 mL) and dialyzed against methanol for 3 days using 
a dialysis tube with a Mw < 3500 g/mol cut off. The solution was concentrated in vacuo to 
afford the product as a white solid (3.13 mg, 67%).
Mn = 10.7x103 g mol-1, PDI = 1.15. FT-IR vmax (cm-1): 3382 (br), 3265, 2956, 2921, 2102, 1633, 
1533, 1448, 1167, 1082, 1047.
Conjugation between the APMA-HPMA copolymer 2 and PEG 8 (7b). A similar procedure was 
used as for bioconjugate 7a. Amounts used: APMA-HPMA copolymer 2 (125 ^L of a 
0.55 mg/mL solution in methanol, azide content of approximately 0.15 ^mol), PEG 8 (600 ^L 
of a 0.55 mg/mL solution in H2O, 0.17 ^mol). The product was obtained as a white solid. 
FT-IR vmax (cm-1): 3481 (br), 2868, 2102, 1728, 1651, 1456, 1348, 1246, 1097, 947.
Conjugation between the APMA-HPMA copolymer 2 and coumarin 9 (7c). A similar 
procedure was used as for bioconjugate 7a. Amounts used: APMA-HPMA copolymer 2 
(5.56 mg, azide content of approximately 0.0122 mmol), coumarin 9 (8.43 mg, 0.0135 mmol) 
and CH2CL (1 mL). The product was obtained as a white solid.
FT-IR vmax film (cm-1): 3357 (br), 2916, 2108, 1711, 1614, 1522, 1225, 1146, 1049.
Bioconjugation between the APMA-HPMA copolymer 2 and gramicidin S 6b (7d). The APMA- 
HPMA copolymer 2 (3.78 mg, azide content of approximately 0.0083 mmol), gramicidin S 6b 
(12.69 mg, 0.0088 mmol), CuBr (3.17 mg, 0.0224 mmol) and tris((1-((O- 
ethyl)carboxymethyl)-(1,2,3-triazol-4-yl)) methyl)amine35 (II, 11.51 mg, 0.0222 mmol) were 
placed under argon atmosphere after three vacuum-argon cycles. Methanol (6.0 mL) which 
had been bubbled through with argon was added and the solution was stirred at 35 °C for
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18 hours. The reaction mixture was dialyzed with methanol as the solvent for 3 days using a 
dialysis tube with a Mw < 3500 g/mol cut off. The solution was concentrated in vacuo and 
redissolved in CH2O 2 (6.0 mL). The excess gramicidin S was removed by shaking the solution 
together with an azide-functional resin (I, 98 mg), CuBr (3.79 mg, 0.0269 mmol) and 
tris((1-((O-ethyl)carboxymethyl)-(1,2,3-triazol-4-yl)) methyl)amine (II, 14.05 mg, 
0.0272 mmol) for 22 hours. The solution was finally concentrated in vacuo, redissolved in 
methanol (6.0 mL) and dialyzed a second time against methanol for 3 days using a dialysis 
tube with a cut off of Mw < 3500 g/mol. The solution was concentrated in vacuo to afford the 
product as a light-green solid (8.15 mg, 52%).
Mn = 16.2x103 g mol-1, PDI = 1.16. FT-IR vmax (cm-1): 3396 (br), 3271, 2956, 2929, 1745, 1635, 
1533, 1448, 1215, 1169.
5-(11,12-Didehydrodibenzo[b,f]azocin-5(6H)-yl)-N-mPEG2000-1-yl-5-oxopentanamide (8). 
5-(11,12-Didehydrodibenzo[b,f]azocin-5(6H)-yl)-5-oxopentanoic acid19 (10 mg, 0.031 mmol) 
was dissolved in dry CH2O 2 (5 mL) and cooled to 0 °C. Subsequently, H2N-PEG2000-OMe (69 
mg, 0.034 mmol), EDC-HCl (13 mg, 0.068 mmol) and DMAP (15 mg, 0.12 mmol) were 
added. The reaction was stirred for 30 minutes at 0 °C, slowly warmed to room temperature 
and stirred overnight. Since the reaction did not go to completion another 0.2 equivalents of 
H2N-PEG2000-OMe (12 mg, 0.006 mmol) were added and the reaction was stirred for an 
additional day. The reaction was diluted with CH2O 2 (15 mL) and washed with 2 M HCl 
(3 x 20 mL), H2O (20 mL) and brine (20 mL) and dried over MgSO4. The crude product was 
purified by column chromatography (CH2Cl2/MeOH, 9:1) to obtain a mixture of 8 and H2N- 
PEG2000-OMe in a ratio of 9:1, which was determined by comparing the methoxy-signal with 
the aromatic signals in the 1H-NMR spectrum. 1H-NMR (CDO 3, 400 MHz), ô: 7.70 (d, 
/  = 6.4 Hz, 1H), 7.62-7.42 (m, 5H), 7.21-7.03 (m, 2H), 5.89 (br s, 1H), 5.16 (d, /  = 13.8 Hz, 
1H), 3.64 (s, 196 H), 3.60-3.54 (m, 4H), 3.49-3.46 (m, 4H), 3.38 (s, 3.3H), 2.31-2.24 (m, 1H), 
2.04-1.83 (m, 3H), 1.76-1.70 (m, 2H) ppm.
The ESI-ToF spectrum showed a clear shift of the molecular weight distribution. In the 
double charge distribution a shift in molecular mass between starting material and product of 
150.557 was observed, where a shift of 150.555 was expected.
2H-1-Benzopyran-4-acetic acid, 7-[(ethoxycarbonyl)amino]-2-oxo-5-[[(7,8-didehydro-1,2:5,6- 
dibenzocyclooctene-3-yloxy)carbonyl]amino]pentyl ester (9). To a solution of 1-(N- 
ethoxycarbonyl-7-amino-coumarin-4-yl) acetic acid aminopentyl ester-TFA30 (37 mg, 
0.1 mmol) and Et3N (30 mg, 0.3 mmol) in dry DMF (10 mL) was added carbonic acid 7,8- 
didehydro-1,2:5,6-dibenzocyclooctene-3-yl ester 4-nitrophenyl ester18, 30 (39 mg, 0.1 mmol)
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under an argon atmosphere. After stirring the reaction mixture overnight at ambient 
temperature, the solvent was removed under reduced pressure and the residue was purified 
by preparative TLC (EtOAc/n-heptane, 1:1) to afford the product as an off-white solid 
(73 mg, 90%). Rf = 0.52 (EtOAc/n-heptane, 1:1).
1H-NMR (300 MHz, CDCL) ô: 7.62-7.22 (m, 10H), 7.01-6.99 (m, 1H), 7.25 (s, 1H), 5.51-5.48 
(m, 1H), 5.04 (br s, 2H, NH), 4.28-4.16 (m, 2H), 4.15-4.09 (m, 2H), 3.73-3.69 (m, 2H), 
3.16-3.10 (m, 2H), 1.72-1.18 (m, 9H) ppm. 13C-NMR (75 MHz, CDCL) ô: 168.7, 162.8, 160.6,
155.5, 154.7, 152.0, 151.0, 147.8, 142.0, 129.9, 128.0, 127.9, 126.3, 125.9, 125.2, 123.6, 114.9,
114.7, 106.1, 65.5, 61.7, 46.2, 40.9, 38.3, 29.8, 28.4, 28.2, 14.5 ppm. HRMS (ESI+) m/z calcd. 
for C36H34N 2O8 [M+H]+623.2392, found 623.2393. FT-IR vmax film (cm-1): 3667, 2963, 2359, 
1699, 1540, 1228, 1051, 608.
Deprotection o f gramicidin S bioconjugates 7a and 7d. The gramicidin S bioconjugates were 
dissolved in AcOH at a concentration of 20 mg/mL. This solution was added drop wise to a 
solution of HCl in EtOAc (2 M, 5 mL) and stirred for 45 minutes. The subsequent suspension 
was concentrated in vacuo, redissolved in dioxane (5 mL) and lyophilized yielding the desired 
products as a white powder.
1H-NMR (400 MHz, DMSO-D6 ) indicated the complete removal of the Boc-groups in both 
products.
Antimicrobial screening assays. Bacteria were stored at -70 °C and grown at 30 °C on 
Columbia Agar with sheep blood suspended in physiological saline until an optical density of 
0.1 AU was achieved (at 595 nm, 1  cm cuvette). The suspension was diluted ten times with 
physiological saline, and 2  ^L of this inoculum was added to 10 0  ^L of nutrient broth with 
yeast extract (2 g/400 mL broth) as growth medium in microtiter plates (96 wells). The 
deprotected gramicidin S bioconjugates were dissolved in DMSO (4 g/L), diluted in water 
(1000 mg/L), and subsequently diluted further in broth to the desired concentration (64, 32, 
16, 8 , 4 and 1 mg/L). The bacterial suspensions were incubated with the different 
bioconjugate solutions at 30 °C for a time series ranging between 24 and 96 hours. The MIC 
values were determined as the lowest concentration which inhibited bacterial growth.
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Copper-free clickable coatings
4.1 | Introduction
The advancement of chemoselective, robust and versatile transformations known as 
‘click’ reactions2 has allowed the modular build-up and functionalization of well-defined 
polymeric materials. The most frequently applied click reaction nowadays is the copper- 
catalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC),2 which has been used for the 
preparation of cross-linked networks3 and for the functionalization of both polymers in 
solution4 and polymeric coatings on surfaces.5-22 Chapter two described how click chemistry 
has played a major role in the development of polymer-based bioconjugates,12 which combine 
the versatility of standard synthetic polymers with advanced biological functions of proteins, 
polysaccharides and DNA. Although potential applications of these polymer-based biohybrid 
systems are envisioned in the area of biology and biomedicine,13 the necessity to use the 
inherently toxic copper for the construction of these materials14 limits their possible use both 
in vitro and in vivo. Alternatively, several non-toxic copper-free click reactions have been 
developed within the field of chemical biology in recent years, such as the strain-promoted 
azide-alkyne 1,3-dipolar cycloaddition (SPAAC)15-17 and the Staudinger,18,19 oxime,20 Diels- 
Alder21, 22 and thiol-ene reactions.23 Chapter three explored the possibilities of the 
dibenzocyclooctyne-based SPAAC reaction for the grafting to of a peptide to a side-chain 
functional polymer.24 This chapter extends this strategy to the construction of clickable 
coatings.
Because of our interest in biologically active interfaces, we have developed the first 
copper-free click procedure for both the synthesis and functionalization of a polymeric 
coating. This method involves a two-step process in which a thermal curing procedure is 
followed by copper-free click functionalization, both of which are performed using azide 
groups. Because of the stability of the azide group, the excess of used azides survives the 
coating procedure and remains present in the coating until suitable reaction partners are 
introduced onto the clickable coating. This modular approach makes it possible to 
incorporate sensitive molecules, such as fluorescent probes and peptides, into the polymer 
coating in a later stage, thereby circumventing exposure to harsh polymerization and coating 
conditions.
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Figure 4.1 outlines the strategy for the construction of the clickable coating in more 
detail. A stable network is formed by thermally reacting azide-functionalized polymers with 
di-alkyne cross-linkers. Alkyne groups on a glass substrate anchor the network to the surface. 
By selecting the appropriate ratio between azide groups and alkyne moieties during the 
coating procedure, a significant number of unreacted azide groups remain present in the 
network after the coating is formed. These unreacted azides are subsequently used for the 
functionalization of the coating. During this functionalization step three methods are 
compared, i.e. the dibenzocyclooctyne-based SPAAC,17 the Staudinger ligation,19 and the 
oxanorbornadiene-based tandem cycloaddition-retro-Diels-Alder (crDA) reaction.25
Figure 4.1 | Schematic overview of the construction of a clickable coating, where both coating formation 
and coating functionalization are performed using azide groups.
4.2 | R esu lts an d  d iscu ssion
The first component required for the clickable coating, i.e. an azide-containing 
polymer, was synthesized from the azide-functionalized monomer 2-azidoethyl methacrylate 
(1, AzMA), which was prepared via a Mitsunobu reaction starting from 2-hydroxyethyl 
methacrylate (HEMA, Scheme 4.1). As discussed in chapter two, copolymerizations of azide- 
containing monomers via a free radical polymerization using benzoyl peroxide (BPO) are 
impossible as azides react with the propagating radicals, resulting in uncontrolled network 
formation. To circumvent this type of cross-linking, living radical polymerization techniques
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such as Atom Transfer Radical Polymerization (ATRP) or Reversible Addition­
Fragmentation chain Transfer (RAFT) were employed. Modified literature procedures for 
both ATRP26, 27 and RAFT,28 afforded copolymerizations with first-order kinetics up to high 
conversions and resulted in products with narrow molecular weight distribution. 
Additionally, it also proved to be possible to modify the azide content of the polymer product 
by simply changing the ratio of AzMA and MMA in the reaction mixture. In this manner, we 
obtained copolymers with build-in ratios of AzMA compared to MMA of 1:1.1 and 1:1.4 for 3 
and 5, respectively (Scheme 4.1).
Monomer synthesis
X Y0 ^ 0  + 0 ^ 0
I
0 ^ 0 +  cr^o 
I
Scheme 4.1 | Synthesis of AzMA and subsequent copolymerization with MMA via ATRP or RAFT 
polymerization. Reagents and conditions: i) Toluene, DEAD, Ph3P, HN3, 0 °C to r.t., 16 h (76%); ii) Toluene, 
Ar-atm., 60 °C, 20 h; iii) Toluene, Ar-atm., 65 °C, 21 h; Table insert provides an overview of the number­
average molecular weight (Mn), polydispersity (PDI) and AzMA:MMA ratio.
Complementary to the azide-functionalized polymers, two alkyne-containing cross­
linking agents3 were constructed consisting of tetra(ethylene glycol) (TEG) equipped with 
either two propyne units (6) or two dibenzocyclooctyne groups (10, Scheme 4.2).
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Scheme 4.2 | Synthesis of TEG based cross-linkers. Reagents and conditions: i) toluene, NaH, 0 °C, 50 
min.; ii) toluene, 0 °C, 6  h (64%); iii) THF, CH3SO2Q, Et3N, Ar-atm., 3.5 h; iv) H2O, NaN3, 85 °C, 24 h (85%); v) 
MeOH, Pd/C, H2-atm., r.t., 3 h (98%); vi) CH2Cl2, Ar-atm., 0 °C to r.t., 19 h (60%).
Prior to coating the glass substrate with a mixture of polymer and cross-linker, the 
glass was first functionalized with terminal alkynes. These groups served as primers and 
tethered the polymeric network to the glass substrate. The attachment of the terminal alkynes 
to the glass surface was achieved via an efficient three step protocol (Scheme 4.3).29, 30 First the 
surface was activated with a piranha solution after which it was directly reacted with an 
amine-containing silane. In the final step the amines introduced were effectively decorated 
with pentynoic acid by applying conventional peptide coupling chemistry.
OH OH OH
I I I Si(OMe)3
- v X rHO ^O
Scheme 4.3 | Glass surface functionalization. Reagents and conditions: i) H2O2, H2SO4 ii) H2O, r.t., 20 h; iii) 
H2O, DMAP, EDC, r.t., 20 h.
The desired azide-containing coatings were then produced by reacting a solution of 
the ATRP copolymer (3) and cross-linker 6 on a functionalized glass substrate. A well- 
defined polymer film was deposited on the surface using a coating bar with grooves of 24 ^m. 
After evaporation of the solvent (CH2Cl2), the glass slide was placed in a vacuum stove at 
120 °C. A thermal 1,3-dipolar cycloaddition between the azides and terminal alkynes resulted 
in the effective copper-free formation of a polymer network which was completely
Copper-free clickable coating.g 93
transparent and highly resistant to a wide range of organic solvents. Moreover, Infrared 
Reflection-Absorption Spectroscopy (IRRAS) measurements indicate that the surplus of azide 
groups in the coating mixture survived this thermal curing procedure (Graph 4.1). 
Alternatively, RAFT copolymer 5 was used in the same coating procedure. The resulting 
coating was again transparent and stable, but surprisingly could not be functionalized in a 
consecutive step. This might be due to radicals originating from the RAFT agent’s end group 
on polymer 5 during heating, which can subsequently react with the azides. The network 
formation was therefore performed with the more reactive cross-linker 1 0 , which allowed the 
curing temperature to be lowered to 65 °C, thus preventing the decomposition of the RAFT 
agent. This afforded a coating that was still reactive and furthermore consisted of components 
that are copper-free themselves.
O
UEtO N 
H
.c a
11
I H O ^ ^ N 'B0C12
O
u
EtO N 
H
13 R = B 0 C  
^ 1 4  R = H
A
3 *
Iv
20
v
O
u
EtO N 
H
■ C O ,
18
9
Scheme 4.4 | Synthesis of coumarin-containing ligation probes 15-18. Reagents and conditions: i) 
CH2Cl2, DMAP, EDC, 0 °C to r.t., 18 h (53%); ii) CH2Cl2, TFA, r.t., 3 d (92%); iii) DMF, Et3N, Ar-atm., r.t., 16 h 
(90%); iv) CH2Q 2, 19, EtCO2Cl, Et3N, Ar-atm., -18 °C to 0 °C, 2 h, then 14 in CH2Q 2, r.t. 18 h (53%); v) CH2Q 2, 
EDC, DMAP, Ar-atm., 0 °C to r.t., 16 h (61%); vi) CH2Q 2, DMAP, EDC, 0 °C to r.t., 18 h (55%).
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The accessibility of the azide groups in the polymeric film was subsequently 
investigated using a variety of coumarin-based clickable reaction partners (Scheme 4.4). To 
this end, coumarin (11) was prepared using a literature procedure,31,32 and subsequently 
esterified with a spacer bearing a Boc-protected amine (12). After Boc-deprotection, the free 
amine was used to attach several reactive moieties by either EDC coupling with an acid or a 
reaction with an activated alcohol, affording products 15-17. The incorporated reactive 
moieties themselves (i.e. Staudinger probe, dibenzocyclooctyne and Me-oxanorbornadiene) 
were all synthesized using literature procedures and have been demonstrated to react 
efficiently with azides in the absence of copper. In addition, coumarin was functionalized 
with a terminal alkyne group (18) by a direct EDC coupling between coumarin (11) and 4- 
pentyn-1-ol and served for the comparison of the copper-free ligation methods with the 
broadly applied CuAAC reaction.
The fluorescently labelled reagents were covalently attached to the azide-containing 
coatings and using both IRRAS and fluorescence, the reaction was monitored by interval 
measurements. Briefly, fluorescent compounds 15-17 were simply dissolved in DMSO and 
deposited on the coating. Fluorescent reagent 18 was dissolved in DMSO and mixed with a 
copper catalyst before being deposited onto the coating. For each selected time interval, all 
four functionalized fluorescent probes were clicked onto a single coated glass slide, 
guaranteeing a fair comparison between the different methods. At the end of each time 
interval, the coating was rinsed by soaking and washing it extensively with DMSO and 
CH2Cl2. As a control experiment, a coating was treated with either a solution of coumarin 11 
or a solution of coumarin 18 omitting the copper catalyst. In both cases, the washing step 
proved to be effective in the removal of the non-covalently attached fluorescent reagents. In 
the case of the covalently attached coumarin 15-18, infrared spectra were obtained using 
IRRAS and the decrease of the azide signal was taken as a measure for the conversion of the 
reaction and plotted versus time (Graph 4.1). Additionally, the fluorescence intensity was 
measured using fluorescence microscopy in combination with a monochromic camera and 
subsequently plotted against time (Graph 4.2).
The IRRAS measurements show a clear decrease of the azide signal for all ligation 
probes, indicative that the fluorescent probes are covalently immobilized via the expected 
click reactions. However, in no instance a full conversion was observed. This is to be expected 
as the clickable coating will only have a limited permeability, making it hard for the ligation 
probes to fully penetrate the network and reach all azide groups.
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Graph 4.1 | A) Azide signal in the IRRAS spectra of a clickable coating constructed from polymer 3 and 
cross-linker 6 before functionalization (solid line) and after reacting for 24 hours with probe 15 (dotted 
line). B) Conversion versus time for the reaction of the four ligation probes: ♦ (15), ■ (16), ▲ (17), x (18). 
The conversion was determined by comparing the intensity of the azide signal in the IRRAS spectra 
before and after the predetermined reaction times. Lines are drawn to guide the eye.
Graph 4.2 | Fluorescence versus time for the reaction of the four ligation probes on a clickable coating 
constructed from polymer 3 and cross-linker 6: ♦ (15), ■ (16), ▲ (17), x (18). Lines are drawn to guide the 
eye.
Looking at the different time series in both the IRRAS and fluorescence 
measurements, quite erratic curves are observed. This can be explained by the set-up of this 
experiment, where each selected time interval required the use of a new functionalized glass 
slide, so that consecutive measurements within a progress curve had to be performed on 
different coatings. The inherent variation between the different coatings made quantitative 
interpretation of the results difficult. Comparison of the relative speed and efficiency of the
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coupling of the fluorescent compounds 15-18 was however still possible, thus providing 
qualitative insight into the immobilization processes over time. Surface functionalization 
using the dibenzocyclooctyne derivative in a SPAAC reaction clearly showed the highest rate 
of reaction. The tandem crDA reaction employing Me-oxanorbornadiene was significantly 
slower, but over time reached a comparable level of functionalization. Both the Staudinger 
ligation and the CuAAC initially demonstrated high reaction rates, which however quickly 
levelled off, leading to limited surface functionalization. Since all experiments were 
performed in air, the reduced reactivity of the Staudinger reaction can be explained by the 
oxidation of the phosphine moiety, whereas oxidation of the Cu(I) catalyst presumably causes 
the inactivation of the CuAAC process.
4.3 | C onclusion
In this chapter we have shown a straightforward procedure for the synthesis of 
clickable coatings by thermally reacting azide-containing polymers with alkyne cross-linkers. 
Because of the stability of the azide group, the excess of azides used survived the coating 
procedure and remained present in the coating until suitable reaction partners were 
introduced onto the clickable coating. This allowed the functionalization step to be 
performed after the network formation, enabling sensitive materials to be introduced in a 
later stage. Accordingly, the azide-containing coatings were functionalized using several 
copper-free click chemistry methodologies, which were compared with one another by 
immobilizing fluorescently labelled reagents. This indicated that the dibenzocyclooctyne 
reagent exhibited the highest reactivity in these surface functionalization experiments. The 
Me-oxanorbornadiene tandem crDA was significantly slower, but over time reached a 
comparable level of functionalization. As a result of the bio-orthogonal nature of the 
functionalization step, biomolecules are expected to retain their activity after immobilization 
on these clickable coatings. Omitting copper during both the synthesis and functionalization 
of the coatings furthermore makes this procedure highly suitable for biomedical applications. 
The adaptation of copper-free clickable coatings for the production of biologically active 
interfaces via SPAAC will be discussed in chapters five and six.
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4.4 | Experim ental
Reagents. All purchased chemicals were obtained from common commercial sources and 
used as received. Methyl methacrylate (MMA) was distilled prior to use. Tetrahydrofuran 
(THF) was distilled from sodium and benzophenone. Dichloromethane (CH2Cl2) was filtered 
over CaCl2 and dried by distilling from CaH2 and triethylamine (Et3N). Dry N,N- 
dimethylformamide (DMF) was purchased from BioSolve. Water was demineralized prior to 
use. MilliQ grade water was obtained using the Labconco Water Pro PS. Microscope glass 
slides from Knittel Gläser (76 x 26 mm) were used.
Instrumentation. NMR spectra were recorded on a Bruker DPX200 (50 MHz for 13C), Bruker 
DMX300 (300 MHz for 1H and 75 MHz for 13C) and Varian Inova 400 (400 MHz for 1H). 
1H-NMR chemical shifts (ô) are reported in parts per million (ppm) relative to a residual 
proton peak of the solvent: ô = 3.31 for CD3OD and ô = 7.26 for CDCL. Multiplicities are 
reported as: s (singlet), d (doublet), t (triplet), q (quartet), p (pentet), se (sextet), dd (double 
doublet), dt (double triplet), tt (triple triplet), ddd (double, double doublet) or m (multiplet). 
Broad peaks are indicated by br. Coupling constants are reported as a /-value in Hertz (Hz). 
The number of protons (n) for a given resonance is indicated as nH, and is based on spectral 
integration values. 13C-NMR chemical shifts (ô) are reported in ppm relative to CD3OD 
(ô = 49.0) or CDCl3 (ô = 77.0). ESI-MS analysis was performed using Thermo Scientific 
Advantage LCQ Linear-Ion trap Electrospray (LRMS). Electrospray ionization time-of-flight 
(ESI-ToF) spectra were measured with a /EOL AccuToF (HRMS). FT-IR spectra were 
recorded on an ATI Matson Genesis Series FT-IR spectrometer fitted with an ATR cell. IRRAS 
measurements were performed on a Bruker Tensor 27  FT-IR spectrometer equipped with a 
liquid nitrogen cooled Mercury Cadmium Telluride (MCT)-detector, using a Harrick 
Scientific Auto-Seagull variable-angle reflection unit. Vibrations (v) are given in cm-1. 
Molecular weight distributions were measured using size exclusion chromatography (SEC) 
on a Shimadzu system (DGU-20A5, LC-20AT, SIL-10AD and CTO-20A) with Shimadzu 
refractive index (RID-10A) and UV-Vis (SPD-20A) detectors. The system was equipped with 
a guard column and a PL gel 5 ^m mixed D column from Polymer Laboratories using THF as 
the mobile phase at 1.0 mL/minute and 35 °C. Poly(methyl methacrylate) (PMMA) standards 
in the range of 1,035 to 772,000 g/mol were used to calibrate the SEC. Data collection was 
performed with the program LCsolution 1.21 SP1 by Shimadzu. Fluorescence experiments 
were performed on a Leica DMIRE2 microscope fitted with an ebq 100 isolated lamp. The 
colour pictures were captured using a Leica DFC420 C camera. The quantitative 
measurements were performed using a Photometrics CoolSNAP fx  Monochrome camera. In
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both cases the program MetaFluor 6.2r5 by Universal Imaging Cooperation was used for data 
handling. Images were analyzed using Image/ 1.41o by the National Institute o f Heath, USA. 
Hydrogenation was performed with a Parr hydrogenation apparatus. Coatings were prepared 
using the Short K-Bar No. 3 (with grooves of 24 ^m) by RK Print Coat Instruments. Thin layer 
chromatography (TLC) was carried out on Merck precoated silica gel 60 F-254 plates (layer 
thickness 0.25 mm). Compounds were visualized by UV, KMnO4, ninhydrin or iodine 
colouring. Preparative TLC was performed on Merck precoated silica gel 60 F-254 plates 
(layer thickness 1 mm). Column chromatography was performed using Acros silica gel 
(0.035-0.070 mm, pore diameter ca. 6 nm).
2-Azidoethyl methacrylate (AzMA) (1). A slurry consisting of sodium azide (10.00 g, 
0.15 mol) and H2O (10 mL) was prepared. Toluene (50 mL) was added and the mixture was 
cooled to 0 °C. Cold concentrated H2SO4 (7.54 g, 0.08 mol) was added drop wise while 
keeping the temperature of the reaction mixture below 5 °C. The two-layer system was 
poured into a separatory funnel and the aqueous layer was separated from the organic layer 
containing the hydrazoic acid (build-up of pressure should be avoided). Caution: Hydrazoic 
acid is highly toxic and volatile and extra precautions should be taken (see experimental chapter 
three).
2-Hydroxyethyl methacrylate (9.90 g, 0.08 mol) and triphenylphosphine (26.00 g, 0.10 mol) 
were dissolved in toluene (200 mL) and cooled to 0 °C. A hydrazoic acid solution (3M in 
50 mL in toluene) was added, followed by drop wise addition of diethyl azodicarboxylate 
(DEAD, 45 mL of 40% solution in toluene, 0.10 mol). After mixing, the reaction was warmed 
to room temperature and was stirred overnight. The white precipitate formed was filtered off 
and the organic layer was washed with aqueous NaOH (1 M, 100 mL). Toluene was removed 
in vacuo and the solid was extracted with hexane (3 x 250 mL). The combined organic layers 
were concentrated in vacuo and the crude was purified by flash chromatography using 
EtOAc/n-heptane (1/7) as eluent affording the product as a colourless oil (9.45 g, 76%). The 
product was stored at -80 °C under an argon atmosphere. Characterization was in accordance 
with literature:28
1H-NMR (400 MHz, CDCL) ô: 6.14 (m, 1H), 5.60 (p, /  = 1.5 Hz, 1H), 4.30 (m, 2H), 3.47 (m, 
2H) ppm.
Propyl-pyridin-2-ylmethylene-amine (2). Prepared according to a modified literature 
procedure:26 A solution of pyridine-2-carboxaldehyde (3.24 g, 30.2 mmol) in Et2O (20 mL) 
was cooled to 0 °C after which a solution of n-propylamine (3.91 g, 66.1 mmol) in Et2O 
(2 mL) was added drop wise. After complete addition, anhydrous MgSO4 (approximately 1 g)
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was added and the resulting suspension was stirred for two additional hours at room 
temperature. After filtration of the reaction mixture the excess n-propylamine and solvent 
were removed in vacuo. The resulting product was isolated as a yellow oil (4.32 g, 96%). 
1H-NMR (300 MHz, CDCk) ô: 8.65 (m, 1H), 8.38 (m, 1H), 8.05 (m, 1H) 7.71 (m, 1H), 7.30 
(m, 1H), 3.65 (dt, /  = 6.9, 1.5 Hz, 2H) 1.76 (se, /  = 7.2 Hz, 2H), 0.97 (t, /  = 7.2 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCk) ô: 161.8, 154.8, 149.5, 136.6, 124.7, 121.3, 63.4, 24.0, 11.9 ppm. 
FT-IR Vmax film (cm-1): 3308, 3278, 3058, 3006, 2958, 2928, 2868, 1645, 1584, 1563, 1467, 1437, 
1381, 1333, 1290, 1225, 1139, 1044.
Preparation o f AzMA-MMA copolymer by ATRP (3). Cu(I)Br (38.0 mg, 0.27 mmol) was 
placed under an argon atmosphere after three vacuum-argon cycles. Toluene (2.5 mL) was 
added, followed by propyl-pyridin-2-ylmethylene-amine (2, 83.5 mg, 0.57 mmol) resulting in 
a dark brown solution. MMA (702 mg, 6.95 mmol) and AzMA (1, 1100 mg, 7.10 mmol) were 
added and toluene (3 mL) was used to rinse the walls of the reaction vessel. The mixture was 
heated to 60 °C and ethyl 2-bromo-isobutyrate (65 |xL, 0.44 mmol) was added. The progress 
of the polymerization was monitored by 1H-NMR spectroscopy and SEC. The polymerization 
was stopped after 20  hours by drop wise addition of the reaction mixture to an aqueous 
EDTA solution (0.065 M, 100 mL). The water layer was extracted with CH2O 2 (4 x 100 mL). 
The volume of the organic layer was reduced to a few millilitres and subsequently precipitated 
in hexane (150 mL). This precipitation step was repeated a second time resulting in an off- 
white powder (1.16 g, 61%).
Mn = 5.4x103 g/mol, PDI = 1.22, AzMA:MMA ratio 1:1.1. 1H-NMR, 400 MHz, CD O 3, ô ppm:
4.10 (m, (-CH2CH2N3)), 3.59 (m, (-CH3)), 3.49 (m, (-CH2CH2N3)), 1.85 (m), 1.73 (m), 1.52 
(m), 1.05 (m), Vmax film (cm-1): 2989, 2946, 2103, 1727, 1446, 1264, 1238, 1143.
Bis(thiobenzoyl) disulfide (I). Prepared according to a modified literature procedure:33 A 
solution of phenylmagnesium bromide in THF (1M, 21.1 mL, 21.1 mmol) was transferred to 
a dry reaction vessel under an argon atmosphere and was subsequently cooled to 0 °C. 
Carbon disulfide (1.61 g, 21.1 mmol) was added drop wise and the resulting red solution was 
stirred for 45 minutes. The reaction was quenched with H2O (2 mL) and THF was removed in 
vacuo. Diethyl ether (30 mL) and H2O (30 mL) were added, followed by acidification of the 
aqueous layer to pH 5 by addition of aqueous HCl (1 M). The layers were separated and the 
aqueous layer was washed with Et2O (3 x 30 mL). The organic layers were combined, dried 
over Na2SO4 and concentrated in vacuo to afford benzodithioic acid as a purple oil (2.93 g, 
90%) which was used without further purification. Benzodithioic acid (2.93 g, 19.0 mmol) was 
dissolved in a mixture of EtOH and DMSO (4/1, 5 mL). A few iodine crystals were added
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after which the reaction was stirred overnight. The purple precipitate formed was filtered off 
and dried. The crude product was recrystallized from EtOH, yielding the product as red 
crystals (2.40 g, 75%).
1H-NMR (400 MHz, CDCk) ô: 8.09 (m, 4H), 7.61 (tt, /  = 7.6, 1.2 Hz, 2H) 7.46 (m, 4H) ppm.
4-Cyano-4-(phenylcarbonothioylthio)pentanoic acid (4). Prepared according to a modified 
literature procedure:34 Bis(thiobenzoyl) disulfide (I, 682 mg, 2.22 mmol) was dissolved in 
EtOAc (25 mL). 4,4-Azobis(4-cyanopentanoic acid) (1.34 g moisturized with 30% H2O, 
3.35 mmol) was added and the mixture was refluxed at 80 °C for 22 hours. The solvent was 
removed in vacuo and the resulting purple oil was purified by flash chromatography using 
EtOAc/n-heptane (2/3) as eluent. The product was isolated as a red powder (706 mg, 96%). 
1H-NMR (400 MHz, CDCk) ô:7.91 (m, 2H), 7.57 (tt, /  = 7.6, 1.2 Hz, 1H), 7.40 (m, 2H), 2.40­
2.82 (m, 4H), 1.95 (s, 3H) ppm. FT-IR vmax film (cm-1): 3300-2500 (br), 2212, 1714, 1446, 1217, 
1048, 681. LRMS (ESI+) m/z calcd. for C 13H 14NO2S2 [M+H] + 280.0, found: 280.1.
Preparation of AzMA-MMA copolymer by RAFT (5). 4,4’-Azobis(4-cyanovaleric acid) 
(moisturized with 30% H2O, 4.66 mg, 12 ^mol) and compound 4 (35.25 mg, 0.127 mmol) 
were placed under an argon atmosphere. Toluene (3 mL) was added and the mixture was 
sonicated to dissolve the initiator. AzMA (1, 600 mg, 3.9 mmol) and MMA (400 mg,
4.0 mmol) were added. The mixture was degassed by five freeze-pump-thaw cycles. The 
mixture was heated to 65 °C while stirring. During the reaction, samples were taken for 1H- 
NMR and SEC analysis. After 21 hours and 15 minutes the mixture was precipitated into 
hexane, filtrated and dried in vacuo resulting in a light pink powder (320 mg, 75%). 
Mn = 7.1x103 g/mol, PDI = 1.42, AzMA:MMA ratio 1:1.5.
1H-NMR, 400 MHz, CDCl3, ô ppm: 4.12 (m, (-CH2CH2N3)), 3.60 (m, (-CH3)), 3.51 (m, 
(-CH2CH2N3)), 1.85 (m), 1.71 (m), 1.51 (m), 1.03 (m), vmax film (cm-1): 2984, 2946, 2107, 1722, 
1636, 1446, 1273, 1234, 1148.
Bis(prop-2-ynyloxy) tetraethylene glycol (6). NaH (219 mg of 60% in mineral oil, 5.48 mmol) 
was suspended in toluene (20 mL) and cooled to 0 °C. A solution of tetraethylene glycol (304 
mg, 1.57 mmol) in toluene (5 mL) was added drop wise. The resulting mixture was stirred for 
50 minutes at 0 °C, followed by the addition of propargyl bromide (550 mg, 4.62 mmol). After 
6 hours, the mixture was allowed to warm to room temperature and was quenched with 
saturated aqueous NH4O  (30 mL). The layers were separated and the aqueous layer was 
washed with CH2O 2 (2 x 30 mL). The combined organic layers were concentrated in vacuo 
and redissolved in H2O (15 mL). The water layer was washed with hexane (3 x 15 mL) and
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the combined organic layers were extracted with H2O (3 x 15 mL). The aqueous layers were 
then combined and lyophilized to give the product as a yellow oil (272 mg, 64%).
1H-NMR (400 MHz, CDCL) ô: 4.21 (m, 4H), 3.68 (m, 16H), 2.43 (m, 2H) ppm. 13C-NMR 
(75 MHz, CDCl3) ô: 79.6, 74.5, 70.6, 70.5, 70.4, 69.1, 58.4 ppm. vmax film (cm-1): 3283, 3244, 
2863, 2107, 1096, 1027, 664. HRMS (ESI+) m/z calcd. for C 14H22O5N  [M+Na] + 293.1365, 
found: 293.1371.
1.11-Diazido-3,6,9-trioxa-undecane (7). Prepared according to a literature procedure.35 
Quantities used: tetraethylene glycol (7.00 g, 36.03 mmol), CH3SO2Cl (6.5 mL, 84 mmol) in 
dry THF (30 mL), dry Et3N (11.5 mL, 83 mmol) in dry THF (5 mL); H2O (20 mL), NaN3 
(4.90 g, 75.37 mmol). The product was obtained as a colourless oil (7.48 g, 85%).
1H-NMR (400 MHz, CDCk) ô: 3.67 (m, 12H), 3.38 (t, /  = 5.0 Hz, 4H) ppm. FT-IR vmax film 
(cm-1): 2863, 2103, 1455, 1346, 1277, 1100. LRMS (ESI+) m/z calcd. for C8H Ä O 3 [M+Na] +
267.1, found: 267.1.
1.11-Diamine-3,6,9-trioxa-undecane (8). 1,11-Diazido-3,6,9-trioxa-undecane (450 mg, 1.84 
mmol) was dissolved in MeOH (5 mL) and Pd/C was added (90 mg). The reaction vessel was 
put under a H2 atmosphere (3 bar) and was shaken for 3 hours. The suspension was filtered 
over Celite and the filtrate was concentrated under reduced pressure. The product was 
obtained as a colourless oil (346 mg, 98%).
1H-NMR (400 MHz, CDCk) ô: 3.61 (m, 8H), 3.50 (t, /  = 5.1 Hz, 2H), 2.85 (t, /  = 5.1 Hz, 2H),
2.29 (br s, 4H) ppm. FT-IR vmax film (cm-1): 3373, 2863, 1597, 1486, 1347, 1104, 919, 862, 737. 
LRMS (ESI+) m/z calcd. for C8H21N2O3 [M+H] + 193.2, found: 193.2.
Carbonic acid 7,8-didehydro-1,2:5,6-dibenzocyclooctene-3-yl ester 4-nitrophenyl ester (9).
3-Hydroxy-7,8-didehydro-1,2:5,6-dibenzocyclooctene (252 mg, 1.14 mmol) was placed under 
an argon atmosphere after three vacuum-argon cycles. Dry THF (20 mL) was added, followed 
by the drop wise addition of Et3N (995 ^L, 7.19 mmol). The mixture was cooled to 0 °C and
4-nitrophenyl chloroformate (229.3 mg, 1.14 mmol) was added, whereupon a white 
precipitate was formed. The mixture was kept at 0 °C for 10 minutes and was then allowed to 
warm to room temperature. After 3 hours the reaction was quenched by addition of saturated 
aqueous NH4O  (6 mL). The layers were separated and the aqueous layer was extracted with 
CH2CL (3 x 15 mL). The organic layers were combined, concentrated in vacuo and purified 
by gradient column chromatography (C^CL/n-heptane 1:2 ^  1:1). The product was 
obtained as white needles (295 mg, 70%). R f  = 0.44 (CH2Cl2/n-heptane 1:2).
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1H-NMR (300 MHz, CDCk) ô: 8.28 (d, /  = 8.7 Hz, 2H), 7.62 (d, /  = 7.5 Hz, 1H), 7.50-7.30 (m, 
9H), 5.59 (br s, 1H), 3.34 (d, /  = 15.3 Hz, 1H), 3.05 (dd, /  = 15.3, 3.6 Hz, 1H) ppm. LRMS 
(ESI-) m/z calcd. for C23H14NO5 [M-H]- 384.1, found: 384.9.
N,N'-(3,6,9-Trioxa-undecane-1,11-diyl)-bis-carbamic acid [7,8-didehydro-1,2:5,6-dibenzo- 
cyclooctene-3-yl] (10). A solution of compound 9 (109.8 mg, 0.30 mmol) in dry CH2O 2 (5 mL) 
was placed under an argon atmosphere and cooled to 0 °C. Compound 8 (27.3 mg, 
0.14 mmol) was dissolved in dry CH2O 2 (1 mL) and added drop wise. After 1 hour, the 
mixture was warmed to room temperature and was stirred for an additional 18 hours. The 
reaction mixture was washed with saturated aqueous NH4O  (3 mL). The aqueous layer was 
extracted with CH2O 2 (2 x 3 mL). The combined organic layers were washed with 5% 
aqueous NaHCO3 (5 mL). The basic aqueous layer was extracted with CH2Cl2 (2 x 5 mL) and 
the combined organic layers were dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The crude product was purified by preparative TLC (MeOH/CH2Cl2, 1:25) 
yielding the product as an off-white solid. (50 mg, 60%). R f  = 0.53 (MeOH/CH2Cl2, 1:10). 
1H-NMR (300 MHz, CDCL) ô: 7.50 (m, 3H), 7.42-7.24 (m, 13H), 5.56 (br s, 2H), 5.50 (br s, 
2H), 3.82-3.54 (m, 12H), 3.41 (m, 4H), 3.16 (d, /  = 15.6 Hz, 2H), 2.90 (dd, /  = 15.6, 3.6 Hz, 
2H) ppm. HRMS (ESI+) m/z calcd. for C42H40N 2O7Na [M+Na]+ 707.2733, found: 707.2723.
Functionalization o f glass slides. Microscope slides were thoroughly cleaned with an abrasive 
and rinsed with MilliQ. They were subsequently immersed in a mixture of concentrated 
sulfuric acid/hydrogen peroxide (5/2, 70 mL) for 1 hour. The glass slides were rinsed with 
MilliQ and placed in a solution of N-(2-aminoethyl)-3-aminopropyl-trimethoxysilane 
(750 mg, 3.37 mmol) in MilliQ (75 mL) to react overnight. After 18 hours the glass slides were 
removed from the solution and rinsed with MilliQ after which they were placed in a solution 
of pentynoic acid (328 mg, 3.34 mmol), 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide 
hydrochloride (EDC-HCl, 798 mg, 4.16 mmol) and 4-dimethylaminopyridine (DMAP, 
109 mg, 0.89 mmol) in MilliQ (75 mL) for 22 hours. The glass slides were then rinsed with 
MilliQ and left to dry.
Coating o f glass slides. AzMA/MMA copolymer 3 (23.93 mg, azide content of 0.087 mmol) 
together with bis(prop-2-ynyloxy) tetraethylene glycol (6, 4.46 mg, 0.017 mmol) were 
dissolved in CH2Q 2 (417 |xL). Each alkyne-functionalized microscope slide was treated with 
50 |iL of this solution after which the wet film was evenly distributed using a K-bar hand 
coater (with grooves of 24 ^m). After evaporation of the solvent the coated glass plates were 
placed in a vacuum oven at 120 °C for 4 hours.
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N-Ethoxycarbonyl-3-aminophenol (II). Prepared according to a literature procedure.31 
Quantities used: 3-aminophenol (12.8 g, 117 mmol), ethyl chloroformate (25.6 g, 237 mmol), 
Et2O (450 mL) and Et3N (1 mL). The product was obtained as white crystals (11.4 g, 54%). 
1H-NMR (400 MHz, CDCL) ô: 7.33 (br, 1H), 7.13 (t, /  = 8.1 Hz, 1H), 6.66 (dd, /  = 2.0, 0.8 Hz, 
1H), 6.64 (dd, /  = 2.0, 0.8 Hz, 1H), 6.57 (ddd, /  = 8.1, 2.4, 0.8 Hz, 1H), 6.19 (br, 1H), 4.23 (q, 
/  = 7.1 Hz, 2H), 1.31 (t, /  = 6.8 Hz, 3H) ppm. LRMS (ESI+) m/z calcd. for C9H12NO3 [M+H] +
182.1, found: 182.1.
N-Ethoxycarbonyl-7-amino-coumarin-4-yl acetic acid (11). Prepared according to a literature 
procedure.32 Quantities used: N -ethoxycarbonyl-3-aminophenol (II, 362 mg, 2 mmol),
1,3-acetonedicarboxylic acid (320 mg, 2.2 mmol), 15 mL 70% H2SO4, 0 °C ^  r.t. for 16 h. The 
product was obtained as a white solid (395 mg, 68%).
1H-NMR (400 MHz, CDCk) ô: 7.65 (s, 1H), 7.63 (d, /  = 6.2 Hz, 1H), 7.35 (dd, /  = 8.8, 2.1 Hz, 
1H), 6.31 (s, 1H), 4.22 (q, /  = 7.1 Hz, 2H), 3.86 (d, /  = 0.8 Hz, 2H), 1.32 (t, /  = 7.1 Hz, 3H) 
ppm. LRMS (ESI-) m/z calcd. for C 14H12NO6 [M-H]- 290.1, found: 290.0.
5-N-(Boc)-1-(N-ethoxycarbonyl-7-amino-coumarin-4-yl) acetic acid aminopentyl ester (13). 
Compound 11 (70 mg, 0.24 mmol) and 5-N-Boc-aminopentanol (12, 53.8 mg, 0.26 mmol) 
were dissolved in DMF (5 mL) and cooled to 0 °C. After 10 minutes of stirring, DMAP (29.0 
mg, 0.24 mmol) and EDC-HCl (49.7 mg, 0.26 mmol) were added. The mixture was stirred for 
an additional 30 minutes at 0 °C, after which the temperature was raised to room temperature 
and the reaction mixture was stirred overnight. After completion of the reaction 10% aqueous 
citric acid (15 mL) was added and the mixture was subsequently extracted with CH2O 2 
(3 x 10 mL). The organic layer was dried over anhydrous Na2SO4 and evaporated under 
reduced pressure, after which the crude mixture was purified by gradient column 
chromatography (EtOAc/n-heptane 1:3 ^  1:1). Compound 13 was obtained as a white solid 
(60 mg, 53%). Rf = 0.2 (EtOAc/n-heptane, 1:3).
1H-NMR (400 MHz, CDCk) ô: 7.62 (s, 1H), 7.50 (d, /  = 8.7 Hz, 1H), 7.33 (s, 1H), 7.31 (dd, /  =
8.8, 2.2 Hz, 1H), 6.27 (s, 1H), 4.56 (s, 1H), 4.25 (q, /  = 7.1 Hz, 2H), 4.12 (t, /  = 6.3 Hz, 2H), 
3.73 (d, /  = 0.8 Hz, 2H), 3.04-2.99 (m, 2H), 1.63-1.57 (m, 2H), 1.46 (s, 9H), 1.44-1.38 (m, 2H),
1.32 (t, /  = 7.1, 3H), 1.23-1.16 (m, 2H) ppm. 13C-NMR (50 MHz, CDCk) ô: 168.7, 160.6, 156.1,
154.8, 153.1, 147.8, 142.1, 125.2, 115.0, 114.8, 114.2, 106.3, 77.2, 65.6, 61.7, 40.5, 38.5, 29.9,
28.4, 28.3, 23.2, 14.5 ppm. HRMS (ESI+) m/z calcd. for C24H32N 10O8 [M+Na] + 499.2048, found 
499.2056. FT-IR vmax film (cm-1): 3330, 2980, 2933, 1718, 1623, 1580, 1524, 1394, 1225, 1160, 
1052.
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1-(N-Ethoxycarbonyl-7-amino-coumarin-4-yl) acetic acid aminopentyl ester-TFA (14). 
Compound 13 (60 mg, 0.13 mmol) was dissolved in CH2Cl2 (7 mL) and cooled to 0 °C. 
Trifluoroacetic acid (TFA, 440 ^L, 5.0 mmol) was added drop wise after which the reaction 
was stirred at 0 °C for 30 minutes. The temperature was raised to room temperature and the 
mixture was stirred for an additional 20 hours. Under a flow of argon the solvent was reduced 
to approximately 1 mL and the crude mixture was extracted with H2O (3 x 5 mL). The water 
layer was subsequently lyophilized yielding the desired product as an off-white powder 
(60 mg, 94%). R f = 0 .0 2  (EtOAc/n-heptane, 3:1).
1H-NMR (400 MHz, CD3OD) ô: 7.62 (d, /  = 8.9 Hz, 1H), 7.61 (d, /  = 2.1 Hz, 1H), 7.38 (dd, /  =
8.7, 2.1 Hz, 1H), 6.30 (s, 1H), 4.22 (q, /  = 7.1 Hz, 2H), 4.16 (t, /  = 6.4 Hz, 2H), 3.90 (d, /  = 7.2 
Hz, 2H), 2.89-2.85 (m, 2H), 1.71-1.58 (m, 4H), 1.41-1.34 (m, 2H), 1.32 (t, /  = 7.1 Hz, 3H). 13C- 
NMR (75 MHz, CD3OD) ô: 163.0, 156.0, 155.5, 151.1, 144.8, 126.9, 115.9, 115.2, 114.9, 106.4,
66.1, 62.4, 40.6, 29.1, 28.2, 23.9, 14.9 ppm. HRMS (ESI+) m/z calcd. for C 19H24N2O6 [M+Na] + 
399.1529, found 399.1532. FT-IR vmax film (cm-1): 3313, 2928, 2358, 1697, 1385, 1195, 832, 724.
2H-1-Benzopyran-4-acetic acid, 7-[(ethoxycarbonyl)amino]-2-oxo-5-[[(7,8-didehydro-1,2:5,6- 
dibenzocyclooctene-3-yloxy)carbonyl]amino]pentyl ester (15). To a solution of 14 (37 mg, 
0.1 mmol) and Et3N (30 mg, 0.3 mmol) in dry DMF (10 mL), carbonic acid 7,8-didehydro- 
1,2:5,6-dibenzocyclooctene-3-yl ester 4-nitrophenyl ester (9, 39 mg, 0.1 mmol) was added 
under an argon atmosphere. After stirring the reaction mixture overnight at room 
temperature, the solvent was removed under reduced pressure and the residue was purified 
by preparative TLC (EtOAc/n-heptane, 1:1) to afford 15 as an off-white solid (73 mg, 90%). 
R f  = 0.52 (EtOAc/n-heptane, 1:1).
1H-NMR (300 MHz, CDCL) ô: 7.62-7.22 (m, 10H), 7.01-6.99 (m, 1H), 7.25 (s, 1H), 5.51-5.48 
(m, 1H), 5.04 (br s, 2H, NH), 4.28-4.16 (m, 2H), 4.15-4.09 (m, 2H), 3.73-3.69 (m, 2H), 3.16­
3.10 (m, 2H), 1.72-1.18 (m, 9H) ppm. 13C-NMR (75 MHz, CDCk) ô: 168.7, 162.8, 160.6,
155.5, 154.7, 152.0, 151.0, 147.8, 142.0, 129.9, 128.0, 127.9, 126.3, 125.9, 125.2, 123.6, 114.9,
114.7, 106.1, 65.5, 61.7, 46.2, 40.9, 38.3, 29.8, 28.4, 28.2, 14.5 ppm. HRMS (ESI+) m/z calcd. 
for C36H34N 2O8 [M+H]+623.2392, found 623.2393. FT-IR vmax film (cm-1): 3667, 2963, 2359, 
1699, 1540, 1228, 1051, 608.
2H-1-Benzopyran-4-acetic acid, 7-[(ethoxycarbonyl)amino]-2-oxo-5-[(5-methyl-3-trifluoro- 
methyl-7-oxo-bicyclo[2.2.1]hepta-2,5-diene-2-carbonyl)amino]pentyl ester (16a) and 2H-1- 
benzopyran-4-acetic acid, 7-[(ethoxycarbonyl)amino]-2-oxo-5-[(6-methyl-3-trifluoromethyl-7- 
oxo-bicyclo[2.2.1]hepta-2,5-diene-2-carbonyl)amino]-pentyl ester (16b). A mixture of
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compounds 19a/b (42 mg, 0.19 mmol) was dissolved in dry CH2Q 2 (6 mL) under an argon 
atmosphere. The solution was cooled to -18 °C, followed by addition of Et3N (32 ^L, 
0.23 mmol) and ethyl chloroformate (17 ^L, 0.18 mmol). After stirring 30 minutes at -18 °C 
the mixture was warmed to 0 °C and was stirred for an additional 1.5 hour. Compound 14 
(75 mg, 0.15 mmol) was dissolved in dry CH2O 2 (4 mL) and was added slowly to the reaction 
mixture while stirring. The mixture was stirred for approximately 3.5 hours. The solvent was 
reduced to about 1 mL using a flow of argon and the crude mixture was dissolved in 
dioxane/H2O (1:1, 10 mL) and lyophilized. Gradient column chromatography (EtOAc/ 
n-heptane from 1:5 ^  1:1) gave the two isomers 16a and 16b as off-white solids (45 mg, 53%). 
R f  compound 16a = 0.16 (EtOAc/n-heptane, 1:1), R f  compound 16b = 0.11 (EtOAc/ 
n-heptane, 1 :1 ).
1H-NMR (300 MHz, CD3OD) peaks assigned to compound 16a ô : 7.64 (d, /  = 2.1 Hz, 1H),
7.62 (d, /  = 8.8  Hz, 1H), 7.37 (dd, /  = 8 .8 , 2.1 Hz, 1H), 6.69-6.67 (m, 1H), 6.30 (s, 1H), 5.48­
5.45 (m, 1H), 5.36-5.33 (m, 1H), 4.22 (q, /  = 7.1 Hz, 2H), 4.16-4.05 (m, 2H), 3.27-3.13 (m, 
2H), 1.98-1.97 (m, 3H), 1.69-1.58 (m, 4H), 1.57-1.46 (m, 2H), 1.32 (t, /  = 7.2 Hz, 3H) ppm. 
Peaks assigned to compound 16b ô : 7.64 (d, /  = 2.1 Hz, 1H), 7.62 (d, /  = 8.8  Hz, 1H), 7.37 
(dd, /  = 8 .8 , 2.1 Hz, 1H), 6.63-6.60 (m, 1H), 6.30 (s, 1H), 5.56-5.52 (m, 1H), 5.49-5.48 (m, 1H), 
4.22 (q, /  = 7.1 Hz, 2H), 4.14 (t, /  = 6.4 Hz, 2H), 3.27-3.13 (m, 2H), 2.07-2.06 (m, 3H), 1.69­
1.58 (m, 4H), 1.57-1.46 (m, 2H), 1.32 (t, /  = 7.2 Hz, 3H) ppm. 13C-NMR (75 MHz, CD3OD) ô :
170.8, 163.0, 155.9, 155.7, 155.5, 151.1, 144.7, 135.4, 134.7, 115.9, 115.2, 114.9, 106.4, 90.5,
87.8, 87.6, 84.9, 66.5, 62.4, 40.5, 40.3 (d), 29.8, 29.4, 29.2, 24.3, 24.2, 14.9, 14.5, 14.1, 14.0 ppm. 
HRMS (ESI+) m/z calcd. for C28H29F3N2O8 [M+H]+ 579.1959, found 579.1954. FT-IR vmax film 
(cm-1): 3296, 2925, 1714, 1617, 1226.
Methyl-2-(diphenylphosphino)-4-(2-(2-(7-(ethoxycarbonylamino)-2-oxo-2H-chromen-4-yl) 
acetoxy)ethylcarbamoyl)benzoate (17). Compound 14 (50.0 mg, 0.137 mmol) and compound 
20 (67.2 mg, 0.137 mmol) were dissolved in dry CH2O 2 (3 mL) and placed under an argon 
atmosphere. Next, DMAP (50.1 mg, 0.41 mmol) was added and the reaction mixture was 
placed in an ice bath. When the temperature reached 0 °C, EDC-HCl (28.8 mg, 0.15 mmol) 
was added and the mixture was stirred for 30 minutes after which the temperature was raised 
to room temperature and the mixture was stirred for an additional 16 hours. AcOH (2 M, 
20 mL) was added to the reaction mixture which was subsequently extracted with EtOAc 
(3 x 20 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The crude product was purified by preparative TLC (CH2Cl2/MeOH, 
9:1) yielding compound 17 as an off-white powder (60 mg, 61%). R f  = 0.63 (CH2CL/MeOH, 
9:1).
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1H-NMR (400 MHz, CDCL) ô: 8.10 (dd, /  = 8.1, 3.6 Hz, 1H), 7.82 (dd, /  = 8.1, 1.8 Hz, 1H), 7.55 
(d, /  = 2.2 Hz, 1H), 7.49 (d, /  = 8.7 Hz, 1H), 7.36-7.33 (m, 7H), 7.31-7.27 (m, 4H), 7.25 (s, 1H), 
7.17 (dd, /  = 3.7, 1.8 Hz, 1H), 6.26 (s, 1H), 5.82 (t, /  =  5.8 Hz, 1H), 4.22 (q, /  =  7.2 Hz, 2H), 4.11 
(t, /  = 6.3 Hz, 2H), 3.75 (s, 3H), 3.72 (s, 2H), 3.23 (dd, /  = 13.5, 7.0 Hz, 2H), 1.61-1.54 (m, 2H),
1.45-1.38 (m, 2H), 1.30 (t, /  = 7.1 Hz, 3H), 1.22-1.15 (m, 2H). 31P-NMR (121 MHz, CDCk) ô: 
-0.90 ppm. HRMS (ESI+) m/z calcd. for C40H40O9N2P [M+H] + 723.2471, found 723.2462.
Pent-4-ynyl 2-(7-(ethoxycarbonylamino)-2-oxo-2H-chromen-4-yl)acetate (18). To a solution of
11 (54 mg, 0.19 mmol) and 4-pentyn-1-ol (14 mg, 0.17 mmol) in CH2O 2 (10 mL) at 0 °C, 
EDC-HCl (39 mg, 0.20 mmol) and DMAP (2.0 mg, 0.02 mmol) were added. The mixture was 
allowed to warm to room temperature and was stirred for 16 hours. The reaction mixture was 
washed with aqueous NaOH (1M, 15 mL) and the aqueous layer was subsequently extracted 
with CH2O 2 (3 x 25 mL). The combined organic layers were neutralized with aqueous HCl 
(1M, 10 mL). Purification was performed using column chromatography (CH2O 2 with 2% 
MeOH) which afforded the product as a white solid (33 mg, 55%).
1H-NMR (400 MHz, CDCk) ô: 7.51-7.48 (m, 2H), 7.39 (dd, /  = 8 .8 , 2.0 Hz, 1H), 7.19 (s, 1H), 
6.27 (s, 1H), 4.24 (m, 4H), 3.75 (s, 2H), 2.22 (dt, /  = 6 .8 , 2.8 Hz, 2H), 1.96 (t, /  = 2.8 Hz, 1H),
1.83 (m, 2H), 1.32 (t, /  = 7.2 Hz, 3H) ppm. 13C-NMR (75 MHz, CDCk) ô : 168.6, 160.6, 154.7,
152.9, 147.7, 141.9, 125.3, 114.9, 114.5, 114.2, 106.0, 82.5, 69.3, 64.2, 61.8, 38.1, 27.2, 15.1, 14.5 
ppm. HRMS (ESI+) m/z calcd. for C19H 19NO6N  [M+Na] + 380.1110, found 380.1117.
5-Methyl-3-trifluoromethyl-7-oxo-bicyclo[2.2.1]hepta-2,5-diene-2-carboxylic acid ethyl ester 
(IIIa) and 6-methyl-3-trifluoromethyl-7-oxo-bicyclo[2.2.1]hepta-2,5-diene-2-carboxylic acid ethyl 
ester (IlIb). Prepared according to literature procedure.36 Quantities used: ethyl 4,4,4- 
trifluorobut-2-ynoate (1.00 g, 0.86 mL, 6.02 mmol) and 3-methylfuran (600 mg, 652 ^L,
7.32 mmol). 4 Days at 40 °C under an argon atmosphere. The crude mixture was purified by 
column chromatography (EtOAc/n-heptane, 1:4) resulting in a mixture of two regio-isomers 
(ratio 1:0.7 for IIIa and IIIb, respectively) as a slightly yellow oil (1.32 g, 8 8%). R f = 0.43 
(EtOAc/n-heptane, 1:4). (As a result of slow quadricyclane formation, the product was 
immediately saponified).
1H-NMR (400 MHz, CDCk) peaks assigned to compound IIIa ô: 6.69-6.62 (m, 1H), 5.38 (s, 
1H), 5.30 (d, /  = 1.5 Hz, 1H), 4.35-20 (m, 2H), 1.99 (d, /  = 2.0 Hz, 3H), 1.31 (t, /  = 6.9 Hz, 3H) 
ppm. Peaks assigned to compound IIIb ô: 6.60-6.55 (m, 1H), 5.61 (s, 1H), 5.56 (d, /  = 1.5 Hz, 
1H), 4.35-4.20 (m, 2H), 2.05 (d, /  = 2.0 Hz, 3H), 1.32 (t, /  = 6.9 Hz, 3H) ppm. LRMS (ESI+) m/z 
calc. for C 11H12F3O3 [M+H]+ 249.1, found 249.0. FTIR vmax film (cm-1): 2977, 1734, 1282, 1163, 
871.
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5-Methyl-3-trifluoromethyl-7-oxo-bicyclo[2.2.1]hepta-2,5-diene-2-carboxylic acid (19a) and
6-methyl-3-trifluoromethyl-7-oxo-bicyclo[2.2.1]hepta-2,5-diene-2-carboxylic acid (19b). 
Modified literature procedure.36 The mixture of Me-oxanorbornadiene ethyl esters IIIa/b 
(700 mg, 2.82 mmol) was dissolved in THF (35 mL). The solution was cooled to 0 °C and 
while stirring, aqueous NaOH (1 M, 2.82 mL, 2.82 mmol) was added drop wise over a period 
of 2 hours. After 2.5 hours, the reaction mixture was warmed to room temperature and 
stirred overnight to complete the conversion. The pH was adjusted to pH 5 with aqueous HCl 
after which the THF volume was reduced to 50 % of the total volume by evaporation in 
vacuo. The solution was diluted with H2O (20 mL) and extracted with CH2Cl2 (3 x 20 mL). 
The organic layers were combined, dried over anhydrous Na2SO4 and evaporated in vacuo to 
obtain an off-white solid (595 mg, 96 %). R f  = 0.04 (n-heptane/EtOAc, 1:1).
1H NMR (400 MHz, CDCL) peaks assigned to compound 19a ô : 6.67 (t, /  = 2.0 Hz, 1H), 5.56 
(s, 1H), 5.34 (d, /  = 1.5 Hz, 1H), 2.01 (d, /  = 2.0, 3H), 1.31 (d, /  = 2.0 Hz, 3H) ppm; peaks 
assigned to compound 19b ô : 6.59 (t, /  = 2.0 Hz, 1H), 5.60 (s, 1H), 5.42 (d, /  = 1.5 Hz, 1H),
2.05 (d, /  = 2.0, 3H) ppm; 13C NMR (75 MHz, CDCL) ô : 166.7, 166.4, 150.9 (q), 149.2 (q),
134.4, 133.2, 121.2 (q, CF3), 121.0 (q, CF3), 88.3, 87.5, 84.9, 84.8, 14.1, 14.0 ppm; FT-IR Vmax 
film: 3443, 3092, 1715, 1662, 1325, 1262, 1166, 1132, 875 cm-1; HRMS(ESI-) m/z calcd. for 
C9H6F3O3 [M-H]- 219.0253, found 219.0269.
1,4-Benzenedicarboxylic acid, 2-(diphenylphosphino)-1-methyl ester (20). Prepared according 
to a literature procedure.37 Quantities used: 3-iodo-4-(methoxycarbonyl)benzoic acid 
(306 mg, 1.0 mmol), diphenylphosphine (0.17 mL, 1.0 mmol), Et3N (0.3 mL, 2.0 mmol), 
Pd(OAc)2 (8.8 mg, 0.02 mmol, Pd-content 47.5%) and dry MeCN (3 mL). The reaction was 
performed under an argon atmosphere at 65 °C. The product was purified by column 
chromatography (CH2Cl2/MeOH, 9:1) yielding a light yellow powder (90 mg, 26%), R f  = 0.45 
(CH2Cl2/MeOH, 9:1).
1H-NMR (300 MHz, CDCk) ô: 8.02 (s, 2H), 7.64 (s, 1H), 7.35-7.26 (m, 10H), 3.73 (s, 3H) 
ppm. 13C-NMR (75 MHz, CDCL) ô: 166.2, 136.9, 136.7, 135.3, 133.8 (2C), 133.5 (2C), 130.3,
129.5, 128.8 (2C), 128.6 (2C), 128.5, 128.4 (2C), 52.1 ppm. 31P-NMR (121 MHz, CDCL) ô: 
-1.52 ppm (the oxidized product i.e. triphenylphosphine-oxide, if present, gave a 31P signal at 
34.47 ppm). HRMS (ESI+) m/z calcd. for C21H 18O4P [M+H] + 365.0943, found 365.0938.
Tris((1-((O-ethyl)carboxymethyl)-(1,2,3-triazole-4-yl))methyl)amine (IV). Prepared according 
to literature procedures.38 Quantities used: ethyl azidoacetate in ethanol (25%, 13.5 mL, 21.3 
mmol), 2,6-lutidine (3.2 mL, 27.6 mmol), tripropargylamine (0.71 mL, 5.0 mmol), MeCN
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(15 mL), Cu(MeCN)4PF6 (88 mg, 0.24 mmol). The product was obtained as a light brown 
solid (1.98 g, 76%).
1H-NMR (400 MHz, CDCk): 7.85 (s, 3H), 5.16 (s, 6H), 4.26 (q, /  = 7.2 Hz, 6H), 3.81 (s, 6H),
1.29 (t, /  = 7.2 Hz, 9H) ppm. LRMS (ESI+) m/z calcd. for C21H31N 10O6 [M+H] + 519.2, found
519.3.
Typical procedure for the functionalization of the polymeric coatings. For the IRRAS 
measurements, 20 mM solutions of coumarins 15-17 were prepared in approximately 120 ^L 
of DMSO. CuBr (0.98 mg, 6.95 ^mol) and tris((1-((O-ethyl)carboxymethyl)-(1,2,3-triazole-4- 
yl)) methyl)amine (IV, 3.62 mg, 6.99 ^mol) were dissolved in DMSO (348 |xL). 140 ^L of this 
solution was added to coumarin 18 (1.00 mg, 2.80 ^mol), resulting in a 20 mM solution of 
this probe. The four solutions containing the fluorescent probes were applied next to each 
other on the coating (for each probe, 30 ^L of solution was spread out over a surface of
1 x 2 cm). All reactions on the same microscope slide were stopped simultaneously by 
washing the glass plate with DMSO (30 mL) and subsequently soaking it in DMSO (90 mL) 
for 15 minutes. The glass slide was then rinsed with CH2O 2 (30 mL) and dried. For the 
evaluation of different reaction times, different microscope slides from the same batch were 
used. For the fluorescence measurements the same approach was used with the exception that 
only 50 ^L solutions were prepared for coumarins 15-18. For the subsequent 
functionalization of the coating, only 5 ^L was taken for each spot.
IRRAS measurement of functionalized polymeric coatings. All coatings were measured before 
functionalization and after the predetermined reaction time using an angle of incidence of 55° 
and S-polarized light. Spectra were obtained with 256 scans at a resolution of 4 cm-1. The raw 
data were divided by the data recorded from an uncoated glass slide. The thus obtained 
spectra were subsequently baseline corrected with a manual interface which allowed the 
reference points to be defined by the user, making it possible to keeps these points constant 
for all spectra. The azide signal was integrated between 2165 and 1939 cm-1 in each spectrum. 
Differences in the azide signal before and after functionalization were expressed in 
percentages and plotted against time.
Fluorescence measurement o f functionalized polymeric coatings. Using the full chip, pictures 
were measured with a 250 milliseconds shutter time (Figure 4.2). In the MetaFluor 6.2r5 
program, auto-scale was turned off and binding was set to 1. Image/ subsequently evaluated 
the median pixel value as a measure for the fluorescence of the pictures taken.
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Antimicrobial coatings
5.1 | Introduction
It is well-known that bacteria can adhere to a wide variety of surfaces and form a slimy 
film. Formation of these biofilms starts with the adhesion of individual planktonic 
(circulating) bacteria.1 The initial adhering bacteria grow denser and ultimately form an 
initial layer which links the subsequent biofilm with the underlining substratum surface.
It was not until the 1980s and 1990s however, that microbial biologists started to 
appreciate the elaborate organization of bacteria in these biofilms. Bacteria in biofilms are 
very different from their planktonic counterparts. Adhesion to a surface triggers a change in 
the transcription of a set of genes, completely altering the bacterial phenotype.2 Bacterial 
communities are consequently held together by an extracellular polysaccharide matrix and 
exhibit spatial heterogeneity.3 Extracellular signalling using small molecules even allows 
bacteria to communicate with each other within the biofilm.4
Formation of these protective communities allows bacteria to survive in hostile 
environments. This mode of growth even imparts a certain resistance to antimicrobial agents 
and is at the root of many persistent and chronic bacterial infections.5 There is hence a strong 
need to mitigate bacterial colonization of surfaces. Applications can be found in the medical 
field where sterilization of implants and devices is essential, but they also extend to water and 
air purification and the packaging industry.6
Making surfaces resistant towards bacterial colonization is no easy task however. 
Smooth surfaces are colonized as easily as rough surfaces and the physical characteristics of 
the surface only slightly influence the microbial adhesion.7 Planktonic bacteria are even so 
resilient as to prefer biofilm formation in rapidly flowing milieus with high shear forces.8 
Bacterial colonization of a surface can indeed only be mitigated by changing the surface 
chemistry.9 As discussed in chapter one, antibiotics can be mixed into a coating after which 
the antibiotic slowly leaches from the polymeric blend.10,11 This blending method exposes 
bacteria to relatively low concentrations of antibiotics for a prolonged time span, which can 
trigger resistance build-up in the bacteria. Alternatively, the antibiotic can be covalently 
attached to the surface so longer lasting activity is achieved.12-14 Although both strategies are
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employed with increasing success, there is still room for improvement. The antibiotics used 
usually lack selectivity for instance, and do not discriminate between pathogenic and benign 
species. Most antibiotics used furthermore destroy the bacterial cell, causing proteins to be 
deposited on the surface. As most surfaces do not have anti-fouling properties, the build-up 
of proteins will eventually cover the surface and shield the bacteria from the underlying 
antibiotics.
Antimicrobial peptides (AMPs) are produced by both eukaryotes and prokaryotes and 
represent an important part of their defence against microorganisms.15 AMPs broad- 
spectrum activity makes them attractive candidates for the development of a new class of 
antimicrobial coatings. AMPs have furthermore proven difficult targets for bacterial 
resistance build-up. However, studies concerning the use of AMPs in antimicrobial 
coatings16-19 have been limited.
In this chapter we therefore want to explore the potential application of AMPs in 
antimicrobial surfaces. Gramicidin S20, 21 served as an example and was covalently coupled to a 
reactive polymer coating.22 The conjugation between peptide and polymer coating was 
realized using two distinct ‘click’ reactions, the copper-catalyzed azide-alkyne 1,3-dipolar 
cycloaddition (CuAAC)23, 24 and the strain-promoted azide-alkyne 1,3-dipolar cycloaddition 
(SPAAC).25-27 The antimicrobial activity of the subsequent hybrid coatings was estimated by 
evaluating the initial rate of microbial adhesion, as this process forms the onset of further 
biofilm growth.1 These results act as a guide for future optimization of the system.
5.2 | R esu lts an d  d iscu ssion
An azide-containing coating was formulated and applied on a glass substrate as 
described in chapter four.22 In short, this coating was produced by reacting a solution of 
azide-containing copolymer 1 and di-alkyne cross-linker 2 on an alkyne-functionalized glass 
substrate at 120 °C (Scheme 5.1).
A thermal 1,3-dipolar cycloaddition between the azides and the terminal alkynes 
resulted in the effective copper-free formation of a polymer network. By selecting the 
appropriate ratio between azide groups and alkyne moieties during the coating procedure, a 
significant number of unreacted azide groups remained present in the network after the 
coating was formed. The thermal stability of the azide group allowed the excess of azides to be 
used in a subsequent functionalization step.
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Scheme 5.1 | Coating formulation for the construction of an azide-containing coating. Reagents and 
conditions: i) 120 °C, 4 h.
The gramicidin S analogs were synthesized as described in chapter three.28, 29 A 
gramicidin S analog was first functionalized with a p-nitro phenylalanine handle (3). The 
side-chain nitro-group was selectively reduced by transfer hydrogenation using ammonium 
formate and palladium on charcoal. The resulting amine (4) was functionalized with either an 
terminal alkyne (5a) or a dibenzocyclooctyne group (DIBAC, 5b) using standard peptide 
coupling conditions with 2-(7-Aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HATU) and N,N-diisopropylethylamine (DiPEA) as coupling agents 
(Scheme 5.2). The crude products (6a and 6b) were finally purified by LH-20 gel-filtration. 
The cationic charge on both ornithine residues present in gramicidin S is essential in its 
mechanism of action, because it dictates the initial interaction between gramicidin S and the 
negatively charged bacterial membrane.30 In order to obtain active analogs, gramicidin S 6a 
and 6b were therefore deprotected using HCl in EtOAc (Scheme 5.2).
Either of two routes was followed for producing coatings decorated with deprotected, 
and thereby active, gramicidin S analogs. In one route the reactive coatings were first 
functionalized with the protected gramicidin S analogs 6a and 6b. The peptides were 
subsequently deprotected using HCl in EtOAc, while bound to the coating. By contrast, a 
similar end result was achieved by functionalizing the coating directly with the unprotected 
peptides 7a and 7b.
The exact procedure followed for the peptide immobilization step was dictated by the 
chemical handle being used. The gramicidin S analogs containing a terminal alkyne (6a and 
7a) were dissolved in DMSO, mixed with copper and a suitable ligand (CuBr with
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tris((1-((O-ethyl)carboxymethyl)-(1,2,3-triazole-4-yl))methyl)amine) and left to react on the 
coated glass slides for 20 hours, followed by extensive washing to remove any uncoupled 
peptides or residual copper catalyst. Alternatively, the DIBAC-containing gramicidin S 
analogs (6b and 7b) were immobilized by simply leaving the peptide solutions in DMSO to 
react by themselves for 16 hours, followed by extensive rinsing to remove uncoupled peptides.
NHR
Scheme 5.2 | Synthesis of clickable gramicidin S analogs 7a and 7b. Reagents and conditions: i) EtOH, 
HCO2NH4, 10% Pd/C, 1 h (quant.) ii) CH2Q 2, HATU, DiPEA, 2 h (80% for 6a and 95% for 6b) iii) 2M HCl in 
EtOAc, 30 min. (quant.)
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The conversion of the reactions was monitored by Infrared Reflection-Absorption 
Spectroscopy (IRRAS) and showed a decrease of the coating’s azide signal after the 
immobilization step, indicating that the peptides were covalently coupled via the expected 
click reactions (Table 5.1). However, the IRRAS measurements registered a smaller decrease 
of the azide signal than those seen for the small fluorescent probes used in chapter four. This 
is to be expected as the clickable coating will only have a limited permeability, making it hard 
for the bigger peptides to penetrate the network. The immobilized peptides 6a and 6b were 
subsequently deprotected by treating the decorated coatings with HCl in EtOAc. This was 
accompanied by an additional decrease of the azide signal. It is unclear what caused the loss 
of azide signal (Table 5.1). As a direct reaction between the azide group and HCl is not 
expected, the decrease could possibly be caused by a change in the macromolecular 
arrangement of the polymeric film.
Peptide After immobilization Immobilization followed by 
deprotection
6a -4% -5% -» -10%
6b -9% -5% -» -12%
7a -5% -
7b -6% -
Table 5.1 | Relative decrease of the azide signal in the IRRAS spectrum of the clickable coating after 
immobilization of the antimicrobial peptides 6a, 6b, 7a and 7b. Peptides 6a and 6b were subsequently 
deprotected using HCl in EtOAc, while bound to the coating. The decrease of the azide signal 
accompanying this deprotection is also reported.
The first step of biofilm formation is microbial adhesion to the surface.1 The initial 
rate of microbial adhesion can therefore be used as a bench mark for the antimicrobial 
properties of the hybrid coatings. After incubating Staphylococcus aureus 7323 for two hours 
on the hybrid coatings, the substrates were dipped in water as to remove loosely adhering 
bacteria, and the remaining biofilm was stained using BacLight. This viability staining kit 
contains the SYTO 9 dye and propidium iodide which together turn living bacteria, with their 
intact membrane, fluorescent green and dead bacteria, with their damaged membrane, 
fluorescent red. Under the fluorescence microscope the background remains virtually non- 
fluorescent, making differentiation between living and dead bacteria easy. Images were finally 
analyzed using the in-house developed program Counting Bacteria II and both living and 
dead bacteria were expressed as percentages of the total number of bacteria in the biofilm 
(Table 5.2).
116 Chapter 5
Entry Substrate % Live % Dead
1 Untreated glass 96 4
2 Coating decorated with 6a (before 
deprotection)
99 1
3 Coating decorated with 6b (before 
deprotection)
82 18
4 Coating decorated with 6a (after deprotection) 97 3
5 Coating decorated with 6b (after deprotection) 68 32
6 Coating decorated with 7a 93 7
7 Coating decorated with 7b 62 38
Table 5.2 Microbial adhesion of S. aureus7323 on several substrates. The biofilm was coloured with the 
ÄaLight bacterial viability stain and evaluated by fluorescence microscopy using light at 488 and 543 
nm. Untreated glass (entry 1) served as a negative control.
Coatings decorated with the Boc-protected gramicidin S analogs (entry 2 and 3 in 
Table 5.2) did not show antimicrobial activity as expected. Unexpectedly, neither did the 
coatings decorated with the deprotected gramicidin S containing a terminal alkyne (entry 4 
and 6 in Table 5.2). The coatings decorated with the deprotected DIBAC-containing 
gramicidin S did show a significant but still low degree of antimicrobial activity (entry 5 and 7 
in Table 5.2). The two routes followed, i.e. immobilization of Boc-protected peptide followed 
by deprotection versus direct immobilization of deprotected peptides, furthermore gave 
comparable results (entry 4 vs. 6 and 5 vs. 7 in Table 5.2).
In order to improve the degree of functionalization, the ligand used in the CuAAC 
immobilization was varied as well as the amount of copper catalyst. The best results were 
however obtained with the above mentioned procedure. The solvent used during both 
CuAAC and SPAAC immobilizations was also varied during an optimization process. DMSO 
was substituted for H2O and acetonitrile in the hope that these solvents would cause more 
swelling of the coating and thereby increase the grafting density. Unfortunately, these 
variations proved to have no influence on either the decrease of the azide signal after the 
immobilization step or the antimicrobial activity of the hybrid coating.
Although the resulting hybrid coatings showed no significant antimicrobial activity in 
vitro, the current hybrid coatings might still prove to be active on bio-implants. AMPs can 
stimulate and enhance the adaptive immune system of their host,31 thereby magnifying their 
own activity. Extrapolation of in vitro results to in vivo activities in an actual clinical situation 
should therefore always be performed with certain caution.
Even so, there are several ways to improve the activity which is exhibited in vitro. The 
point of attachment and chemical linkage were chosen in such a way as to minimize their 
influence on gramicidin S.28 However, comparison between the terminal alkyne- and DIBAC-
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containing coatings suggests that increasing the distance between the peptide and the 
polymer film is favourable for the antimicrobial activity. The length of the spacer molecule is 
so important because it governs the ease with which the conjugated peptides can interact with 
the membranes of approaching bacteria.32,33 In the course of this research, poly(ethylene 
glycol)-based spacers with a terminal alkyne- and BCN-handle were synthesized. It proved 
difficult however, to couple these molecules to gramicidin S.
Recent studies have indicated that the production of a large number of structurally 
similar AMPs within the same animal is a strategy used by nature to increase the spectrum of 
its antimicrobial defence, by using combinations of the peptide's isoforms.34 Moreover, data is 
becoming available which suggests that there is a common theme of functional synergism 
between specific couples of antimicrobial peptides. It would therefore also be interesting to 
extend this modular technology towards the immobilization of peptide ‘cocktails’.
The procedure used to evaluate the microbial adhesion provided a fast and facile way 
to screen the antimicrobial properties of the hybrid coatings. This experimental design has 
some shortcomings however. First, the number of adhering bacteria is only evaluated for one 
point in time. Temporal effects such as deposition kinetics that reach a pseudo-end stage are 
therefore completely neglected. This will make the actual end result of a growing biofilm on 
the hybrid coatings different from a simple linear extrapolation of the initial deposition rates 
measured.1
The microbial adhesion experiments furthermore involve a static system which can 
only model relative stagnant environments, such as on the surface of medical implants, where 
sedimentation and diffusion are the main means of mass transport. However, in dynamic 
environments, such as water works, microbial adhesion is primarily controlled by the mass 
transport induced by liquid flow of suspended organisms.1
A final limitation in the experimental design was the dipping procedure following the 
inoculation and incubation of the hybrid coatings. This procedure does not provide adequate 
control over the applied rinsing forces. The dipping procedure can furthermore cause 
artefacts by the ability of passing air-liquid interfaces to detach adhered bacteria.35,36 The 
evaluation of the microbial adhesion on the hybrid coatings is therefore distorted by 
microbial retention, i.e. the ability of the adhering organisms to withstand detachment.
All problems with the current experimental design can be solved by performing the 
microbial adhesion experiments in a parallel plate flow chamber under controlled 
hydrodynamic conditions.37 The only disadvantage of this superior setup is that it is far more 
time consuming than the current procedure used. Because of the higher predictive power, it 
will still be worthwhile to use flow chambers during future exploration of these hybrid 
coatings.
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5.3 | C onclusion
In chapter four we showed a procedure for the synthesis of reactive coatings by 
thermally reacting azide-containing polymers with alkyne cross-linkers. Besides the 
immobilization of small organic probes, this chapter shows that this technology can be 
extended for the effective and straightforward immobilization of antimicrobial peptides 
(AMPs). The success of the immobilization of far bigger and structurally more complicated 
molecules underlines the modular and robust nature of this technology. The resulting hybrid 
coatings showed no significant antimicrobial activity unfortunately. As discussed, there are 
several ways to improve the activity which is exhibited however. Future exploration of these 
hybrid coatings should furthermore be guided by microbial adhesion experiments performed 
in a parallel plate flow chamber under controlled hydrodynamic conditions.
5.4 | Experim ental
Reagents. Reagents for the coating application and peptide synthesis were obtained from 
common commercial sources and used as received. Methyl methacrylate (MMA) was distilled 
prior to use. Solutions used in the biofilm growth assays were autoclaved before use. Todd 
Soya Broth (TSB) was bought from OXOID. Baclight bacterial viability stain was purchased 
from Molecular Probes Europe. Water was demineralized prior to use. MilliQ grade water was 
obtained using the Labconco Water Pro PS. Microscope glass slides from Knittel Gläser (76 x 
26 mm) were used. The HCl solution in EtOAc was prepared by saturation of EtOAc with 
chlorine gas.
Instrumentation. NMR spectra were recorded on a Bruker DMX300 (75 MHz for 13C) and 
Varian Inova 400 (400 MHz for 1H). 1H-NMR chemical shifts (ô) are reported in parts per 
million (ppm) relative to a residual proton peak of the solvent: ô = 3.31 for CD3OD and ô = 
7.26 for CDCLs. Multiplicities are reported as: s (singlet), d (doublet), t (triplet), q (quartet), p 
(pentet), se (sextet), dd (double doublet), dt (double triplet), tt (triple triplet), ddd (double, 
double doublet) or m (multiplet). Broad peaks are indicated by br. Coupling constants are 
reported as a /-value in Hertz (Hz). The number of protons (n) for a given resonance is 
indicated as nH, and is based on spectral integration values. 13C-NMR chemical shifts (ô) are 
reported in ppm relative to CD3OD (ô = 49.0) or CDCLs (ô = 77.0). ESI-MS analysis was 
performed using Thermo Scientific Advantage LCQ Linear-Ion trap Electrospray (LRMS). 
Electrospray ionization time-of-flight (ESI-ToF) spectra were measured with a /EOL AccuToF 
(HRMS). FT-IR spectra were recorded on an ATI Matson Genesis Series FT-IR spectrometer 
fitted with an ATR cell. IRRAS measurements were performed on a Bruker Tensor 27 FT-IR
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spectrometer equipped with a liquid nitrogen cooled Mercury Cadmium Telluride (MCT)- 
detector, using a Harrick Scientific Auto-Seagull variable-angle reflection unit. Vibrations (v) 
are given in cm-1. Molecular weight distributions were measured using size exclusion 
chromatography (SEC) on a Shimadzu system (DGU-20A5, LC-20AT, SIL-10AD and CTO- 
20A) with Shimadzu refractive index (RID-10A) and UV-Vis (SPD-20A) detectors. The 
system was equipped with a guard column and a PL gel 5 ^m mixed D column from Polymer 
Laboratories using THF as the mobile phase at 1.0 mL/minute and 35 °C. Poly(methyl 
methacrylate) (PMMA) standards in the range of 1,035 to 772,000 g/mol were used to 
calibrate the SEC. Data collection was performed with the program LCsolution 1.21 SP1 by 
Shimadzu. Coatings were prepared using the Short K-Bar No. 3 (with grooves of 24 ^m) by 
RK Print Coat Instruments. Peptide purification was performed on a Gilson GX-281 
automated HPLC system, equipped with a preparative Gemini C18 column (150 x 21.20 mm, 
5^). The applied buffers were: A: 0.2% aqueous TFA and B: MeCN. The bacterial 
concentration was evaluated using the BürkerTurk. Fluorescence experiments were 
performed on a Leica DM4000 B microscope. The pictures were captured using a Leica 
DFC350 FX  camera. Images were analyzed using the in-house developed program Counting 
Bacteria II.
Preparation o f azide-containing AzMA-MMA copolymer (1). Prepared according to a 
literature procedure.22 Quantities used: Cu(I)Br (38.0 mg, 0.27 mmol), toluene (2.5 mL), 
propyl-pyridin-2-ylmethylene-amine (83.5 mg, 0.57 mmol), methyl methacrylate (MMA, 
702 mg, 6.95 mmol), 2-azidoethyl methacrylate22 (AzMA, 1100 mg, 7.10 mmol). The progress 
of the polymerization was monitored by 1H-NMR spectroscopy and SEC. The polymerization 
was stopped after 20 hours. This afforded the product as an off-white powder (1.16 g, 61%). 
Mn = 5.4x103 g/mol, PDI = 1.22, AzMA:MMA ratio 1:1.1.
Characterization was in accordance with literature: 1H-NMR (400 MHz, CDCL) ô ppm: 4.10 
(m, (-CH2CH2N3)), 3.59 (m, (-CH3)), 3.49 (m, (-CH2CH2N3)), 1.85 (m), 1.73 (m), 1.52 (m),
1.05 (m). FT-IR vmax film (cm-1): 2989, 2946, 2103, 1727, 1446, 1264, 1238, 1143.
Bis(prop-2-ynyloxy) tetraethylene glycol (2). Prepared according to a literature procedure.22 
Quantities used: NaH (219 mg of 60% in mineral oil, 5.48 mmol) in toluene (20 mL), 
tetraethylene glycol (304 mg, 1.57 mmol) in toluene (5 mL), propargyl bromide (550 mg,
4.62 mmol). The product was obtained as a yellow oil (272 mg, 64%).
Characterization was in accordance with literature: 1H-NMR (400 MHz, CDCL) ô: 4.21 (m, 
4H), 3.68 (m, 16H), 2.43 (m, 2H) ppm. 13C-NMR (75 MHz, CDCL) ô: 79.6, 74.5, 70.6, 70.5,
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70.4, 69.1, 58.4 ppm. FT-IR vmax film (cm-1): 3283, 3244, 2863, 2107, 1096, 1027, 664. HRMS 
(ESI+) m/z calcd. for C 14H22O5N  [M+Na] + 293.1365, found: 293.1371.
Functionalization o f glass slides. Prepared according to a literature procedure.22 Quantities 
used: mixture of concentrated sulfuric acid/hydrogen peroxide (5/2, 70 mL), 
N-(2-aminoethyl)-3-aminopropyl-trimethoxysilane (750 mg, 3.37 mmol) in MilliQ (75 mL), 
pentynoic acid (328 mg, 3.34 mmol), 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide 
hydrochloride (EDC-HCl, 798 mg, 4.16 mmol) and 4-dimethylaminopyridine (DMAP, 
109 mg, 0.89 mmol) in MilliQ (75 mL).
Coating o f microscope glass slides. Prepared according to a modified literature procedure:22 
AzMA/MMA copolymer 1 (23.93 mg, azide content of 0.087 mmol) together with 
bis(prop-2-ynyloxy) tetraethylene glycol (2, 4.46 mg, 0.017 mmol) were dissolved in CH2O 2 
(417 |xL). Each alkyne-functionalized microscope slide was treated with 50 ^L of this solution 
after which the wet film was evenly distributed using a K-bar hand coater (with grooves of 
24 ^m). After evaporation of the solvent the coated glass plates were placed in a vacuum oven 
at 120 °C for 4 hours.
General procedure for the synthesis o f the clickable gramicidin S analogs (6a and 6b). Prepared 
according to a modified literature procedure:29 The acid (3 eq, 150 ^mol, 5a or 5b) was 
dissolved in CH2O 2 (2 mL) after which HATU (2.9 eq, 145 ^mol) and DiPEA (3 eq, 
150 ^mol) were added. The mixture was preactivated for 1  minute and finally added to a 
solution of amine-functional gramicidin S (50 ^mol, 4) in CH2O 2 (100 |xL). The reaction 
mixture was stirred for 2  hours and the solvent was then evaporated in vacuo. The crude was 
purified by LH-20 gel filtration using methanol as eluent. The amides were obtained in 
80-95% yield.
Gramicidin S-dibenzocyclooctyne (6 a): LC/MS: Rt = 11.62 minutes (10 ^  90% MeCN, 
15 minutes). LRMS (ESI+) m/z calcd. for C90H125N 14O16 [M+H] + 1657.93, found: 1658.20. 
Gramicidin S-pentyne amide (6b): LC/MS: Rt = 11.69 minutes (10 ^  90% MeCN, 
15 minutes). LRMS (ESI+) m/z calcd. for C75H114N 13O15 [M+H] + 1436.85, found 1436.20.
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Deprotection o f gramicidin S 6a and 6b. The gramicidin S analogs were dissolved in AcOH at 
a concentration of 40 mg/mL. This solution was added drop wise to a solution of HCl in 
EtOAc (2 M, 10 mL) and stirred for 20 minutes. The subsequent suspension was concentrated 
in vacuo, redissolved in water (5 mL) and lyophilized yielding the desired products as a white 
powder. 1H-NMR (400 MHz, DMSO-D6) indicated the complete removal of the Boc-groups 
in both products.
Typical protocol for the functionalization of the polymeric coatings with Gramicidin S 6a and 
7a. 35 ^M solutions of Gramicidin 6a or 7a were prepared in approximately 80 ^L of DMSO. 
CuBr (2.16 mg, 15.32 ^mol) and tris((1-((O-ethyl)carboxymethyl)-(1,2,3-triazole-4-yl)) 
methyl)amine (7.85 mg, 15.15 ^mol) were dissolved in DMSO (1500 |xL). The copper catalyst 
solution was mixed with either peptide solution in a 1/1 ratio, resulting in two reaction 
mixtures with approximately 290 equivalents of copper catalyst compared to the peptide 
present. Each reaction mixture (80 ^L) was applied on a separate coated microscope slide and 
spread out over a surface of 1 x 2 cm. The reaction was left for 20 hours during which freshly 
made copper catalyst solution (10 ^L, 35 equivalents) was added three times. The reactions on 
the coated microscope slides were stopped by washing the glass plate with DMSO (30 mL) 
and subsequently soaking it in DMSO (90 mL) for 15 minutes. The glass slide was then rinsed 
with MeOH (30 mL) and dried.
Typical protocol for the functionalization o f the polymeric coatings with Gramicidin S 6b and 
7b. A 23 ^M solution of Gramicidin S 6b or 7b was prepared in DMSO (200 |xL). 50 ^L of the 
peptide solution was applied on individual coated microscope slides and spread out over a 
surface of 1 x 2 cm and left to react for 16 hours. The reactions on the coated microscope 
slides were stopped by washing the glass plate with DMSO (30 mL) and subsequently soaking 
it in DMSO (90 mL) for 15 minutes. The glass slide was then rinsed with MeOH (30 mL) and 
dried.
Deprotection o f coatings decorated with gramicidin S 6a and 6b. The coated microscope glass 
slides were submerged in a solution of HCl in EtOAc (2 M, 20 mL) and left to react for 
30 minutes. The microscope glass slides were subsequently rinsed with MeOH and left to dry 
to the air.
IRRAS measurement of functionalized polymeric coatings. All coatings were measured before 
and after each immobilization or deprotection step using an angle of incidence of 55° and
S-polarized light. Spectra were obtained with 256 scans at a resolution of 4 cm-1. The raw data
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were divided by the data recorded from an uncoated glass slide. The thus obtained spectra 
were subsequently baseline corrected with a manual interface which allowed the reference 
points to be defined by the user, making it possible to keeps these points constant for all 
spectra. The azide signal was integrated between 2165 and 1939 cm-1 in each spectrum. 
Differences in the azide signal before and after functionalization were finally expressed in 
percentages.
Culture conditions and harvesting. Staphylococcus aureus 7323, originally isolated from a 
clinical hip prosthesis, was first taken from frozen stock and grown on blood agar plates for 
24 hours at 37 °C in sterile TSB. A fresh colony was inoculated in sterile TSB and aerobically 
cultured for 24 hours at 37 °C. This culture was subsequently used to inoculate a second 
culture for 16 hours under similar conditions. The microorganisms were harvested by 
centrifugation for 5 minutes at 6500 g (= 5000 rpm) at 10 °C. The pellet was washed twice 
with sterile PBS (0.01 M, pH 7.0). The microorganisms were subsequently suspended in 
sterile PBS (10 mL) and sonicated on ice for 10 seconds to break bacterial aggregates. The 
bacterial suspension was further diluted in sterile PBS to a concentration of 3x108 cell mL-1.
Biofilm growth experiment. The coated microscope glass slides were placed in sterile petri 
dishes, inoculated with a suspension of Staphylococcus aureus 7323 (100 mL, 3x108 cell mL-1) 
and incubated for 2 hours at room temperature. The samples were washed by carefully 
dipping them twice in sterile water and subsequently placed in sterile petri dishes. Sterile TSB 
(100 mL) was added and the glass plates were incubated for an additional 2 hours at 37 °C. 
The samples were finally washed a second time using the same dipping procedure before 
evaluation.
Biofilm evaluation. The BacLight bacterial viability stain was prepared by mixing the stock 
solutions of SYTO 9 and propidium iodide in a volume ratio of 1/1 (v/v). 3 ^L of this mixture 
was subsequently diluted in 1 mL sterile water. Approximately 25 ^L of the final BacLight 
bacterial viability stain mixture was spread over the surface of the microscope glass slides and 
left to react in the dark for 15 minutes. The samples were evaluated by fluorescence 
microscopy using light at 488 and 543 nm. Emitted light with wavelength between 495 and 
535 nm was assigned the colour green and interpreted as viable bacteria. Light from 580 to 
700 nm was assigned the red colour and interpreted as non-viable bacteria. The ratio of red 
bacteria over the sum of red and green bacteria was calculated and expressed as a percentage 
of dead bacteria.
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Copper-free clickable ELISA
6 . 1  | Introduction
The enzyme-linked immunosorbent assay (ELISA)1 is a well-established biochemical 
technique that is used on a large scale as a diagnostic tool within medicine, like in pregnancy 
tests, and for quality control in various industries, for instance while monitoring food 
allergens. ELISA is based on the specific binding between an antigen and its appropriate 
antibody, which can be quantified with an enzyme label on either binding partner. The 
principle of specific recognition of a particular epitope make ELISAs a valuable medical tool 
for the diagnosis of infectious diseases and auto-immune diseases.
One common human auto-immune disease is rheumatoid arthritis (RA), which is 
characterized by chronic inflammation of the joints. The inflammatory process results in the 
posttranslational modification of a range of proteins. The immune system no longer 
recognizes these modifications as ‘self, and starts producing antibodies against the modified 
proteins. Although the exact pathogenic nature of the different antibodies is still under 
debate,2 several antibodies have been identified that are exclusively associated with RA and 
can therefore serve as specific biomarkers. One of the most promising groups of antibodies 
are those against citrullinated proteins.3 During a runaway inflammation process, dead cells 
release the enzyme peptidylarginine deiminase, which subsequently transforms arginine 
residues present in extracellular peptides into the neutral residue citrulline. As a consequence 
of continuous deimination of arginines, this process ultimately leads to the formation of 
autoimmune anti-citrulline antibodies (ACAs).4 Because they are already present during the 
early stages of RA, autoimmune human ACAs have a high predictive value for RA and can be 
used during early diagnosis and prognosis up to 10 years before the manifestation of clinical 
signs of the disease.
In order to detect ACAs in a pathological case, the associated citrullinated peptides need 
to be immobilized on a surface, which may be achieved by one of several methods applied in 
traditional ELISAs, such as passive absorption,5 chemical conjugation to reactive groups such as 
maleic anhydride6 and the non-covalent interaction between (strept)avidin and biotin.7 
However, these approaches are either very expensive or give little to no control over the 
attachment site of the peptide, which can ultimately reduce the sensitivity of the ELISA.
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Because of the above mentioned disadvantages, we set out to develop a new microtiter 
plate coating following the ‘click’ strategy described in chapters four and five. Clickable 
coatings were based on either the broadly applied copper-catalyzed azide-alkyne 1,3-dipolar 
cycloaddition (CuAAC)8 or the more recently developed copper-free strain-promoted azide- 
alkyne 1,3-dipolar cycloaddition (SPAAC).9-13 Both of these chemoselective, robust and 
versatile click reactions have already been successfully used in the construction and 
functionalization of polymeric coatings.14-21 This chapter describes our exploration of the 
potential of CuAAC and SPAAC as cost-effective and selective immobilization methods for 
the production of ELISAs that can detect ACA or any other disease specific antibodies 
(Figure 6.1).
Figure 6.1 | Surface immobilization of a diagnostic peptide using click reaction (I) and subsequent ELISA 
(II-IV): II) The primary antibody from the sample of the patient binds to the epitope (triangle) of the 
immobilized antigen and thereby becomes immobilized itself. III) A secondary enzyme-labelled antibody 
conjugates to any primary antibodies which have been bound. IV) The bound enzyme converts substrate 
'A' into product 'B' which can be measured by optical density which is directly correlated to the amount 
of primary antibody present in the patient's sample.
6 . 2  | R esu lts an d  d iscu ssion
For the fabrication of our clickable coatings, monomers were required that were 
suitable to take part in azide-alkyne 1,3-dipolar cycloadditions. For the ELISA based on 
CuAAC, commercially available prop-2-yn-1-yl methacrylate, also known as propargyl 
methacrylate, was used.
Alternatively, a methacrylate was decorated with a bicyclo[6.1.0]non-4-yne (BCN) 
moiety (2) for use in the ELISA based on SPAAC. Exo-1 and endo-1 were synthesized as a 
mixture of diastereomers according to a literature procedure.13 Because both BCN
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stereoisomers exhibit similar reactivity toward azides,13 they were not separated and used as a 
mixture for the rest of the synthesis. The hydroxyl group of 1 was subsequently reacted with 
an excess of methacryloyl chloride under basic conditions using 4-dimethylaminopyridine 
(DMAP) as a catalyst for the esterification reaction (Scheme 6.1).
Scheme 6.1 | Synthesis of monomers 2. Reagents and conditions: i) EtßN, DMAP, CH2Q 2, 0 °C to r.t., 16 h 
(70%).
For the ELISA based on CuAAC, a monomer mixture was made containing 10% v/v 
of the functional propargyl methacrylate together with poly(ethylene glycol) dimethacrylate, 
ethylene glycol dimethacrylate and 2-hydroxyethyl methacrylate. Poly(ethylene glycol) 
dimethacrylate serves as a cross-linker and provides a hydrophilic, water-swellable polymer 
network. Ethylene glycol dimethacrylate is an additional cross-linker and furthermore 
ensures proper adhesion to the microtiter plate by interacting with the poly(styrene) 
substrate. As the final monomer component, 2-hydroxyethyl methacrylate was used to lower 
the viscosity of the monomer mixture, making it easier to handle. The final coating 
formulation was prepared by diluting the monomer mixture with methanol to a monomer 
content of 5% (v/v). The ratio of the different components was varied during an optimization 
process and proved to have a big influence on the physical properties of the final coating, 
such as its stability, adhesion and transparency. The final coating formulation is shown in the 
experimental session.
UV-initiated free-radical polymerization was chosen as the curing method because of 
the speed of this process. Before proceeding however, the reactivity of the terminal alkyne 
moiety of propargyl methacrylate towards radicals was examined. A solution of the monomer 
with the UV initiator Irgacure 1000 was exposed to UV for 15 minutes, after which only 
minimal decomposition of the terminal alkyne was seen on 1H-NMR. After proven 
compatibility with propargyl methacrylate, Irgacure 1000 was added to the coating mixture. 
The final coating formulation was applied as a thin liquid film to each well of a microtiter 
plate (96 wells) and then polymerized by exposing the microtiter plate for 2 x 60 seconds to a 
strong UV source. This procedure led to a reactive, stable and transparent coating, which did 
not interfere with the read-out of the ELISA in the visible spectral region.
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1H-NMR analysis of a solution of BCN methacrylate 2 and Irgacure 1000 after UV 
exposure indicated that the strained alkyne system 2 was fully resilient towards the radicals 
generated during polymerization. The same coating procedure and compound ratios could 
therefore be used for fabricating a second coating containing the clickable monomer 2.
Scheme 6.2 | Synthesis of Fmoc-protected azidonorleucine and subsequent incorporation into peptides 
5 and 6 . Reagents and conditions: i) HCl, EtOAc, r.t., 2 h (90%); ii) CuSO4, K2CO3, MeOH, r.t., 16 h (89%); iii) 
Fmoc-protected amino acid, DIPCDI, HOBt, DMF, r.t., 45 min; iv) piperidine, DMF, r.t., 3 x 6  min; v) DMF, 
r.t., 45 min; vi) trifluoroacetic acid, H2O, triisopropylsilane, r.t., 4 h.
The reactivity of the clickable coatings was subsequently investigated using an azide- 
functional peptide containing citrulline (5), a known epitope for specific recognition by a 
proprietary monoclonal human ACA available from ModiQuest Research. The 
corresponding arginine analog (6) was synthesized as a negative control. To this end, Fmoc- 
lysine(Boc) was deprotected with HCl in EtOAc and converted into an azide derivative via a 
diazo transfer reaction using imidazole-1-sulfonyl azide hydrochloride (3) (Scheme 6.2).22, 23 
The resulting Fmoc-protected azidonorleucine (4) was bound to a Breipohl resin and the 
consecutive amino acids were built in a stepwise fashion by solid-phase peptide synthesis 
(SPPS).24, 25 Introduction of a biotin group on the N-terminus of the peptides containing
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either arginine or citrulline, using an activated p-nitrophenyl ester, resulted in peptides 5 and
6 respectively (Scheme 6.2). The peptides were finally cleaved from the resin using a mixture 
of trifluoroacetic acid, water and triisopropylsilane. Radical scavengers were omitted from the 
cleavage mixture, because of the possible reduction of azides under the influence of 1,2- 
ethanedithiol (EDT).26
By virtue of the biotin function on the N-terminus, either peptide 5 or 6 could be 
immobilized on an avidin-functional microtiter plate and the resulting microtiter plates were 
evaluated for their potential to bind ACA. After having confirmed that the citrullinated 
peptide 5 was recognized by human ACA and peptide 6 was not, either peptide was 
immobilized on both clickable coatings using the azide handle on the C-terminus. In the case 
of the coated microtiter plate containing propargyl functionality, peptides 5 and 6 were 
dissolved in DMSO/H2O (1/2), mixed with copper and a suitable ligand (CuBr with 
tris((1-((O-ethyl)carboxymethyl)-(1,2,3-triazole-4-yl))methyl)amine) and left to react in the 
microtiter plate for 22 hours. Alternatively, functionalization of the microtiter plate featuring 
the BCN functionality 2 was performed by simply leaving the peptide solutions in 
DMSO/H2O (1/2) to react by themselves for 2 hours. The protocol for the ELISA comprised 
of first blocking each microtiter plate using bovine serum albumin (BSA) followed by 
incubation with a solution of human anti-citrulline antibody (ACA) for 1 hour. In the 
detection step, monoclonal rabbit anti-human antibody conjugated to the horseradish 
peroxidase enzyme (HRP) was added to the microtiter plates and incubated for 1 hour. The 
microtiter plates were finally developed with a 3,3',5,5'-tetramethylbenzidine (TMB) solution 
for 5 minutes in the dark. The absorbance at 450 nm is a direct measure of the activity of HRP 
bound to the microtiter plates, which in turn indicates how much ACA was initially bound to 
the peptide-decorated coatings.
The coated microtiter plate containing propargyl methacrylate showed a positive 
ELISA response after treatment with peptide 5 and copper catalyst, which was taken as a 
strong indication that the peptide functionalization step using CuAAC had worked. 
Unfortunately, the same coating also gave a strong, false positive signal after treatment with 
the arginine-containing peptide 6 and copper catalyst (Table 6.1). On the other hand, when 
either copper catalyst or peptide was omitted from the functionalization step, low background 
values were obtained. It therefore appears that the copper catalyst together with the peptide 
interfere with the subsequent ELISA. A possible explanation could be that the copper cannot 
be sufficiently removed after the functionalization step due to coordination to the amide 
bonds of the immobilized peptides.27
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Table 6.1 | ELISA Optical Density (OD) measurement at 450 nm. Measurements were carried out for 
microtiter plates (96 wells) prepared with either propargyl methacrylate (PMA), BCN methacrylate 2 or 
only 2-hydroxyethyl methacrylate (HEMA). Each microtiter plate was functionalized with either citrulline- 
containing peptide (5) or an arginine-containing peptide (6). For the microtiter plate containing 
propargyl functionality, additional negative controls were carried out by either omitting the copper 
catalyst or the peptide during the functionalization step of the coating. Error bars depict the standard 
deviation as determined from duplicate measurements.
The microtiter plate prepared with BCN methacrylate 2 was functionalized using the 
SPAAC conjugation, which has the major advantage that it does not require a copper catalyst. 
Much to our satisfaction, performing the peptide immobilization step in a copper-free 
manner resulted in a high positive response on the citrulline-containing peptide, while 
maintaining low background levels in combination with the arginine-containing peptide 
(Table 6.1). These results illustrate that this BCN-based immobilization technology is suitable 
for diagnostic ELISAs.
Replacing the clickable monomer in the coating with 2-hydroxyethyl methacrylate 
resulted in low signals on both citrulline- and arginine-containing peptides (5 and 6; Table 
6.1). This confirmed that the results seen with the coating containing propargyl or BCN 
functionality were not caused by aspecific absorption to the coating, but were indeed due to 
specific conjugation between the clickable monomers and the azide-functional peptides.
6.3 | C onclusion
In this chapter we have shown a straightforward procedure for the formulation and 
application of two clickable coatings onto microtiter plates with either a terminal alkyne or 
BCN as a chemical handle. Use of a fast UV curing procedure resulted in stable and 
transparent coatings. A citrulline-containing peptide, known to be recognized by human anti-
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citrulline antibodies (ACAs) from rheumatoid arthritis (RA) diseased patients, was 
functionalized with an azide and immobilized on either the coating containing the terminal 
alkyne using the copper-catalyzed CuAAC or on the BCN-containing coating using SPAAC. 
Subsequent ELISAs using human ACAs showed that the coating containing the terminal 
alkyne suffered from high background levels due to the copper catalyst used in the 
immobilization step. The BCN-containing coating on the other hand, was successfully 
employed in an ELISA against RA and illustrates how important it is to perform 
bioconjugations in a copper-free manner when pursuing biomedical applications. This 
technology is a cost-effective alternative to existing (strept)avidin-biotin immobilization 
methods, and can be easily adapted for ELISAs with various diagnostic targets, because of the 
modular and robust nature of the chemistry used in the immobilization step.
6.4 | Experim ental
Reagents. All purchased chemicals were obtained from common commercial sources and 
used as received. Prop-2-yn-1-yl methacrylate was purchased from Alfa Aesar. A monoclonal 
human anti-citrulline antibody (MQR2.101) was provided by ModiQuest Research. 
Monoclonal rabbit anti-Human IgG-HRP was purchased from Dako. Tetrahydrofuran (THF) 
was distilled from sodium and benzophenone. Dichloromethane (CH2CL) was filtered over 
CaCl2 and dried by distilling from CaH2 and triethylamine (Et3N). Water was demineralized 
prior to use. MilliQ grade water was obtained using the Labconco Water Pro PS. The HCl 
solution in EtOAc was prepared by saturation of EtOAc with chlorine gas. Nunc Lockwell 
MaxiSorp microtiter plates (96 wells) were used for the coating and subsequent 
functionalization experiments.
Instrumentation. NMR spectra were recorded on a Varian Inova 400 (400 MHz for JH). 
JH-NMR chemical shifts (ô) are reported in parts per million (ppm) relative to a residual 
proton peak of the solvent: ô = 3.31 for CD3OD and ô = 7.26 for CDCLs. Multiplicities are 
reported as: s (singlet), d (doublet), t (triplet), q (quartet), p (pentet), se (sextet), dd (double 
doublet), dt (double triplet), tt (triple triplet), ddd (double, double doublet) or m (multiplet). 
Broad peaks are indicated by br. Coupling constants are reported as a /-value in Hertz (Hz). 
The number of protons (n) for a given resonance is indicated as nH, and is based on spectral 
integration values. ESI-MS analysis was performed using Thermo Scientific Advantage LCQ 
Linear-Ion trap Electrospray (LRMS). FT-IR spectra were recorded on an ATI Matson Genesis 
Series FT-IR spectrometer fitted with an ATR cell. Vibrations (v) are given in cm-1. As UV 
source an UVA Spot 400T from Hönle UV Technology outfitted with a Quartz filter and a
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Hönle 400 H/2 lamp was used. Thin layer chromatography (TLC) was carried out on Merck 
precoated silica gel 60 F-254 plates (layer thickness 0.25 mm). Compounds were visualized by 
UV, KMnO4, ninhydrin or iodine colouring. Column chromatography was performed using 
Acros silica gel (0.035-0.070 mm, pore diameter ca. 6 nm).
Synthesis o f (1R,8S,9r,Z)-Ethyl bicyclo[6.1.0]non-4-ene-9-carboxylate and (1R,8S,9s,Z)-ethyl 
bicyclo[6.1.0]non-4-ene-9-carboxylate. Prepared according to a modified literature 
procedure.13 Quantities used: 1,5-cyclooctadiene (19.6 mL, 160 mmol) and Rh2(OAc)4 
(380 mg, 0.86 mmol) in CH2Q 2 (15 mL); ethyl diazoacetate (2.1 mL, 20 mmol) in CH2Q 2 (12 
mL). After eluting the excess of 1,5-cyclooctadiene from silica with EtOAc/heptane (1/200), 
the mixture of the exo- and endo-diastereomers was not purified any further, which afford a 
colourless oil (2.4 g, 61%) containing the exo- and endo-diastereomers in a ratio of 2:1. 
exo: 1H NMR (CDCk, 400 MHz): ô 5.68-5.60 (m, 2H), 4.10 (q, /  = 7.2 Hz, 2H), 2.35-2.27 (m, 
2H), 2.24-2.16 (m, 2H), 2.13-2.04 (m, 2H), 1.59-1.53 (m, 2H), 1.53-1.43 (m, 2H), 1.25 (t, 
/  = 7.2 Hz, 3H), 1.18 (t, /  = 4.8 Hz, 1H).
endo: 1H NMR (CDCL, 400 MHz): ô 5.65-5.57 (m, 2H), 4.12 (q, /  = 7.2 Hz, 2H), 2.53-2.46 (m, 
2H), 2.25-2.16 (m, 2H), 2.10-2.01 (m, 2H), 1.87-1.79 (m, 2H), 1.70 (t, /  = 8.8 Hz, 1H), 
1.43-1.34 (m, 2H), 1.26 (t, /  = 7.2 Hz, 3H).
Synthesis o f (1R,8S,9r)-Bicyclo[6.1.0]non-4-yn-9-ylmethanol (exo-1) and (1R,8S,9s)- 
Bicyclo[6.1.0]non-4-yn-9-ylmethanol (endo-1). Prepared according to a modified literature 
procedure.13 Quantities used: 2:1 mixture of (1R,8S,9r,Z)-Ethyl bicyclo[6.1.0]non-4-ene-9- 
carboxylate and (1R,8S,9s,Z)-ethyl bicyclo[6.1.0]non-4-ene-9-carboxylate (240 mg, 1.24 
mmol) in Et2O (5 mL); LiAlH4 (56 mg, 1.46 mmol) in Et2O (5 mL); Br2 (69 ^L, 1.02 mmol) in 
CH2CL (1 mL); KOtBu (4.6 mL, 1 M in THF, 4.60 mmol). This afforded the product as a 
white solid (130 mg, 79%) containing the exo- and endo-diastereomers in a ratio of 2:1. 
exo-1: 1H NMR (CDCL, 400 MHz) ô: 3.54 (d, /  = 6.4 Hz, 2H), 2.44-2.40 (m, 2H), 2.32-2.25 (m, 
2H), 2.18-2.14 (m, 2H), 1.88 (br s, 1H), 1.44-1.34 (m, 2H), 0.74-0.63 (m, 3H). 
endo-1: 1H-NMR (CDCL, 400 MHz) ô: 3.73 (d, /  = 8.0 Hz, 2H), 2.35-2.20 (m, 6H), 1.66-1.56 
(m, 2H), 1.39- 1.30 (m, 1H), 1.18 (br s, 1H), 0.99-0.90 (m, 2H).
Synthesis o f (1R,8S,9r)-Bicyclo[6.1.0]non-4-yn-9-yl methacrylate (exo-2) and (1R,8S,9s)- 
Bicyclo[6.1.0]non-4-yn-9-yl methacrylate (endo-2). Alcohol 1 (136 mg, 0.91 mmol) was 
dissolved in dry CH2O 2 (50 mL) and cooled to 0 °C. Dry triethylamine (Et3N, 1.85 mL,
18.10 mmol) and a drop o f 4-dimethylaminopyridine (DMAP) were added. A solution of 
methacryloyl chloride (116 ^L, 1.18 mmol) in dry CH2O 2 (5 mL) was added drop wise. The
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reaction mixture was allowed to warm to room temperature and stirred for 16 hours. The 
reaction mixture was washed with saturated aqueous NH4O  (3 x 50 mL), and dried with 
Na2SO4. The organic layer was concentrated in vacuo and the crude mixture was purified 
using column chromatography (EtOAc), affording the product as a colourless oil (130 mg, 
70%).
1H NMR (CDCl3, 400 MHz) ô: 6.23 (p, /  = 1.0 Hz, 2H), 6.11 (m, 3.5H), 5.82 (dq, /  = 1.1, 
0.5 Hz, 2H), 5.56 (m, 3.5H), 4.24 (d, /  = 8.3 Hz, 2H), 4.08 (d, /  = 6.6  Hz, 3.5H), 2.43-2.11 (m, 
20H), 2.01 (dd, /  = 1.0, 0.6 Hz, 6 H), 1.95 (dt, /  = 1.0, 0.63 Hz, 11H), 1.69-1.51 (m, 12H),
1.46-1.22 (m, 17.5H), 1.02-0.70 (m, 17.5H).
Synthesis o f imidazole-1-sulfonyl azide hydrochloride (3). Prepared according to a literature 
procedure.22 Quantities used: NaN3 (3.26 g, 50 mmol) in MeCN (50 mL); sulfuryl chloride 
(4.1 mL, 50 mmol); imidazole (6.50 g, 95 mmol); HCl in EtOAc (2 M, 40 mL). This afforded 
the product as white needles (7.05 g, 67%).
In accordance with literature: 1H-NMR (400 MHz, D2O) ô: 7.44 (dd, 1H), 7.85 (dd, 1H), 9.17 
(dd, 1H). LRMS (ESI+) m/z calcd. for C3H3N5O2S [M-Cl] + 174.0, found 173.9. FTIR vmax film 
(cm-1): 2362, 2169, 1436, 1196.
Synthesis o f Fmocs-azido-L-norleucine (4). 9-Fluorenylmethyloxycarbonyl-L-lysine(tert- 
butoxycarbonyl) (Fmoc-L-lysine(Boc), 3.0 g, 6.40 mmol) was dissolved in a solution of HCl in 
EtOAc (2 M, 150 mL) and stirred at room temperature for 2 hours. The white precipitate that 
formed was isolated by filtration and dried in vacuo overnight to afford Fmoc-lysine as a 
white solid (2.13 g, 90%), which was used without further purification.
Fmoc-lysine (2.03 g, 5.51 mmol), CuSO4 (88 mg, 0.35 mmol) and K2CO3 (2.46 g, 17.83 mmol) 
were dissolved in MeOH (70 mL). Imidazole-1-sulfonyl azide hydrochloride (3, 1.40 g, 
6.70 mmol) was added in small portions and the suspension was stirred overnight at room 
temperature. The solvent was evaporated in vacuo, and the residue was redissolved in CH2O 2 
(50 mL). The solution was washed with aqueous HCl (1 M, 50 mL), and the aqueous phase 
was extracted with CH2Q 2 (3 x 50mL). The crude mixture was purified using gradient 
column chromatography (C^CL/M eOH/AcOH from 96.5%/3%/0.5% ^  93.5%/6%/0.5%) 
and lyophilized from dioxane, resulting in a colourless oil (1.94 g, 89%).
In accordance with literature:28 1H-NMR (400 MHz, CDCL) ô: 7.76 (d, /  = 7.5 Hz, 2H), 7.59 
(d, /  = 6.9 Hz, 2H), 7.40 (t, /  = 7.5 Hz, 2H), 7.31 (t, /  = 7.5 Hz, 2H), 5.34 (d, /  = 7.8 Hz, 1H), 
4.54 (br s, 1H), 4.43 (d, /  = 6.6 Hz, 2H), 4.22 (t, /  = 6.6 Hz, 1H), 3.27 (t, /  = 6.6 Hz, 2H), 1.3-2.0 
(m, 2H). HRMS (ESI+) m/z calcd. for C21H23N4O8 [M+H] + 395.1719, found 395.1718.
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Synthesis o f Peptides 5 and 6. Prior to the peptide synthesis, the Breipohl resin24, 25 was swollen 
for 20 minutes in DMF. Stepwise solid-phase peptide synthesis (SPPS) was performed using 
standard Fmoc-chemistry: Each peptide coupling was executed using 3 equiv. of the 
appropriate Fmoc-protected amino acid together with diisopropylcarbodiimide (DIPCDI,
3.3 equiv.) and N-hydroxybenzotriazole (HOBt, 3.6 equiv.) in DMF for approximately 
45 minutes. Fmoc-groups were removed with piperidine in DMF (20% v/v, 3 x 6 min). In the 
final step, the N-terminus was reacted with 3 equiv. of (+)-Biotin 4-nitrophenyl ester in DMF 
for 45 minutes.
After coupling the biotin group, the resin-bound peptide was washed thoroughly with DMF, 
CH2CL, MeOH, Et2O and finally air dried. The peptide was cleaved from the resin by 
treatment with trifluoroacetic acid/H2O/triisopropylsilane (92.5/2.5/5.0, v/v) for 4 h. After 
precipitation in diethyl ether, the peptide was lyophilized from acetic acid. The peptide was 
characterized using HPLC, FTIR and LRMS (ESI+) (data not shown).
Coating application. A monomer mixture of poly(ethylene glycol) dimethacrylate (3000 ^L), 
ethylene glycol dimethacrylate (2000 ^L), 2-hydroxyethyl methacrylate (3700 ^L) and 
Irgacure 1000 (300 ^L) was prepared. This monomer mixture was subsequently mixed with 
either propargyl methacrylate or BCN methacrylate 2 in a 9:1 ratio (v/v), affording two stock 
mixtures containing 30% v/v poly( ethylene glycol) dimethacrylate, 20% v/v ethylene glycol 
dimethacrylate, 37% v/v 2-hydroxyethyl methacrylate, 10% v/v of the clickable monomer 
(either propargyl methacrylate or BCN methacrylate) and 3% v/v of initiator. The stock 
mixtures were diluted in methanol to a final monomer content of 5% (v/v).
Wells of a microtiter plates (96 wells) were filled with 100 ^L of coating solution and shaken 
gently to wet the walls completely. Excess mixture was removed by turning the microtiter 
plate upside down and forcibly knocking the liquid out, taking care not to cross-contaminate 
the wells. The liquid film, which remained in the wells, was polymerized using a strong UV 
source that was positioned 20 centimetres above the sample for 60 seconds. After 30 minutes 
the UV exposure was repeated in order to improve the clarity and stability of the coating.
Typical procedure for peptide immobilization on a coating containing propargyl methacrylate. 
0.37 mM solutions o f peptides 5 and 6 were prepared by first dissolving the peptides in 
DMSO and then adding H2O to a final ratio of 2:1 (v/v). CuBr (1.29 mg, 9.15 ^mol) and 
tris((1-((O-ethyl)carboxymethyl)-(1,2,3-triazole-4-yl))methyl)amine (6.20 mg, 11.96 ^mol) 
were dissolved in H2O/DMSO (3/1 v/v, 1040 |xL). 30 ^L of each peptide solution together with 
30 ^L of the copper catalyst solution were added to each well. This resulted in reaction 
mixtures containing approximately 25 equivalents o f copper catalyst compared to the
Copper-free clickable ELIS/ 135
peptides used. Negative controls were prepared by either mixing a peptide solution (30 ^L) 
with H2O (30 ^L) or mixing the copper catalyst (30 ^L) with H2O (30 |xL). The microtiter 
plate (96 wells) was covered with aluminium foil and left to react at room temperature for 
22 hours while gently shaken at 300 rpm. During the coupling reaction, freshly made copper 
catalyst solution (5 ^L) was added three times to each reaction mixture. The coupling reaction 
was stopped by removing the reaction mixtures from the wells and washing the microtiter 
plate three times with phosphate buffer (PBS, 10 mM, pH 7.2), followed by three times with 
phosphate buffered saline Tween-20 solution (PBST, 10 mM, pH 7.2, 0.05% Tween-20) and 
finally three times with PBS buffer. The microtiter plate (96 wells) was stored in the fridge 
while filled with PBS buffer. The extent to which the peptides were coupled to the reactive 
coating was finally evaluated in an ELISA assay.
Typical procedure fo r peptide immobilization on a coating containing 2. 0.18 mM solutions of 
peptides 5 and 6 were prepared by first dissolving the peptides in DMSO and then adding 
H2O to a final ratio of 2:1 (v/v). Each of the wells was filled with 80 ^L of the peptide solution. 
The microtiter plate (96 wells) was covered with aluminium foil and left to react at room 
temperature for 2 hours while gently shaken at 300 rpm. The coupling reaction was stopped 
by removing the reaction mixtures from the wells and washing the microtiter plate three 
times with phosphate buffer (PBS, 10 mM, pH 7.2) followed by three times with phosphate 
buffered saline Tween-20 solution (PBST, 10 mM, pH 7.2, 0.05% Tween-20) and finally three 
times with PBS buffer. The microtiter plate was stored in the fridge while filled with PBS 
buffer. The extent to which the peptides were coupled to the reactive coating was finally 
evaluated in an ELISA assay.
ELISA protocol. The microtiter plate (96 wells) was washed three times with a phosphate 
buffered saline Tween-20 solution (PBST, 10 mM, pH 7.2, 0.05% Tween-20; 200 |xL/well), 
then blocked with 1% Bovine Albumin (BSA) in PBST (380 |xL/well) for 1 hour at room 
temperature. After three additional washes with PBST, 100 ^L of human anti-citrulline 
antibody solution (MQR2.101; 100 ng/100 ^L PBST + 1% BSA) was added per well and 
incubated for 1 hour at room temperature. After three washes with PBST, 100 ^l/well of the 
secondary HRP labelled antibody (monoclonal rabbit anti-Human IgG-HRP diluted 1/2000 
in PBST + 1% BSA) was added to the microtiter plate for an additional incubation of 1 hour 
at room temperature. After three final PBST and four PBS washes, the microtiter plate was 
developed with 100 ^l/well 3,3',5,5'-tetramethylbenzidine (TMB) solution (Tebu-Bio) for 
5 minutes at room temperature in the dark. The reaction was stopped by adding 100 ^l/well
2 M H2SO4, and the absorbance was read at 450 nm.
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Conclusion
Historically, materials were selected because of their desirable physical properties, but 
now there is a growing interest in developing materials that are also biologically active. These 
biofunctional materials can respond to, and operate within, complex biological systems and 
offer unprecedented applications in industries ranging from food to medicine.
One way to produce biofunctional materials is to couple peptides to polymers. 
Peptides are an attractive constituent because they offer a wide variety of biological functions 
such as catalysis and receptor-ligand recognition. They are, however, chemically sensitive and 
have very complicated structures, which impose special requirements on the chemistry used 
to link the peptides to the polymers. ‘Click’ reactions can overcome this challenge because of 
their bio-orthogonal nature. This thesis presents new and flexible strategies for the 
production of biofunctional materials based on two different click reactions: the broadly 
applied copper-catalyzed azide-alkyne 1,3-cycloaddition (CuAAC) and the recently 
developed copper-free strain-promoted azide-alkyne 1,3-cycloaddition (SPAAC). These two 
methods were not only applied in solution, as is common practice, but were also applied on 
coatings.
In solution, comb-shaped bioconjugates were created by grafting side-chain azide- 
functional polymers with alkyne-containing peptides. In an inert atmosphere, CuAAC gave 
quantitative functionalization with a corresponding high grafting density. SPAAC on the 
other hand, exhibited limited grafting density because of the steric bulk of the conjugation 
moiety used. These results show that the size of the conjugation moiety limits the feasibility of 
certain architectures. In the on-going search for better click reactions, researchers tend to 
focus solely on efficiency, biocompatibility and water-solubility. However, our research 
clearly shows that reducing the size of the conjugation moiety is a worthwhile goal as well.
Alternatively, the azide-functional polymers were also used in the construction of a 
coating. By heating these polymers with di-alkyne linkers, cross-link formation was achieved 
without the need of a copper catalyst. The ratio between azide and alkyne groups was chosen 
carefully so that a significant number of azide groups remained within the polymeric 
network. These unreacted azides can be functionalized in a consecutive step, effectively giving 
rise to a clickable coating. Both CuAAC and SPAAC were employed in the functionalization
140 Conclusion
step. In contrast to the solution scenario, CuAAC offered very limited grafting density on the 
coating. The size of the coated substrate made it difficult to shield the reaction from air, 
leading to deactivation of the copper catalyst by oxidation. This problem was partially 
overcome by adding several batches of fresh copper during the functionalization step. Even 
so, SPAAC proved to be a far better method for functionalizing the coating. Whereas the 
grafting density achieved by SPAAC in solution was limited by the size of the conjugation 
moiety, on the coating the permeability of the peptide into the polymeric network was the 
limiting factor. Because the size of the conjugation moiety did not influence the diffusion of 
the peptide into the coating, SPAAC proved to be an effective functionalization method for 
the clickable coating.
The coating technology described above was subsequently used in two different 
applications. Firstly, the clickable coating was adapted for the construction of antimicrobial 
surfaces where the antimicrobial peptide gramicidin S was immobilized on the clickable 
coating using both CuAAC and SPAAC. However, neither CuAAC nor SPAAC afforded a 
bioactive coating with significant antimicrobial activity, but there are several prospects for 
improvement. The most important modification that needs to be explored is the length of the 
spacer molecule between gramicidin S and the coating. The spacer molecule could be 
important as it governs the ease with which the immobilized peptides can interact with the 
approaching bacteria.
Secondly, the use of clickable coatings was explored as a cost-effective and selective 
immobilization method for the production of an enzyme-linked immunosorbent assay 
(ELISA) against rheumatoid arthritis (RA). CuAAC and SPAAC were again both evaluated as 
potential methods. It was found that residual copper from the CuAAC functionalization 
interfered with the read-out of the final ELISA. SPAAC on the other hand, was successfully 
employed in the construction of an ELISA against RA. This result underlines the importance 
of functionalizing the clickable coating in a copper-free manner.
To conclude, a straightforward procedure for the synthesis of bioactive surfaces by 
coupling peptides to clickable coatings has been demonstrated. It was found that SPAAC is 
the preferable method for the functionalization step. The absence of a copper catalyst not only 
simplifies the procedure, it also leads to higher grafting densities and ensures that the 
obtained materials perform properly. The ease with which this technology was adapted for 
different peptides illustrates the modular nature of this coating technology. This strategy 
could therefore be extended to additional applications, such as catalytic surfaces and scaffolds 
for tissue engineering, and thereby become a valuable tool for advancing the use of 
biofunctional materials.
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